Quantification of Stem Cell Derived Cardiomyocyte Beating Mechanics using Video Microscopy Image Analysis by Ahola, Antti
4XDQWL¿FDWLRQRI6WHP&HOO
'HULYHG&DUGLRP\RF\WH
%HDWLQJ0HFKDQLFVXVLQJ
9LGHR0LFURVFRS\
,PDJH$QDO\VLV
$177,$+2/$
7DPSHUH8QLYHUVLW\'LVVHUWDWLRQV

Tampere University Dissertations 34
ANTTI AHOLA
Quantification of Stem Cell 
DerivedCardiomyocyte
Beating Mechanics using
Video Microscopy 
Image Analysis
ACADEMIC DISSERTATION
To be presented, with the permission of
the Faculty Council of Medicine and Health Technologies
of Tampere University,
for public discussion in the auditorium TB109
of the Tietotalo building, Korkeakoulunkatu 1, Tampere,
on 29.3.2019, at 12 o’clock.
ACADEMIC DISSERTATION
Tampere University, Faculty of Medicine and Health Technologies
Finland
Responsible 
supervisor
and Custos
Prof. Jari Hyttinen
Tampere University
Finland
Pre-examiners Prof. Risto Kerkelä
University of Oulu
Finland
PhD Marko Vendelin
Tallinn University of Technology
Estonia
Opponent Dr. Ing. Gunnar Seemann
University Heart Center Freiburg · 
Bad Krozingen
Germany
The originality of this thesis has been checked using the Turnitin OriginalityCheck 
service.
Copyright ©2019 author
Cover design: Roihu Inc.
ISBN 978-952-03-1006-6 (print)
ISBN 978-952-03-1007-3 (pdf)
ISSN 2489-9860 (print)
ISSN 2490-0028 (pdf)
http://urn.fi/URN:ISBN:978-952-03-1007-3
PunaMusta Oy – Yliopistopaino
Tampere 2019
iii 
ACKNOWLEDGEMENTS 
The studies presented in this thesis have been carried out during the years 2010-2018 
at BioMediTech and the Faculty of Biomedical Sciences and Engineering, as well as 
former Department of Electronics and Communications Engineering, and 
Department of Biomedical Engineering at Tampere University of Technology, 
Finland. 
Firstly, I would like to thank my supervisor, Professor Jari Hyttinen for his 
scientific guidance and unwavering support in all matters during these years. 
Working under him has allowed for growth as a researcher, with academic freedom 
to try and pursue different venues of research, while still providing the vision to keep 
this thesis project on track. Thank you for providing me with the chance to work in 
such an exciting field of science. I am very grateful to the thesis pre-examiners, 
Professor Risto Kerkelä MD, PhD; and Marko Vendelin, PhD for their careful 
evaluation. They provided valuable comments and constructive feedback, which 
greatly improved the thesis. I would especially wish to thank Professor Katriina 
Aalto-Setälä. Throughout the thesis work, she has encouraged me and reminded of 
the importance of the study, as well as guided my work. This has made me feel like 
a member of her own research group as well.  
I wish to express my gratitude to my former and present colleagues and staff at 
both Tampere University of Technology and University of Tampere. I have had the 
privilege of working with so many talented and supportive people, many of whom 
have become good friends as well. I greatly appreciate the contribution of all my co-
authors. In particular I would like to thank Anna Kiviaho, PhD, for the exciting first 
studies and findings in the field; Eeva Laurila, PhD, for all the shared learning 
experiences in commercialization endeavors; Markus Honkanen, PhD, for providing 
me with important technical background and expertise in image-based 
measurements; Paruthi Pradhapan, MSc, for the great co-operation in development 
of the analysis tool; and Risto-Pekka Pölönen, MSc, for providing essential 
understanding of cellular electrophysiology in the later parts of the thesis work and 
beyond. 
iv 
The works presented here have been made possible by various sources of 
funding. I am very grateful for the research grants received from the Finnish Cultural 
Foundation Pirkanmaa regional fund and Central fund, which represent the largest 
contribution to this thesis project. In addition, I want to thank for the funding 
received from the Human Spare Parts projects, funded by EU, Business Finland 
(former TEKES), Academy of Finland and the Council of Tampere Region as well 
as grants for finalizing the thesis from Faculty of Biomedical Sciences and 
Engineering, Tampere University of Technology. I also want to thank Business 
Finland for the funding related to development of the analysis tool, a project closely 
related to this thesis topic. Not only did these sources of funding motivate me to 
continue in this field, but also this thesis work would not have been possible without 
them.  
I warmly thank all my friends and family for continuous support. I cannot express 
my gratitude enough to my mother Pirjo, my father Kari, and my sister Akira. The 
love and support you have provided has laid a solid foundation for me to do this 
work. Finally, I want to thank my wife Reea for the love, care and understanding 
during the whole thesis work, all the while being a wonderful mother to our children 
Liina and Tiitus. You all bring love and joy to each and every day of my life. 
 
 
 
 
 
Tampere, January 2019 
Antti Ahola 
  
v 
ABSTRACT 
Until recently, the studying of human cardiac cells had been a difficult and to some 
extent dangerous task due to the risks involved in cardiac biopsies. Induced 
pluripotent stem cell technology enables the conversion of human adult cells to stem 
cells, which can be further differentiated to cardiac cells. These cells have the same 
genotype as the patient from whom they were derived, allowing the studying of 
genetic cardiac diseases, as well as the cardiac safety and efficacy screening of 
pharmaceutical agents using human cardiac cells instead of animal cell models. Using 
the stem cell derived cardiac cells in these studies, however, requires novel and 
specialized measurement methods for understanding the functioning of these cells. 
Long QT syndrome and catecholaminergic polymorphic ventricular tachycardia 
(CPVT) are genetic cardiac diseases, which can induce deadly arrhythmias. The 
induced pluripotent stem cell derived cardiac cells allow the studying of these 
diseases in laboratory conditions. A greater understanding of these diseases is 
important for prevention of sudden cardiac death, more accurate diagnosis, and 
development of possible treatment options. In order to understand the functioning 
of these cells, new methods are sought after. Traditionally, the electrical function of 
these cells are measured. However, the primary function of the cardiac cells is to 
beat in order to pump blood for circulation. The methods to quantify this mechanical 
function, the contraction and relaxation movement of cells, has been in lesser focus. 
The main objective of this work is to develop a measurement method, which 
allows the in vitro quantification of biomechanics of single human cardiac cells using 
video microscopy. The method uses digital image correlation to determine 
movement occurring in cardiac cells during contractile movement. The method is 
implemented in a software tool, which enables the characterization and 
parametrization of the cardiomyocyte beating function. The beating function itself 
can be affected by environmental factors, pharmacological agents and cardiac 
disease.  
Here, the quantification of mechanical function is performed using digital image 
correlation to estimate displacement between subsequent video frames. Velocity 
vector fields can then be used to calculate signals that characterize the contraction 
and relaxation movement. We estimate its accuracy in cardiac cell studies using 
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artificial data sets and its feasibility with concurrent electrical measurements. Cardiac 
diseases are studied by quantifying beating mechanics from Long QT and CPVT 
specific cell lines. Traditional electrophysiological measurements are used for 
validation and comparison. The interaction between calcium and contraction is 
studied with a simultaneous measurement of biomechanics and calcium imaging. 
This thesis resulted a new and accessible analysis method capable of measuring 
cardiomyocyte biomechanics. This method was determined to be non-toxic and 
minimally invasive, and found capable to be automated for high-throughput analysis. 
Due to not harming the cells, repeated measurements are enabled. Using the method, 
we observed for the first time abnormal beating phenotypes in two long QT 
associated mutations in single cardiomyocytes. Further, we demonstrated a 
concurrent calcium and motion measurement without background corrections. This 
provided also evidence that this combined analysis could be particularly useful in 
some cardiac disease cases. The methods and results shown in the thesis represent 
key early advances in the field. 
The method was implemented in a software tool, which enabled cell biologists to 
use it different stages of cardiomyocyte studies. Overall, the results of the thesis 
represent an accessible method of studying cardiomyocyte biomechanics, which 
improves the understanding of contraction-calcium coupling and paves way for 
high-throughput analysis of cardiomyocytes in genetic cardiac disease and 
pharmacological research. 
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TIIVISTELMÄ 
Viime aikoihin asti ihmisen sydämen solujen tutkiminen on ollut vaikeaa ja 
vaarallista, sillä näytepalojen ottamiseen sydämestä liittyy paljon riskejä. Menetelmä 
indusoitujen pluripotenttien kantasolujen tuottamiseen sallii aikuisten solujen 
muuntamisen takaisin kantasolumuotoon, josta ne voidaan vielä erilaistaa 
sydänsoluiksi. Näillä soluilla on sama geeniperimä kuin potilaalla, josta ne on 
johdettu. Tämä luo mahdollisuuden tutkia geneettisiä sydänsairauksia, ja sallii 
lääkeaineiden sydänturvallisuuden ja tehokkuuden tutkimisen käyttäen ihmisen 
sydänsoluja eläinkokeiden sijaan. Kantasolupohjaisten sydänsolujen käyttäminen 
näissä tutkimuksissa kuitenkin vaatii uusia ja erityisiä mittausmenetelmiä solujen 
toiminnan ymmärtämiseksi. 
Pitkä QT-syndrooma (LQTS) ja katekolamiiniherkkä polymorfinen 
kammiotakykardia (CPVT) ovat perinnöllisiä sydänsairauksia, jotka voivat aiheuttaa 
kuolemaan johtavia rytmihäiriöitä. Indusoiduista pluripotenteista kantasoluista 
johdettujen sydänsolujen avulla voidaan tutkia näitä sairauksia laboratorio-oloissa. 
Ymmärtämällä paremmin näitä sairauksia voidaan saavuttaa tarkempia diagnooseja 
ja kehittää mahdollisia uusia hoitomuotoja sydänperäisten äkkikuolemien 
estämiseksi. Uusia mittausmenetelmiä tarvitaan, jotta näiden solujen toimintaa 
voidaan tutkia. Näiden solujen toiminnallisuutta on perinteisesti tutkittu mittaamalla 
niiden sähköistä toimintaa. Sydänsolujen pääasiallinen tehtävä on kuitenkin 
mekaaninen: pumpata verta sydämestä verenkiertoon. Tätä solujen supistumista ja 
rentoutumista mittaavia menetelmiä on tutkittu vähemmän. 
Tämän väitöskirjan päämäärä on kehittää mittausmenetelmä, jolla voidaan 
määrittää yksittäisten ihmisen sydänsolujen biomekaniikkaa in vitro 
videomikroskopiaa käyttäen. Menetelmä käyttää digitaalista kuvien korrelaatiota 
määrittämään sydänsoluissa supistusliikkeen aikana tapahtuvan liikkeen. Menetelmää 
käytetään ohjelmistotyökalussa, jolla voidaan karakterisoida ja parametrisoida 
sydänsolun syketoimintaa. Syketoimintaan voi vaikuttaa niin ympäristötekijät, 
lääkeaineet kuin sydänsairaudetkin. 
Tässä väitöskirjassa sydänsolujen mekaanista toimintaa mitataan 
videomikroskopian avulla määrittämällä liikettä videon peräkkäisistä kuvista 
digitaalista kuvakorrelaatiota käyttäen. Saaduista nopeusvektorikentistä lasketaan 
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supistumista ja rentoutumista kuvaavia signaaleja. Arvoimme sen tarkkuutta 
sydänsolututkimuksissa käyttäen keinotekoisia tietoaineistoja ja sen soveltuvuutta 
yhtäaikaisilla sähköisillä mittauksilla. Tutkimme perinnöllisiä sydänsairauksia (LQTS 
ja CPVT) mittaamalla sykinnän mekaniikkaa yksittäisistä sydänsoluista, jotka ovat 
johdettu näitä sairauksia kantavien potilaiden kantasolulinjoista. Perinteisiä 
sähköfysiologisia mittauksia käytetään menetelmän validointiin ja vertailuun. 
Kalsiumin ja sykinnän vuorovaikutusta tutkitaan yhtäaikaisella biomekaniikan ja 
kalsiumaineenvaihdunnan mittauksella. 
Tämän väitöskirjan tuloksena saatiin aikaan uusi ja helposti lähestyttävä 
menetelmä sydänlihassolujen biomekaniikan tutkimiseen. Menetelmä ei ole soluille 
haitallinen ja se vaikuttaa solujen toimintaan perinteisiin menetelmiin verrattuna vain 
vähän. Se on automatisoitavissa suuria näytemääriä varten. Koska se ei vahingoita 
soluja, mittaukset voidaan myös toistaa samoilla soluilla. Tätä menetelmää käyttäen 
havaitsimme ensimmäisinä kahdesta eri LQT1-mutaatiota kantavista potilaista 
johdetuissa yksittäisissä sydänsoluissa poikkeavia sykintätyyppejä. Lisäksi, osoitimme 
yhtäaikaisen kalsiumin ja liikkeen mittauksen olevan mahdollinen ilman laskennallisia 
taustan korjauksia ja havaitsimme, että näin yhdistetystä analyysista voi olla erityistä 
hyötyä sydänsairauksien tutkimisessa. Väitöskirjassa esitetyt menetelmät ja tulokset 
edustavat alan tärkeitä ensimmäisiä edistysaskelia. 
Tätä menetelmää käytettiin väitöskirjan ohella tehdyssä ohjelmistotyökalussa, jota 
voidaan käyttää sydänlihassolujen tutkimuksen eri vaiheissa. Väitöskirjan tuloksena 
syntynyt helposti lähestyttävä menetelmä sallii sydänlihassolujen biomekaniikan 
analyysin. Sen avulla voidaan myös ymmärtää paremmin supistusliikkeen ja kalsiumin 
kytkentää. Kokonaisuutena, väitöskirja luo pohjaa sydänlihassolujen suurten 
näytemäärien analyysille sydänsairauksien ja lääkeaineiden tutkimuksessa. 
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1 INTRODUCTION 
Cardiovascular diseases present a major cause of mortality and chronic disability in 
the world 1. Greater understanding of the heart, cardiac diseases and cardiac function 
paves way for new and more efficient options for treatment and prevention of 
cardiac disease. Studying the functioning of cardiac cells has previously been difficult 
due to the high risks involved in cardiac biopsies. These studies have become 
considerably easier with the advent of induced pluripotent stem cells, which allow 
the derivation of patient specific cardiac cells from somatic cells from a number of 
tissue types, such as skin or blood samples, and culturing them in laboratory 
conditions towards cardiomyocytes 2,3. These patient specific cell lines retain the 
same genotype as the cell donor, making it possible to study the cells in laboratory 
conditions. Analyzing in vitro cellular disease models derived from carriers of genetic 
cardiac diseases can help to understand the disease mechanisms and assess the risk 
of individuals developing symptoms. As the first symptom of such disease, for 
instance long QT syndrome, can be sudden cardiac death, it is difficult for a 
physician to evaluate possible treatments for an otherwise asymptomatic carrier of 
the gene defect. 
In pharmaceutical studies, it is essential to determine the adverse effects of 
pharmaceutical agents as early as possible, since drug discovery and development is 
expensive and the costs are increasing at a rapid annual rate 4. Cardiac side effects 
are among the leading causes of drug market withdrawal 5,6. Cancer drugs in 
particular have a greater risk of affecting cardiac function 7. Stem cell derived 
cardiomyocytes have provided alternatives to animal testing, which not only causes 
suffering for the animals, but is also time consuming and expensive. Further, the 
results obtained with animal models do not necessarily translate well to the human 
physiology due to differences in species 8. Thus, there exists a substantial need in 
drug research to develop new, effective methods capable of screening large numbers 
of substances for abnormal cardiac function. Eliminating substances which cause 
adverse effects, in as early phase as possible shortens the drug development time and 
lowers the related expenses. 
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Previously, the in-vitro analysis of cardiomyocytes has focused mainly on the 
electrophysiological measurements, such as patch clamp, microelectrode arrays and 
calcium imaging 9. While these methods provide a detailed and accurate view on 
cardiomyocyte functionality, they are typically either invasive - such as patch clamp, 
toxic – such as calcium imaging, or do not provide detailed information on single 
cells, as has previously been the case with microelectrode arrays. In addition, they do 
not describe the primary function of cardiac cells – contraction and relaxation 
processes which pump blood through the circulatory system.  
The biomechanical side of the cardiomyocyte function has been less in focus, 
partly due to the lack of easily implementable in vitro methods. These 
mechanobiological measurements have been previously done using methods such as 
atomic force microscopy 10 and mechanical transduction platforms, such as 
microposts 11. However, they are not typically well suited for high-throughput 
applications as they are labor intensive or require specific measurement platforms. 
The quantification of the beating motion in vitro from video microscopy has been 
demonstrated briefly to provide information on the cardiomyocyte biomechanics 
without using labels or probes in live cell imaging, or without external 
instrumentation 12. 
The general aim of the thesis is to develop a video microscopy-based method 
capable of characterizing the cardiomyocyte biomechanics on a single dissociated 
cell level, and to quantify the abnormal biomechanics observed in cell models of 
genetic cardiac diseases. At the time of the beginning of the study, adult and 
embryonic stem cell derived cardiomyocytes had been studied using similar methods. 
Induced pluripotent stem cell derived cardiomyocytes, however, had not yet been 
characterized, and we were among the first to measure the biomechanics of these 
cells using video image microscopy. These cells have immature cellular physiology, 
which influences their contractile function 13. During the course of the thesis work, 
video microscopy analyses of cardiomyocytes were conducted also by different 
groups in addition to us 12,14–18. In their studies, they analyzed the effects of various 
different pharmacological agents on cardiomyocyte beating using video microscopy 
based methods. Different software tools have also been developed by these groups. 
Thus, the field of study presented in this thesis was – and still is – a topical subject 
and very pertinent to the understanding of cardiomyocytes. Based on our findings 
and the results obtained by the other groups, video microscopy based methods can 
be regarded as a feasible option for high-throughput analysis of cardiomyocytes. 
The main, and start hypothesis regarding the thesis is that stem cell derived 
cardiomyocyte beating mechanics can be quantified accurately on a single cell level 
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with video-based methods, specifically minimum quadratic difference based particle 
image velocimetry. In this thesis, we aim to study the feasibility of calculating velocity 
vector fields from consecutive video frames to determine contraction and relaxation, 
and validate the method using artificial data sets and concurrent electrophysiological 
measurements, such as patch clamp and calcium imaging. Patch clamp represents 
the gold standard in cellular electrophysiological measurements, whereas calcium 
imaging provides a view on cellular calcium exchange, a key aspect of contraction. 
We aim to assert that video-based analysis of cardiomyocyte biomechanics combined 
with other measurement methods can provide a detailed and comprehensive view 
on the cardiomyocyte functionality. 
The validation of the video measurement is done using healthy control cell lines 
and artificial data by assessing the results in conjunction with traditional 
electrophysiological measurements of cardiomyocytes. Based on the visual 
observation of abnormal mechanical manifestations in cardiomyocytes derived from 
disease specific stem cell lines, we hypothesize that the method can be used for 
characterizing different beating phenotypes rising from abnormal electrical function 
in genetic cardiac disease. Long QT syndrome and CPVT are studied using the 
developed method: cardiomyocytes derived from patient specific stem cell lines are 
measured and characterized. The obtained results are again compared with results 
obtained using traditional electrophysiological measurements. During the studies, 
the question of optimal recording parameters and requirements for videos became a 
topical subject as the method accuracy depends greatly on the recording of video 
microscopy data. We hypothesize that using multiple comparable data sets with 
different variables of interest the effect could be quantified. High quality video 
recordings were performed and by gradually decreasing the measurement length and 
frame rate, different data sets were obtained. We aim to answer if a concurrent 
contraction-calcium measurement without fluorescence corrections can be achieved 
using the method to increase the understanding of cardiomyocyte calcium-
contraction coupling. A measurement is performed in a setting consisting of 
alternating frames of fluorescence imaging and brightfield microscopy, allowing the 
measurement of both signals individually and together to achieve this aim. In 
addition to these aims, a software tool is developed alongside the research for 
biologists to use in assessing cardiomyocyte biomechanics in different stages of 
research. 
Together, these objectives will allow us to demonstrate the feasibility of video 
microscopy-based analysis of cardiomyocyte biomechanics in vitro. 
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2 REVIEW OF LITERATURE 
2.1 Anatomy of the human heart and cardiac cells 
The human heart contracts and relaxes periodically to pump blood in the blood 
vessels of the circulatory system. This pumping action delivers blood to and from all 
the body. The human circulatory system consists of two parts. In the systemic 
circulation, oxygenated blood and nutrients are transferred to tissues and organs in 
arteries, and metabolism waste products are transferred out of them in veins. In 
pulmonary circulation, carbon dioxide is released in the lungs and oxygen enters the 
blood. 
The heart is a muscular organ, covered by a protective pericardial sac. The heart 
consists of four chambers: left and right atria, and left and right ventricles, with the 
left and right halves of the heart separated by septum. The blood flow within the 
heart is controlled by valves, located between the atria and ventricles on both sides 
and between the atria and main blood veins. The heart wall consists of three layers: 
myocardial, pericardial and endocardial layers, depicted in Figure 1. Myocardium 
forms the main layer consisting of groups of spirally oriented cardiac muscle fibers. 
This layer performs the main function of the heart, being capable of contracting and 
relaxing. Pericardium represents the outermost layer, which protects the heart. It 
consists of a fibrous layer and a serous layer, which in turn consists of parietal layer, 
pericardial cavity, and visceral layer, known as epicardium. The innermost layer, 
endocardium is layer of connective tissue, which lines the heart chambers and covers 
the valves. 19 
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Figure 1.  An illustration of the anatomy of heart wall and myocardial tissue. The heart is covered with 
a protective pericardial sac consisting of fibrous and serous layers. The serous layer is 
composed of a parietal and a visceral layer, which surround the pericardial cavity. 
Myocardium performs the contractile function of the heart. Endocardium lines the inner 
surface of the heart. The myocardial tissue contains cardiomyocytes, striated cardiac 
muscle cells that may contain up to two nuclei, connected to each other by intercalated 
discs. 
Adult mammalian cardiac tissue in myocardium illustrated in Figure 1 consists of 
numerous cell types. Striated cardiac muscle cells - cardiomyocytes (CM) – account 
for 70-85 % of heart volume, while still representing only 25-35% of the number of 
cells in the heart. The composition of non-myocyte cell population, consisting of 
fibroblasts, endothelial cells, leukocytes, smooth muscle cells and pericytes, has been 
a point of debate. Previously, cardiac fibroblasts had been considered the largest 
group. However, this view has been challenged recently by Pinto et al., who showed 
that endothelial cells are the most numerous non-myocyte cell type. 20,21. Typically, a 
ventricular CM is 50-150 μm long and 10-20 μm wide whereas atrial CMs are slightly 
smaller 22. The cells contain 1-2 nuclei and a proportionally large number of 
mitochondria. The bulk of the cell consists a bundle of long myofibril strands, which 
create the contractile force. Adjacent CMs are connected to each other longitudinally 
via intercalated discs, native only to cardiac muscle cells. The discs contains three 
intercellular junctions: desmosomes, adherens junctions and gap junctions. 
Additionally, the discs contain proteins such as Coxsackie virus and adenovirus 
 22 
receptor (CAR) protein, Claudin-5, and zonula occludens-1, which are associated 
with tight junctions, intercellular junctions associated with epithelial cells 23.  
Desmosomes keep the cells from detaching from each other during contraction. 
Adherens junctions transmit power between adjacent cells, and serve as end points 
for myofibrils. Gap junctions can transport ions, and thus serve as the electrical 
connection between each CM, allowing the cells to function together in a syncytium. 
The CAR protein in CMs facilitates the propagation of excitation from atrium to 
ventricle. 19,23–25 Figure 2 illustrates the organization of the cell organelles. 
 
Figure 2.  An illustration of cardiac cell and its structure at different magnifications. The bundle of 
myofibril strands is encapsulated by the sarcolemma and connected to another cell via the 
intercalated disc. The cells have a high number of mitochondria. A single myofibril consists 
of multiple sarcomeres connected by Z-discs. The sarcomeres are composed of thin and 
thick filaments. 
Each myofibril strand consists of sarcomeres, longitudinal units connected in series 
with each other. Sarcomeres are separated from each other by Z-discs, to which they 
are anchored. In addition to the structural task, Z-discs are involved in sensing 
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stretching and in signaling 26. Each sarcomere can further be divided into thin actin 
and thick myosin filaments, forming the basic contractile unit of the cell, as illustrated 
in Figure 2.  The thick filaments (approximately 1.5 μm in length) are surrounded on 
six sides by thin filaments (approximately 1 μm in length). A thick filament consists 
of two myosin heavy chains (MHC) and two myosin light chains (MLC 1 and MLC 
2). Thin filaments consist of actin polymers, tropomyosin and troponin (with its 
subunits troponin C, I and T). 22,25 Together, these form sarcomere lines, bands and 
zones, determined based on microscopy in contracted and relaxed states. A-band 
indicates the location of thick filaments, I-band indicates the location of thin 
filaments without overlapping thick filaments, H-zone the subregion of A-band with 
no overlapping thin filaments, M-line the center of A-band, and Z-disc at the ends 
of thin filaments (and sarcomeres). At Z-discs, the thin filaments are separated by 
actin binding protein D-actinin. M-line serves to hold together the thick filaments. A 
third filament, titin, is a giant protein that connects the Z-disc with the M-line, 
holding the structure together. It also has spring like properties, which help the cell 
to return to its relaxed state. 26 The process of contraction and force generation is 
described in 2.2.4. 
2.2 Cardiac electrophysiology and mechanobiology 
2.2.1 Electrical activity of the whole heart 
In order for the different areas of the heart to contract and relax in unison, a 
mechanism of rapid activation is required. CMs can be roughly divided into 
pacemaker cells, which spontaneously create electrical activity and work cells, which 
generate the force. The electrical activity consisting of depolarization and 
repolarization of the cell membranes normally begins in pacemaker cells in sinoatrial 
(SA) node. Being the fastest of the excitatory cells, the SA node sets the beating 
rhythm for the whole heart. The activity then propagates through gap junctions 
between cells, through the atria to the atrioventricular (AV) node. The AV node 
delays the propagation of the impulse, in order for the atria to contract before the 
ventricles. From the AV node, the impulse spreads to AV bundle, which serves as 
an electrical connection between the atria and the ventricles. Next, the activity splits 
to left and right bundle branches, which go along the setup all the way to the apex 
of the heart, reaching finally the Purkinje fibers. The fibers are long strands of few 
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myofibrils, which spread the impulse throughout the ventricles. While SA node acts 
as the primary pacemaker, AV node and the ventricular system can act as accessory 
pacemakers in the case of SA failure or AV block. 24 
The electrophysiological functioning of the whole heart can be measured and 
monitored using electrocardiogram (ECG). Typically used 12-lead ECG is recorded 
to measure the action potentials of the atrial and ventricular CMs on the surface of 
the body using electrodes. In an ECG trace, the resting membrane potentials of the 
CMs are represented as the baseline, with each deviation is denoted with a letter, as 
illustrated in Figure 3. 27 
 
 
Figure 3.  Normal ECG, with deviations from baseline defined with specific letters. P wave denotes the 
atrial depolarization, QRS complex the depolarization of ventricles and T wave the 
repolarization of ventricles. QT time signifies the time from ventricular depolarization to 
ventricular repolarization. 
P wave denotes the depolarization of the atrial cells. The potential of atrial 
repolarization is typically too low to be detected using with surface electrodes, even 
if the depolarization of ventricles was delayed. The following Q, R and S waves form 
the QRS complex, which represents the depolarization of ventricles. The ventricular 
repolarization can be seen on ECG, and is represented by the T wave. 22,27,28 
The main time intervals of interest between waves are PQ, ST and QT –intervals. 
The PQ –interval is mostly due to the slow conduction in AV node. During ST 
segment, the ventricular CMs are depolarized. The QT interval is the period from 
the beginning of ventricular depolarization to the end of ventricular repolarization 
24. As the intervals change as a function of heart rate, a measure of corrected QT 
(QTc) interval is calculated to normalize it using one of several methods, such as 
Bazett’s formula and Fridericia’s formula, where the QT interval is divided by the 
square or cubic root, respectively of the preceding interval of R peaks in seconds. 29 
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2.2.2 Cardiac action potential 
On a cellular level, this electrical propagation process is established with cardiac 
action potential (AP).  During an AP, the cell goes through different phases, during 
which different ions flow through the cellular membrane via ion channels. The most 
important ions related to cardiac action potential are sodium, potassium and calcium. 
With no activity, there is an electrical potential difference, transmembrane potential 
between the inside and the outside of the cell, called the resting potential. The shape 
and magnitude of the AP depend on which region of the heart the CM is located, as 
illustrated in Figure 4.  
 
Figure 4.  The phases of cardiac action potential waveforms in A) ventricular cells, B) atrial cells and 
C) pacemaker cells. The ventricular-type CMs exhibit a more square-shaped AP with a long 
plateau phase, whereas the shape of atrial AP is triangular. The shape of AP in pacemaker 
cells do not feature the same phases as the atrial and ventricular APs, such as the high 
peak associated with phase 1. 
The phases for an AP in atrial and ventricular CMs are described in detail below. 30,31 
Phase 4. The cell is at the resting potential (about -90 mV), maintained by 
different ion pumps and mechanisms working against the 
electrochemical gradient, and the inward rectifying K+ current IK1 due 
to K+ ions leaving the cell. The Na+ and Ca2+ channels remain closed. 
Phase 0. An action potential reaches the cell and when the transmembrane 
potential reaches the threshold potential (about -75 mV) it starts rapidly 
depolarizing due to the activation of rapid inward Na+ current through 
voltage-gated Na+ channels. The rectifying K+ channels close, stopping 
IK1. 
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Phase 1. The early repolarization begins, due to the closing of rapid voltage-gated 
Na+ channels and opening of transient outward K+ channel current, 
composed of transient outward current Ito1 and in atria, the ultra-rapid 
current IKur. This causes the transmembrane potential to decrease, 
creating a notch in the AP. The depolarization of the membrane 
activates the voltage-gated L-type Ca2+ channels.  
Phase 2. Transmembrane potential reaches a plateau phase, due to the inward 
flow of Ca2+ ions ICaL through L-type Ca2+ channels and the delayed 
outward rectifier K+ current, composed of currents flowing through the 
rapidly (IKr) and slowly (IKs) activating K+ channels, balancing out each 
other. 
Phase 3. When the voltage dependent L-type Ca2+ channels close, the delayed 
outward K+ currents dominate, starting the repolarization of the cell. 
The L-type Ca2+ channels inactivate mainly due to the release of Ca2+ 
from SR. Inward rectifying current IK1 opens (at about -20 mV), and 
the cell finally reaches its resting membrane potential and returns to 
phase 4. 
The APs in human SA node, AV node and other excitatory system CMs are less 
steep in contrast to atrial and ventricular CMs: the pacemaker AP is more triangular 
in shape, as they are missing phases 1 and 2 and the associated rapid membrane 
voltage changes. In addition, phase 4 is not stable as they are constantly depolarizing 
due to the influx of N+ as an effect of various currents. The process is described 
below in phases: 
Phase 4. As the cell is hyperpolarized at the end of repolarization, the pacemaker 
current channel (If, funny current) opens, playing a major role in the 
initiation of the depolarization along with slow T-type Ca2+ channels. 
This depolarization brings the cell to a threshold potential and 
eventually reaches phase 0 by itself, or alternatively, when an external 
depolarization reaches the cell. 
Phase 0. The cell membrane reaches threshold potential at about -40mV, which 
opens L-type Ca2+ channels, further depolarizing the membrane as 
more Ca2+ ions flow in. 
Phase 3. As the inward Ca2+ current reverses the transmembrane potential, K+ 
leakage channels open, increasing the outward K+ currents. L-type Ca2+ 
channels close. This causes the cell to repolarize and return to its 
unstable resting potential. 
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The pacemaking If current can also be activated by cyclic nucleotides, allowing the 
cell to depolarize faster than its intrinsic rhythm. 32,33 
2.2.3 Excitation-contraction coupling 
Cardiac excitation-contraction coupling is the process, in which electrical stimulus is 
relayed to mechanical contraction. The main driving force for contraction of a CM 
is the influx of Ca2+ ions through L-type Ca2+ channels during phase 2 of the AP. 
Ca2+ concentrations are maintained by the electrochemical gradient and L- and T-
type voltage dependent Ca2+ channels, located near sarcolemmal-sarcoplasmic 
reticulum (SR) junctions. The influx of Ca2+ causes SR - smooth endoplasmic 
reticulum in myocytes for regulating Ca2+ ion concentration in cytoplasm - to further 
release Ca2+ into intracellular matrix in a process known as calcium-induced calcium 
release (CICR) through ryanodine receptors (RyR). This interaction increases the 
local concentration of Ca2+, which regulates further influx of Ca2+. The free Ca2+ 
binds to the protein troponin C within actin filaments, causing the contraction to 
occur. In order for the cell to return to relaxed state, it is necessary for the 
intracellular Ca2+ ion concentration to decline, allowing the bound Ca2+ to dissociate 
from troponin. Due to the concentration gradient, adenosine triphosphate (ATP) is 
required for removing Ca2+ from cytosol. The pathways involved lowering the 
concentration are Ca2+-ATPase in SR, Na+/Ca2+ exchange and Ca2+-ATPase in 
sarcolemma, and Ca2+ uniport in mitochondria. During diastolic depolarization, 
oscillatory local SR Ca2+ release events occur. Thus, in addition to the ionic currents, 
Ca2+ released from SR spontaneously participates in the pacing of the cell. It has 
been shown that these release events are independent of the membrane potential, 
indicating that there is a Ca2+ clock that participates in the initiation of the AP. 34,35 
In CICR, the amount of released Ca2+ is greater than the triggering influx of Ca2+ 
in humans. The ratio of the released Ca2+ and the amount of Ca2+ due to influx is a 
measure of excitation-contraction coupling efficiency. 36,37 A number of proteins, 
such as RyR, related to excitation-contraction coupling are located in the vicinity of 
transverse tubules, or T-tubules, which are small infoldings of the surface membrane. 
While the majority of T-tubules are near Z-discs, T-tubules form an extensive system 
which has branching tubules in both axial and transverse directions of the CM. This 
tubular network is essential to the spatially and temporally synchronous release of 
Ca2+ in the cell. 38 
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2.2.4 Force production and contractility 
The myosin-actin interaction in force generation is explained in a cross-bridge cycle 
model, which refined the original sliding filament theory. In the cross-bridge model, 
the proteins involved in the process undergo a number of conformational changes 
in a cycle. When the cell is relaxed, tropomyosin is bound to actin, inhibiting myosin 
from binding to actin. When Ca2+ molecules bind to troponin C in actin filaments, 
tropomyosin changes its position so that myosin binding sites are revealed, allowing 
myosin to bind to the thin filament. Myosin segments with attached adenosine 
diphosphate (ADP) and phosphate molecules move to bind with an actin binding 
sites, releasing the phosphate molecules. Myosin then spends the ADP to generate a 
power stroke, which pulls the actin filament. This increases the overlap of thick and 
thin filaments, decreasing the sarcomere length. The myosin segment can then bind 
ATP, which allows myosin and actin to detach. ATP is subsequently broken down 
in hydrolysis to ADP and a phosphate molecule, and myosin returns to its resting 
position. Relaxation requires ATP, as actin remains bound to myosin. This cycle 
repeats itself as long as a required Ca2+ concentration is present in the cell, keeping 
the tropomyosin-troponin complex from inhibiting myosin binding. 39 
The force expressed by the CM is dependent on the Ca2+ bound to troponin C, 
which in turn is dependent on the total Ca2+ ion concentration, i.e. free intracellular 
Ca2+ and the buffered Ca2+ is further dependent on the amplitude and duration of 
the Ca2+ transient, the number of myofilaments that can participate in contraction, 
their sensitivity to Ca2+, as well as the strength of Ca2+ binding 40. As a myofilament 
is stretched, it becomes more sensitive to Ca2+ and creates a stronger contraction. 
Further, sensitivity can be increased by caffeine and drugs. Sensitivity of force 
generation to Ca2+ concentration can decrease under certain conditions, such as 
ischemia, as the process needs ATP and is dependent on the energy available. Thus, 
the dependence of force on Ca2+ ion concentration is not linear. 41 The force is also 
dependent on the overlap ratio of thick and thin filaments, which determines the 
sarcomere length, and the aforementioned factors. Optimally, the sarcomere length 
is about 2.2 μm, with lower or higher distances decreasing the strength of 
contraction. 39 Along with the intracellular Ca2+ concentration, the rate at which Ca2+ 
ions detach from troponin C regulates the relaxation of the cell. As the Ca2+ pumps 
require energy to function, fluctuations in ATP levels can slow down the process. 22 
Methods used in measuring CM contractility are presented in section 2.7. 
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2.3 Cardiac arrhythmias on cellular level 
2.3.1 Abnormal electrophysiological phenomena in cardiac cells 
The mechanisms of cardiac arrhythmias related to single cells can be divided into 
two categories: disorders in impulse formation and disorders in impulse conduction. 
Whereas the disorders in impulse formation occur mostly at cellular level, the 
disorders in impulse conduction occur predominantly at macro level, including issues 
such as blocks in conduction and impulse reentry. Impulse formation disorders 
include altered normal automaticity, abnormal automaticity and triggered activity. 
Altered normal automaticity may occur when another pacemaker site takes priority 
over SA node. Abnormal automaticity occurs when non-pacemaker cells reach their 
threshold potential without a stimulus, for example due to an increase in extracellular 
K+ or changes in K+ channel activity. Triggered activity includes abnormal electrical 
activity that occurs after an initial impulse has already been generated within the cell. 
42,43 
Triggered activity is the underlying mechanism behind most ventricular 
arrhythmias. It can be divided into early afterdepolarizations (EAD) and delayed 
afterdepolarizations (DAD). EADs are depolarizing oscillations occurring during AP 
plateau at potential higher than -30mV (phase 2) or late repolarization at lower 
potentials (phase 3), whereas DADs occur after a full repolarization. If an EAD or 
DAD is sufficiently large and brings the membrane potential to a threshold, it may 
result in a spontaneous AP referred to as triggered activity. 42,44  
During the plateau phase in AP, membrane potential is maintained by the balance 
of inward and outward currents. A number of different factors can change ionic 
balance and bring forth arrhythmic events, with the major currents being L-type Ca2+ 
current and Na+-Ca2+ -exchanger current. Typically, EADs may occur when the AP 
is prolonged in such a way that the voltage-dependent calcium current through L-
type Ca2+ channels can recover from inactivation and cause another upstroke. In the 
repolarization phase 3, the EADs may occur due to a reduced K+ influx, or due to 
partially recovered Na+ current. In ECG, this can be seen as QT prolongation, 
associated with long QT (LQT) syndrome (LQTS). When sustained, EADs can lead 
to Torsade de Pointes, a ventricular tachyarrhythmia. 42,45,46 
The mechanism behind DADs is closely related to cellular Ca2+ loading. In an 
abnormal case, spontaneous RyR2 opening during diastole causes a transient inward 
current, primarily (and possibly solely in humans) due to the activation of the Na+-
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Ca2+ exchanger. If the current is large enough, it may cause a DAD. 47 There are 
various conditions which may increase the probability of RyR2 opening, including 
an overload of Ca2+ within SR 48,49. Ca2+ overloading can be facilitated by digitalis, 
β-adrenergic receptor stimulation by catecholamines and low extracellular K+ 50. In 
catecholaminergic polymorphic ventricular tachycardia (CPVT), the mutations may 
increase the probability of RyR channel opening, causing DADs and arrhythmias. 
The abnormality of Ca2+ exchange has only limited effect on excitation-contraction 
coupling, as the patients do not suffer from arrhythmias in baseline conditions. As 
the release process of Ca2+ from SR is auto-regulated, compensatory mechanisms 
are capable of normalizing the coupling. When the auto-regulation cannot 
compensate sufficiently, abnormalities in the form of DADs and arrhythmias 
become more apparent. 51 
LQTS and CPVT are two genetic cardiac diseases studied in this thesis, described 
in 2.3.2 and 2.3.3. Cellular models of these diseases are described in section 2.4.5. 
2.3.2 Long QT syndrome 
 
LQTS is an inherited or acquired cardiac disorder. It is typically characterized by 
lengthening of the QT interval and T wave abnormalities on ECG. It represents an 
elevated risk for Torsade de Pointes, syncope, and sudden cardiac death. 52 
LQTS is caused by genetic or acquired factors 53. In its congenital form, there are 
three major (LQT1-LQT3) and 10 minor (LQT4-LQT13) LQTS susceptibility 
genotypes. Additionally, there are three genotypes with atypical LQTS or 
multisystem disorders associated with prolonged QT time. 54 The three major 
genotypes (KCNQ1, KCNH2 and SCN5A, respectively) account for the greatest 
majority (75-90%) of all LQTS cases 55,56. Normally, a QTc interval is less than 440 
ms in males and 450 ms in females. In LQTS, the interval is defined to be greater 
than 450-460 ms in males and 460-470 ms in females, depending on classification of 
borderline cases 54,57. Usually, arrhythmias are associated with a QT interval of 500 
ms. 57  
In LQT1, the most common subtype of LQTS, the gene KCNQ1 responsible 
for the encoding the primary subunit of the Kv7.1 channel protein is mutated. The 
subunit generates the slowly activating component of the delayed rectifier K+ current 
IKs. Its proper function is essential to the shortening of the QT interval in increased 
heart rates, as a reduction in the current reduces the repolarization capacity of the 
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cell. In the KCNQ1 sequence, hundreds of different LQTS causing mutations have 
been found, and the number is growing 58. In this thesis, two Finnish founder 
mutations G589D and ivs7-2A>G, located at the C-terminal domain of KCNQ1, 
are considered. The loss-of-function mutation in KCNQ1 can thus cause cardiac 
events during physical or emotional stress when the heart rate is high. 54 
2.3.3 Catecholaminergic polymorphic ventricular tachycardia 
CPVT is an inherited cardiac disorder. Its typical characteristics include stress-
induced bidirectional and polymorphic ventricular tachycardia in structurally healthy 
heart. It may cause syncope and sudden death at a young age, with a 30-35% 
mortality rate when untreated. The resting ECG for CPVT patients is normal and 
alterations can only be seen during exercise or intense emotion 59–61. During exercise, 
premature ventricular contractions may occur, followed by bidirectional or 
polymorphic ventricular tachycardia.  
There are a number of CPVT subtypes, with the number of types being a matter 
of debate. Initially, autosomally dominant RyR encoding gene RYR2 in chromosome 
1q42-q43 was recognized as a cause of CPVT phenotype. 60,62,63 As previously 
described in 2.2.3, RyR encodes a Ca2+ release channel in SR. CPVT has been also 
shown to be caused by a mutation in the autosomally recessive calsequestrin 2 
encoding gene CASQ2, which serves as a Ca2+ store in SR 64. Later, a mutation in 
gene TRDN, responsible for encoding triadin - a transmembrane protein in SR - has 
been shown to cause CPVT 65. Another cause of CPVT has been shown to be a 
mutation in the gene CALM1 which encodes calmodulin, an accessory protein of 
RyR 66. RYR2 mutation represents the most common subtype of CPVT. 
2.4 Stem cells 
2.4.1 Stem cell hierarchy and classification 
Unlike somatic cells, stem cells are cells capable of differentiating into specialized 
cells and proliferating almost indefinitely. Their potency differs depending on the 
phase of development. The most potent stem cells, totipotent stem cells, can be found 
in fertilized oocytes and the first few days of the embryonic development. They can 
differentiate into all cells of the organism, including extraembryonic structures such 
as the placenta. Later in blastocyst phase, the cells can be divided into two categories: 
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the outer trophoblast cells and the inner cells. The stem cells of the inner cell mass 
can differentiate into all cell types of the actual embryo, and thus they are called 
pluripotent stem cells (PSC). In adults, stem cells are multipotent and can repair damage 
by replacing dead and lost cells based on their location, e.g. small intestinal stem cells 
can differentiate into the principal cell types of its epithelium: paneth, goblet, 
absorptive columnar and enteroendocrine cells. Previously, it was believed the cells 
could only become more differentiated, and thus lose their potency. In the last 
decade, it has been shown to be possible to induce pluripotency in cells and thus 
caution should be exercised with strict classification of these cells. 67–69 
Due to their properties, PSCs have various applications in regenerative medicine, 
understanding diseases and drug studies. First human embryonic stem cell (ESC) 
lines in 1998 from the blastocyst inner cell mass 70. However, there are various ethical 
and moral issues with the derivation of PSC lines from oocytes and embryos 71. 
The ethical issues were circumvented using an alternative solution to procuring 
PSCs: somatic cells were reprogrammed to regain their pluripotent state, first in mice 
69 and then in human cells 72,73, resulting in induced pluripotent stem cells (iPSC). In 
the study by Takahashi et al., four transcription factors (OCT3/4, SOX2, KLF4, and 
c-MYC) were introduced to a colony of adult human dermal fibroblasts using 
retroviral transfection 72. In the study by Yu et al., another set of four transcription 
factors (OCT4, SOX2, NANOG, and LIN28) were cloned into a lentiviral vector 
and used to induce pluripotency 73. As the iPSCs are adult cells that have been made 
pluripotent, they allow the generation of individual- and patient specific cell lines 
72,73. 
2.4.2 Stem cell induction 
There are a number of main factors that have an effect on the induction: the 
transcription factors, the methods used to deliver the factors to cells, the original cell 
type and culturing conditions 74. There have been various alternative approaches to 
inducing pluripotency, with different efficiencies and advantages 75. 
As the first two studies by Takahashi et al. and Yu et al. showed, variation in the 
transcription factors used in inducing pluripotency is possible. It has further been 
shown, that the combination of the aforementioned six transcription factors 
increases efficiency 76. The factors required for inducing pluripotency are dependent 
on the cell type, as endogenous gene expression can be used to compensate: for 
example, melanocytes express Sox2 endogenously and thus ectopic Sox2 is not 
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needed 77. Further, by only using OCT4 human neural stem cells can be converted 
to iPSCs 78. Small molecule compounds present an option for altogether replacing 
the factors. Instead of introducing exogenous genes into cells, small molecule 
compounds are used. The number of required genes had previously been reduced 
using the compounds, but Oct4 remained necessary up until Hou et al. managed to 
chemically induce pluripotency using only 7 small molecule compounds in mice 79,80. 
Entirely small molecule based reprogramming for human cells remains yet to be 
discovered. 
Retro- and lentiviruses were used in the first iPSC studies for transferring the 
transcription factors. The delivery method has been shown to affect the 
differentiation 81. Additionally, when using the more efficient integrative methods, 
there is a risk of integrating viral transgenes into the genome of the cell and ultimately 
resulting in tumorigenicity. The use of other viral delivery methods, such as 
adenoviruses or sendai viruses, is less efficient, but does not have the risk of 
integration 82,83. Further, non-integrative methods have been shown to produce 
iPSCs with greater resemblance to fully reprogrammed pluripotent state 75.  
Non-viral methods include using plasmids 84, minicircle vectors 85, RNA and 
proteins such as cell-penetrating peptides 86. Although plasmids do not require 
sophisticated laboratories, further studies are needed to improve their efficiency. 
Minicircle vectors have a greater efficiency, but when compared to other non-
integrating methods, they require technology that is more complicated. Synthetic 
RNA based methods are efficient, non-integrating and non-mutagenic, but the 
RNAs are difficult to generate in laboratories. Although protein based methods 
would provide control over the reprogramming procedure, they have thus far had 
problems with efficiency and production and it is not definitely known, if they can 
be used for adult cells. 79 
The first human iPSC studies were done using dermal fibroblasts 72,73. After that, 
a multitude of cell types have been used for deriving human iPSCs, including 
hematopoietic, amniotic fluid, adipose, dental pulp and urinary cells 74. The 
reprogramming efficiency differs between cell types, as keratinocytes have been 
shown to be 100 times more efficient than skin fibroblasts, and reprogramming time 
was two times faster 87. Additionally, the induced cells may retain epigenetic memory, 
which may affect the direction in which they eventually differentiate, favoring their 
original cell type. For example, iPSCs derived from blood cells differentiate easier 
towards hematopoietic cells 81. This behavior can be eliminated by continuous 
passaging of the cell line and suggests that iPSCs can lose their inherited 
characteristics over time 88. 
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Reprogramming efficiency and quality can be improved by optimizing the 
culturing conditions. By introducing growth factors, such as fibroblast growth factor 
or human leukemia inhibitory factor, differentiation can be inhibited and long-term 
culturing enabled. Hypoxia has been shown to increase the efficiency 74,89. 
2.4.3 Cardiomyocyte cell cultures and cell lines 
Studying CMs in vitro had been until recently, a daunting task. A cardiac biopsy is a 
risky procedure, and maintaining the colony is challenging as the cells start to 
dedifferentiate 90. Previously, CMs have been differentiated from human ESC lines, 
which provided not only a powerful tool for studying CM development and 
function, but also for using them in pharmacological testing 91. With the discovery 
of iPSCs, it became possible to create human iPSC (hiPSC) lines and thus individual-
specific CMs 3. This advance has sparked the creation of a multitude of disease 
models based on specific cell lines, paving way for individualized medicine in the 
treatment of genetic cardiac diseases. 92,93 
Differentiation of PSCs to CMs can be induced using different methods: co-
culturing with mouse visceral endoderm-like (END-2) stromal cells, embryoid body 
differentiation in suspension and 2D monolayer differentiation 94. The first beating 
CMs are observed on day 7 after induction of differentiation and a maximum is 
reached on days 12-14. Aggregates provide a larger number of CMs, whereas 
monolayers allow the monitoring of individual cells. 95 
2.4.4 Differences between stem cell derived and mature cardiomyocytes 
While the PSC derived CMs (PSC-CMs) are similar to CMs in a developing heart, in 
that they express the same proteins, behave electrically similarly and display other 
promising characteristics, the derived CMs do not have the same morphological and 
functional characteristics of primary adult CMs under current culturing conditions. 
These differences originate from mainly environmental factors: in vivo, the cells 
experience organized mechanical and electrical stress, as well as humoral factors. 96 
This in total results in a contractile behavior that is different from adult CMs 97. Table 
1 lists key differences between PSC-CMs and adult CMs.  
The differences are numerous. The CMs vary in size, with PSC-CMs being 
significantly smaller. Size is significant, as it has an effect on impulse propagation, 
depolarization rate and contractile force. By measuring membrane capacitance, 
which is directly proportional to cell surface area, human ESC derived CMs (ESC-
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CMs) have been reported to have a capacitance of 17.5 pF, whereas adult ventricular 
CMs have a capacitance of approximately 150 pF. 98 The shape of the CMs is 
different as well: whereas adult CMs are elongated and aligned, in vitro CMs are flat 
and round 3. Their sarcomeric structure is immature and the sarcomeres are shorter 
13. In 2D-cultures, they have few, or no T-tubules which are essential to a 
coordinated contraction 99. Their mitochondria are long and slender and either 
clustered near the nucleus or situated near the cell boundaries as opposed to being 
regularly distributed 100.  
A distinct difference in electrophysiology is that PSC-CMs beat spontaneously, 
whereas adult CMs do not. A likely explanation for this can be the combination of 
the funny current If - absent in adult CMs but present in the developing heart and 
PSC-CMs - and a reduced inward rectifier K+ current 101. The latter also contributes 
to an approximately 30 mV higher resting membrane potential 9. PSC-CMs also have 
a reduced number of Nav1.5 and L-type Ca2+ channels, which contribute to the 
slower AP upstroke velocity and reduced AP plateau phase 101. There have been 
studies with differing results considering the handling of Ca2+ and the use of 
intracellular Ca2+ stores, suggesting that the variability may be dependent on the 
maturity status of the cell 102.  
The electrophysiological differences have been studied also with in silico models, 
which have indicated the cells to be more sensitive of blocks of L-type Ca2+ channels 
and inward rectifier K+ current 103. The models further highlight their greater 
tendency for arrhythmic events than adult CMs 104. The contractile force of a cell 
depends on not only the cell characteristics, but also on the underlying substrate and 
the measurement technique. In general, however, the force output is not as high as 
in adult cells. On single cell level, the contraction force measured from PSC-CMs 
has been measured to be in the 10-9 N range 11,105 whereas for adult rat CMs, the 
force has been in the 10-6 N range 106. The contractile force itself is influenced by 
multiple factors presented here. 
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Table 1.  Key differences between PSC-CMs and mature CMs related to electromechanical activity. 
Modified and appended from 102. 
Parameter Human PSC-CM Mature 
Morphology Cell shape Flat, round Elongated 
Membrane capacitance 17.5 pF 150 pF 
Sarcomeres Structure Disorganized Highly organized 
Length 1.6 μm 2.2 μm 
T-tubules  Few/none Yes 
Mitochondria Distribution Irregular, clustered Regular 
Electrophysiology Spontaneous APs Yes Only pacemaker cells 
Resting membrane potential -60 mV -90 mV 
AP upstroke velocity 50 V/s 250 V/s 
Repolarization reserves Reduced Normal 
Na+/Ca2+ exchanger  Overexpression Normal 
IK1 current Reduced Normal 
If current Large Only pacemaker cells 
Ca2+ handling  Stage dependent Mature 
Contractile force  10-9 N range 10-6 N range 
There has been evidence to support the idea that the PSC-CMs are capable of 
maturing to resemble adult CMs 13. Various techniques have been presented to 
promote this maturation of the human PSC cells. In addition to longer time in 
culture 13,101, different approaches such as electrical stimulation 107–109, mechanical 
stretching 110–112, 3-dimensional scaffolding 113, topographical cues 114,115 and 
biochemical cues 116,117 have been tested. From drug testing perspective, the 
feasibility of using iPSC derived CMs has been debated due to their immature state 
118,119. More mature CMs may represent better the adult heart and thus they would 
be preferable. For transplantation purposes, however, immaturity is preferred to the 
adult phenotype 102,120. 
 
2.4.5 iPSC derived cardiomyocyte disease models 
As iPSC derived CMs carry their original genotype, they provide a platform for 
culturing and analysis of patient specific CMs in vitro. The number of cell models for 
different diseases has greatly increased, allowing the development of in silico models. 
Recently developed hiPSC models of inherited cardiac arrhythmias have been 
reviewed by Shinnawi and Gepstein 121, as well as Chunbo and colleagues 122. 
In LQTS, for example, the subtypes LQT1 123, LQT2 92 and LQT3 124,125 have 
been developed and characterized. These LQTS cell models have demonstrated 
APD and field potential duration prolongation, spontaneous EADs, differences in 
ion channel currents and impaired rate adaptation of APDs. Positive results in 
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inhibiting abnormal function have been obtained using various substances, such as 
beta blockers, beta antagonists, Ca2+ channel blockers and K+ channel enhancers. 121 
As with LQTS, human iPSC derived CMs (hiPSC-CMs) from patients with CPVT 
can serve as in vitro disease models. A number of models for different mutations have 
been created: a RYR2 model 93,126 and a CASQ2 model 127. These cell models have 
exhibited EADs and DADs in adrenergic stimulation, higher diastolic Ca2+ levels 
and higher CICR. Rescue of function in the cell models has been achieved using 
dantrolene, beta agonists, CAMKII inhibitors and Ca2+ channel agonists. 121 In 
addition to the restoring of function in cell models, dantrolene response similarity in 
cell models and patients has been evaluated 128. 
2.5 Electrophysiological in vitro cardiomyocyte studies 
2.5.1 Patch clamp 
Patch clamp technique refers to a number of experiment setups, where a glass 
micropipette, filled with a solution similar to intracellular content, is brought to 
contact with the cell membrane to measure the electrical activity of the cell against 
another reference electrode. It is considered to be a gold standard for ion channel 
measurements 129 and has been used in studies since 1949 in its earliest form with 
the invention of glass microelectrodes 130. The method was expanded in later studies, 
with patch clamp method developed in 1976 131. It allows the studying of ion 
channels even in single cells. There are several configurations for measurements, 
which have different uses: cell-attached, inside-out, outside-out, whole-cell and 
perforated patch modes. Cell-attached mode serves as a starting point for the other 
measurement configurations. 129,132 
In the cell-attached mode, the pipette is placed against the cell surface and suction 
is applied. This creates a strong electrical seal in the range of gigaohms, allowing the 
measurement of single ion channels now inside the pipette. While it provides a 
physiological measurement environment, it does not allow intracellular changes. If 
the pipette is then withdrawn quickly, the patch of membrane is torn from the cell, 
making it possible to study the cell membrane by manipulating the solution inside 
the pipette. This is referred to as inside-out technique. Alternatively, if suction is 
applied to destroy the membrane and the pipette is pulled away, the membrane 
should reseal to make the membrane intracellular side face the pipette solution. This 
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is referred to as outside-out technique. In whole-cell configuration, suction is again 
applied to destroy the membrane patch, making the cell interior come in contact 
with the pipette solution. This process, however, dilutes the cytoplasm. The dilution 
effect is reduced in perforated-patch configuration, where the cell membrane is not 
ruptured. Instead, channel forming compounds such as fungicides are inserted in the 
pipette. These agents form channels in the cell membrane, and allow small ions flow 
through. 132,133 
The measurements can then be done in two configurations: voltage clamp and 
current clamp. Voltage clamp refers to a measurement, where the membrane voltage 
is held constant and the current is being measured, whereas current clamp refers to 
a study where the voltage is being measured when current is held constant. The 
activity of ion channels can be determined by measuring current flowing through a 
patch. When the voltage across the membrane is held constant, changes in 
membrane resistance – opening and closing of ion channels – will result in a change 
in current. The activity of ion channels in the patch can be measured by measuring 
the current while manipulating the opening conditions of ion channels, such as 
voltage and ligands. For studying a specific channel, the other currents are blocked 
using specific ion channel blockers or by eliminating the ions in question. The 
opening and closing of channels can then be seen as small changes in the 
transmembrane current. 132,133 
Patch clamp provides a way to measure cardiac APs and calculate different 
measures for classifying them. In addition to membrane potentials and slopes, AP 
duration (APD) has been a commonly used metric for characterization. Different 
APD measures, such as APD at 90% of amplitude (APD90) and 50% (APD50) have 
been calculated. These have then been used for categorization of PSC CMs to either 
nodal, atrial or ventricular 123,134–136. This approach has, however, been recently 
debated, as seeding densities may affect the AP morphology and that it should not 
be used for categorization 137,138. Despite the debate, it is agreed that patch clamp 
recordings of CM electrophysiological parameters are the most accurate way to study 
APs. Further, it is uncontested that potassium current and resting membrane 
potentials remain important measures 139.  
While patch clamp is commonly done manually, automated systems exist. Manual 
patch clamp is not well suited for high throughput analysis, as it is work intensive 
and its use requires extensive training. Recent advancements in automated patch 
clamp has made its use in drug screening applications more feasible due to possibility 
for higher throughputs. Manual patch clamp, however, remains necessary in research 
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applications including ion channel studies, cell populations with mixed cell types and 
differentiated cells, such as iPSCs and ESCs. 129,134 
2.5.2 Microelectrode arrays 
In vitro microelectrode array (MEA) refers to a typically 2-dimensional electrode 
arrangement, which can measure the electrical activity of tissues and cell cultures, 
and stimulate them electrically. Typically, the cells to be studied are placed on top of 
the electrode grid in a culture well. The activity of each electrode can be measured, 
showing the field potential changes of the culture. Such arrays have been in used 
since 1972 140. They have been a mainstay in CM studies 92,141–143 due to their non-
invasive nature, capability for long-term measurements and the possibility to 
stimulate and record from different sites 144,145. 
MEA provides an alternative to more complex techniques, such as patch clamp, as 
less manual work and expertise is required 146. However, MEAs are not very well 
suited towards single cell studies, as the electrodes themselves and the distances 
between electrodes are large compared to single cells. Further, the electrical coupling 
between the electrodes and cells is not optimal. 147 
2.6 Optical fluorescence methods 
2.6.1 Fluorescent dyes 
Fluorescence is used in cellular studies to tag certain proteins and molecules for 
imaging. Here, potentiometric dyes, and calcium dyes in particular are examined. 
Potentiometric dyes allow the measurement of the cell membrane potential by 
optical measurements. These dyes bind to the cell membrane and they change their 
optical properties - fluorescence or absorption - based on the alterations of the 
electrical field on cell membrane. This method provides high-resolution spatial 
measurements of the membrane potential, enabling the studying of phenomena such 
repolarization patterns. Fluorescent dyes are the most sensitive probes, as they 
provide the highest signal-to-noise ratio. Their fluorescence changes linearly with 
membrane potentials. The setup consists of a light source to excite the fluorescent 
reporters, optical filters, optics, a photodetector, and data acquisition hardware. 148,149 
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The most commonly used potentiometric fluorescent dyes in cardiac measurements 
are aminonaphthylethenylpyridinium (ANEP) dyes, di-4-ANEPPS, di-8-ANEPPS 
and RH237. For a 100 mV change in membrane potential, their fluorescence changes 
by 10%. 148 
Fluorescent calcium indicators provide a way to visualize and measure the Ca2+ 
fluctuations within the cell, in a similar fashion as voltage indicators. The Ca2+ 
indicator fluorophores bind to free Ca2+ ions within the cell and emit fluorescent 
light, which can then be detected with a similar setup as with voltage indicators 
described above. 148,150 There are a number of different chemical Ca2+ indicator dyes, 
which have different properties. The dyes can be divided in two categories: single 
wavelength (non-ratiometric) and ratiometric dyes. The single wavelength dyes (such 
as Fluo-3, Calcium Green-1) emit the same excitation and emission wavelengths 
independent of their binding status. This is advantageous, when multiple fluorescent 
compounds are used as no spectral overlap will occur. In general terms, the more 
Ca2+ is present, the brighter the signal. Ratiometric dyes (such as Fura-2 and Indo-
1) not only change their intensity, but shift their emission or excitation peak when 
they bind to Ca2+. This allows a precise measurement of intracellular Ca2+ 
concentration by the ratio of excitation and emission amplitudes. While it requires a 
greater wavelength spectrum, it helps counteract effects such as uneven dye loading, 
dye leakage, photobleaching and cell volume changes 150. While ratiometric dyes 
provide more precise results, quantitative calcium recordings have been shown to be 
possible with single wavelength dyes as well 151. 
The fluorescent dyes, however, suffer from different degrees of cytotoxicity and 
may induce electrophysiological changes in the cells 152,153. The phototoxicity results 
from free radical production by the excited states of the dyes, due to excitation with 
the UV light 154. These effects, along with bleaching of the probe molecules – the 
photo-induced chemical destruction of fluorescence – severely limit the use of in 
short-term measurements 153. For voltage-sensitive dyes, di-4-ANEPPS has not been 
widely used for single cells due to imminent phototoxicity 148, with RH237 having 
similar levels of phototoxicity 149. While di-8-ANEPPS is less phototoxic, the time 
window for recordings is still limited. 153,155 There have been different approaches to 
counteract the effects, but in general a greater signal-to-noise ratio lead to greater 
photodynamic damage 156. In addition, the dyes are compartmentalized and extruded 
from the cells during the measurement, and precise targeting is difficult 157,158. In 
addition, they have been shown to affect the cell stiffness and adhesion 159. As the 
Ca2+ indicators bind to free Ca2+, they also serve as Ca2+ buffers. While a higher 
concentration of the dye would produce a greater signal, it would also have an effect 
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on the Ca2+ kinetics of the cell. Further, the dyes have different speeds with which 
they bind to Ca2+ 150. 
In cardiac studies, Ca2+ imaging has been widely used due to the importance of 
Ca2+ in the CM biomechanics. In fact, the role of CICR in excitation-contraction 
coupling was discovered by using fluorescent calcium probes 160. It has been used 
e.g. in hiPSC-CM functionality assessments 161,162, assessment of drug effects using 
hiPSC models 163,164 and characterization of diseases 93,165,166. 
2.6.2 Genetically encoded fluorescent probes 
A number of issues related to dyes can be circumvented by introducing fluorescent 
genetically encoded fluorescent probes to the cells. For potentiometric 
measurements, genetically encoded voltage indicators (GEVI) were initially used in 
1997 167, and the method has been applied recently in various studies with different 
cell types 168,169. Further, these indicators have been tested in hIPSC-CMs as well 
170,171. In addition to longer studies, GEVIs make it possible to target specific cells 
and the uptake in cells is more homogeneous 169. Most GEVIs are not without 
cardiotoxic effects, as they may affect the myocardial structure and function 172. With 
the recently developed VSFP2.3, no evidence for cardiotoxicity has been found 169. 
For Ca2+ imaging, the same approach can be use as Ca2+ indicator proteins can 
be genetically encoded to cells. When compared to Ca2+ sensitive dyes, the GECI 
have a substantially lower signal-to-noise ratio due to their 10-times higher resting 
baseline fluorescence, and inferior kinetics and ion selectivity 173,174. Recent studies 
with genetically encoded fluorescent dyes have shown their high potential in CM 
studies 171,175. However, there have been results indicating that the genetic probes 
may interfere with the Ca2+ release activity of the cells 176. 
2.7 Mechanical analysis 
2.7.1 Atomic force microscopy 
Initially when discovered in 1986, atomic force microscopy (AFM) was developed 
for analyzing 3D nanoscale features of solid materials with very high resolution and 
sensitivity 177. It has since been used in various biomedical studies as well. 
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In AFM, a sharp probe is descended on top of the surface to be measured. AFM 
then measures all forces occurring between the probe and the surface by attaching 
the probe to a cantilever, which acts as a spring. The sample is then scanned in x-y 
plane and the bending or deflection of the cantilever is measured e.g. using a 
piezoelectric actuator or lately, a laser beam to cover the entire sample to be 
measured 177,178. AFM can be used in different imaging modes. In the most 
commonly used mode, contact mode, the probe is in mechanical contact with the 
sample. The deflection of cantilever is kept constant and measured using a feedback 
loop. There is a risk of damaging the sample, and there is no constant zero force 
reference level. In dynamic modes, the probe is not in contact with the sample, but 
oscillates near its resonance frequency. Typically, amplitude of oscillation is the 
measured parameter, although frequency and phase can be measured as well. 
Jumping mode is a combination of the contact and dynamic mode: the probe is 
moved in and out of contact, which retains a zero force reference point. 179 
In CM studies, the topographical mapping of the cell is not always necessary, as 
the biomechanics of contraction and relaxation are temporal in nature. As the cell 
beats, its surface movement can be detected using AFM. Due to its high sensitivity, 
it has been widely used in CM studies. It has been used to determine the contractile 
behavior 10,180 as well as measure the relation between force and calcium 
concentration using a concurrent Ca2+ fluorescence imaging and AFM 181. In studies 
using hIPSC-CMs, AFM has been used to study the mechanobiological properties 
of single CMs and characterize cells derived from patients with dilated 
cardiomyopathy 182, and the contraction-relaxation parameters of CMs with different 
compounds 183. 
2.7.2 Mechanical transduction methods 
Mechanical transduction has a long history of measuring cellular forces. The first 
method was based on optically measuring the bending of fine glass filaments by cells 
184,185. Methods such as using microelectromechanical systems 186 and viscous loading 
187 have been proposed. However, new methods have been in demand as the 
instrumentation for these methods has been difficult and obtaining exact results has 
not been straightforward. 
A force measuring technique was proposed by Tan and colleagues in 2003. They 
developed a platform where cells are seeded on top of a microarray of elastomeric 
microposts, allowing the studying of mechanical interactions between cells and 
substrates. The deflection of each micropost is measured to characterize contractile 
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force, velocity and power. The method has high spatial resolution and it can be used 
in conjunction with other methods, such as immunofluorescence. Tan and 
colleagues used bovine pulmonary artery smooth muscle cells 188. Rodriguez and 
colleagues used microposts extensively in their studies of hIPSC-CMs. The effect of 
substrate stiffness, extracellular matrix and tri-iodo-L-thyronine has been studied. 
The contact between the cell and microposts may have an effect on the cell 
membrane and thus the cell function. 11,189,190  
Wilson et al. measured rat skeletal muscle contractile function using cells plated 
on silicon cantilever chips 191. The chip platform consists of multiple cantilevers, 
which can be used to measure the force and the spatial coordinates of the beating. 
Human ESC-CMs were later studied using the same method by Stancescu et al. from 
the same research group 192. Goßmann et al. developed a method, where monolayers 
hiPSC-CMs were grown on thin silicone membranes. As the CMs beat, the 
membrane moves up and down. The pressure beneath the membrane is measured 
using a pressure sensor and the tension calculated from the deflection 193.  
Yin and colleagues presented a method of measuring contractile force using 
magnetic beads in 2005. Their approach is based on attaching a magnetic bead to 
one end of a CM. When the cell beats, the bead moves with the cell. An external 
magnetic field can then be used to have the cell contract under different force loads. 
They studied a rat chronic ischemic cardiomyopathy model. 194 The effect of 
dynamic loads has also been studied by Iribe and colleagues in 2007 using a pair of 
piezo translator -positioned carbon fibers. The relation between force and length 
was studied in ventricular guinea pig CMs 195. 
2.7.3 Traction force microscopy 
Traction force microscopy is an indirect measurement of contractility and force of 
adherent cells using elastic substrate embedded with microbeads. The method was 
pioneered by Harris and colleagues in 1980 196. From a general point of view, a 
reference force microscopy image, or “null force” image, is taken before seeding of 
cells. When the cells are seeded on top of a suitable substrate, the cells exert their 
force on the substrate. Its deformation and subsequent measured movement of the 
microbeads from a second image is used to compute the traction force after the cells 
are detached from the surface. By using the reference image and the second image, 
traction fields can be calculated by measuring individual bead movement or by 
applying different displacement analysis methods, such as particle image velocimetry 
(PIV), described in more detail in section 2.8.2. 197 The force by itself is not 
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quantifiable from displacement alone, but can be inferred from the mechanical 
properties of the system. The substrates used in traction force microscopy can be 
assumed to have linear and isotropic properties, as well as to be incompressible. With 
the substrate stress-strain properties known, the inverse problem of elastic theory 
can be calculated using inverse Boussinesq formulation. Alternatively, if high quality 
3D imaging is available, the stress tensor can be calculated directly from the image 
data. 198,199 
2.7.4 Impedance assays 
Impedance assay platforms are non-invasive and label-free method of analyzing CM 
functionality. The assays consist of electrodes embedded to the bottom of cell 
culture wells. CMs are seeded and attached to the wells and a weak alternating current 
is applied between the electrodes. The cells in between act as insulators and restrict 
the flow of current between the electrodes. CM beating causes small changes in the 
range of 0.1% in the cellular impedance. These fluctuations can be measured, 
enabling the beating analysis of CM monolayers. 200 While impedance is an electrical 
property, impedance assays measure the mechanical function – the movement of 
cells over electrodes 201.  
The method has been used recently in studying cardiotoxicity. The xCELLigence 
Real-Time Cell Analysis Cardio platform was developed and validated with mouse 
ESC-CMs, hiPSC-CMs and neonatal rat CMs 202. Responses to drugs and various 
arrhythmic agents were tested on mouse ESC-CMs 203, hIPSC-CMs were analyzed 
in the presence of compounds 204. The sensitivity of the method provides a challenge, 
as the sensitivity is highly dependent on electrode distance and layout 205. 
 
2.8 Video based motion estimation 
2.8.1 Method classification 
Determining change between two consecutive visual states forms the basis of 
motion estimation. Motion can occur due to movement of either the measured 
object or the observer, in 2D or 3D. The purpose of motion estimation is to measure 
the movement using visual methods and quantifying it. While measuring the 
movement of macroscopic objects is somewhat trivial, measuring the movement, or 
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flow, of liquids has been a relevant question for ages in engineering. In its most 
primitive form, flow can be visualized by following a floating object in a stream. In 
image-based measurements, movement in 3D is projected to a 2D plane, creating an 
ill-posed problem.  
Motion estimation methods can be roughly divided in two categories: optical flow 
methods and feature tracking methods. Optical flow methods use the changes in 
spatio-temporal pixel intensity values in determining motion, whereas the feature-
based methods use specific features such as corners, templates and color tones to 
match features between frames. 206 Optical flow methods can be further divided into 
differential techniques, block matching, energy-based techniques and phase-based 
techniques 207. Block matching method is focused on in this study. Feature based 
methods are typically used in video compression: although the calculations are 
performed faster, they have lower accuracy 208. 
2.8.2 Block matching background 
Only in the past 40 years has it been actually feasible to quantify accurately the fluid 
velocities in multiple points. The study in question, particle image velocimetry (PIV) 
means the “accurate, quantitative measurement of fluid velocity vectors at a very 
large number of points simultaneously”, as well defined by R. J. Adrian 209. Typically, 
in a PIV measurement, the planar or volumetric flow being measured is seeded with 
tracer particles that follow the flow. These tracer particles are then illuminated twice 
within a short time period and the images are recorded. The displacement of the 
seeder particles can then be calculated from the obtained images by dividing the 
recording into small interrogation areas for block matching. For each of these 
interrogation areas, a local displacement vector is calculated using statistical methods. 
It is assumed that the particles in an interrogation window move homogeneously. 
As per definition of velocity, the first derivative of position with respect to time, the 
displacement vector and the known time interval between the frames is used to 
calculate the velocity vector for each interrogation window, resulting in a velocity 
vector field between the two frames 210. Due to the application of block matching in 
the context of CM analysis as opposed to flow dynamics, the technical background 
of PIV measurement methods - including seeding of gases/liquids, light sources, 
optics and sensors along with the necessary model corrections related to these 
factors - is not presented here. Additionally, only single exposure PIV processing 
methods are presented, as double exposure is not relevant for CM studies. A more 
focused view on PIV methods can be found in the review article Fundamentals of 
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digital particle image velocimetry 211 and the book Particle Image Velocimetry: A 
Practical Guide by Raffel et al 210. 
In a digital grayscale image, each picture element, or pixel, is assigned an integer 
value: a higher pixel value indicates a brighter element. As previously mentioned, the 
recordings are divided into interrogation areas of size M*N, or preferably N2. In 
general, a degree of similarity is calculated for an interrogation window in the first 
image with a number of interrogation windows in the second image to match the 
block 212 at a specified search distance. The windows may overlap each other, and in 
most algorithms an overlap of 50% is used 213. This process generates a degree of 
similarity matrix, which shows a composition of peaks, as shown in Figure 5.  The 
signal peaks in the figure illustrate the locations with the highest cross-correlation 
factor, surrounded by noise. A key issue in a successful block matching evaluation 
relies on whether the signal peak is higher than the noise peaks. 209 
 
Figure 5.  A composition of cross-correlation peaks within the specified search distance in a PIV 
recording. The highest correlation peak represents the most likely location of displacement. 
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A number of algorithms using cross-correlation in one form or another have been 
developed for evaluating the recordings. The digital implementations of a few 
commonly used ones are presented here. In its simplest form, cross-correlation (߶஺) 
can be defined for the consecutive images f and g as: 
߶஺(݉, ݊) =෍෍݂(݅, ݆)݃(݅ + ݉, ݆ + ݊)
ே
௝ୀଵ
ெ
௜ୀଵ
 
Here, f and g represent the gray value intensities in the interrogation window of size 
M x N pixels, with (m,n) representing the offset required for matching. Due to the 
direct multiplication of values, the correlation of the matching area may have a 
smaller value than bright spots with high intensity value. This concern has been taken 
into account in another cross-correlation measure (߶஻) where the mean gray value 
of each interrogation area is reduced, as shown below: 
߶஻(݉, ݊) =
1
(ܯ −݉)(ܰ − ݊) ෍ ෍ൣ݂(݅, ݆) − ݂൧̅[݃(݅ + ݉, ݆ + ݊) − ݃̅]
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The values ݂̅ and ݃̅ indicate the mean values for images f and g, respectively. The 
denominator applies to the overlapping area of the interrogation windows. 
Ultimately, it is divided by the overlapping area of the interrogation window. The 
last step can be left out to achieve another measure of correlation (߶஼).  
Mean absolute error (MAE) method tries to find the best degree of similarity by 
minimizing the error in absolute differences of gray value distributions. The function 
can be defined as following: 
ܦ(݉, ݊) = 1ܯܰ෍෍|݂(݅, ݆) − ݃(݅ +݉, ݆ + ݊)|
ே
௝ୀଵ
ெ
௜ୀଵ
 
In 1996, Gui and Merzkirch proposed a new method, based on minimizing the 
quadratic differences of matrices to find the degree of similarity, namely minimum 
quadratic difference (MQD) method 214. MQD is also known as mean squared error, 
least squares matching or sum of squared differences 215. Using this approach, the 
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displacement D(m,n), where the maximum similarity can be found, is described as 
below:  
ܦ(݉, ݊) = 1ܯܰ ෍ ෍[݂(݅, ݆) − ݃(݅ +݉, ݆ + ݊)]
ଶ
ேିଵ
௝ୀ଴
ெିଵ
௜ୀ଴
 
The performance of these different methods have been evaluated, and the results 
indicate that the latter two produce the best results. Fei, Gui and Merzkirch found 
the correlation based measures (߶஺, ߶஻ and ߶஼) to have lower accuracy than the 
error-based measures, with MQD algorithm to provide the most accurate values 216. 
Ghanbari found MAE to be marginally more accurate than MQD 212.  
Due to the images being discrete, the resulting displacements are limited by the 
pixel count in the interrogation windows. In order to increase the accuracy of 
displacement estimation, interpolation methods are used to achieve sub-pixel 
accuracy. Once a motion vector with integer precision accuracy has been calculated, 
fractional positions around the first estimate is are calculated and considered. Bilinear 
interpolation is commonly used in deriving the fractional pixel values due to its 
simplicity and robustness, but higher-order polynomial functions are used for greater 
accuracy. However, the process of searching the matching block again in 
interpolated image data is computationally expensive. A combination of block 
matching and optical flow method without interpolation has been presented as an 
alternative. 217 
Typically, the raw vector field data is not without errors. There may be spurious 
vectors of unusual magnitude, missing vectors and background Gaussian noise. 
Thus, post-processing of the vector field data is often required before analysis of the 
results. The errors may be evident when compared with neighboring vectors, but 
correcting them without human pattern recognition ability may be difficult. 218 
Various different methods, such as global histogram operator and dynamic mean 
value operator have been used for validation 210. 
2.8.3 Cardiomyocyte contractility studies 
Traditionally, video-based CM contractile motion analysis has been conducted by 
measuring the movement of the cell extremities or sarcomere length 219–221 or 
measuring the intensity variations during beating with fast Fourier transform 222. In 
its simplest form, the length of CMs are measured while relaxed and contracted. 
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While not an immediately intuitive solution due to its primary use in flow 
dynamics, PIV/image correlation analysis has been used in CM studies in the past 
decade. These methods had only been applied in few applications or in minor roles 
concerning cell dynamics until recently, regarding cell migration and wound healing 
process with fibroblasts, estimation of motion in hemicochlear preparates and only 
later with CMs 223–225. Even though the cell environment is not seeded with particles, 
as opposed to traction force microscopy presented in 2.7.3, the PIV methods are 
capable of determining the cellular deformations due to differing cell textures. 
Typically, CM deformations during cell beating resulting from contraction and 
relaxation is recorded with a camera and a phase contrast or brightfield microscope. 
A suitable motion detection is then applied to quantify the motion in the videos to 
obtain a beating signal. 
In terms of use in cellular studies, analysis of video microscopy has the advantage 
of not requiring probes or tracer substances. The cells are, however, still subject to 
visible light – a condition the cells are not exposed to in vivo. While white light per se 
has not been shown to produce immediately obvious adverse effects to the cells, it 
has potential for phototoxicity if the light sources do not carefully exclude near 
ultraviolet/infrared frequencies. 226 
A number of groups have developed video microscopy based methods 
12,14,16,17,222,227–231, presented in Table 2. The block matching methods are most 
commonly used. A wide range of cardioactive substances have been studied, 
including autonomic agents, ion channel blockers and other pharmaceuticals. 
Varying frame rates (frames per second, fps) have been used. The directionality of 
CM contraction has been in focus only by some groups. The typical measured 
parameters include beating frequency, durations of contraction and relaxation, total 
duration of mechanical activity, time from baseline to peak, displacement and 
magnitude. The characteristics of wild type cardiomyocyte biomechanics have not 
been widely reported, with the effect of substances being more in focus. 
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Table 2.  Recent key publications regarding video microscopy analysis of CMs, and their analysis 
features. 
 
Publication  Method 
[fps] 
Cell culture Substances  
studied 
Parameters Measured  
characteristics 
Kamgoué et 
al. (2009) 12 
Block matching (cross-
correlation) 
[9 fps] 
Adult rat CM (single) 
- 
Displacement, time 
from baseline to 
peak. 
Contraction/relaxation 
cycle 2.05 s. Time to 
maximum contraction 
0.57 s, 0.33 s. 
Hossain et 
al. (2010) 222 
Variation in total pixel 
intensities 
[30 fps] 
Mouse ESC derived 
CM 
Caffeine hydrate, p-
hydrox-
yphenylacetamide, 
calcium chloride 
dehydrate 
Amplitude, 
frequency 
 
Motion direction 
detection 
- 
Hayakawa et 
al. (2012) 14 
Block matching (MAE) 
[14, 125 fps] 
Neonatal rat CM 
(monolayer) 
E-4031, dl-sotalol, 
terfenadine, 18-beta-
flycyrrhetinic acid, 1-
heptanol, acetylcholine, 
epinephrine, 
propranolol 
Frequency, 
maximum velocities 
of contraction and 
relaxation, peak 
width 
- 
Liu et al. 
(2012) 228 
Demons registration with 
principal component 
analysis 
[15-30 fps] 
Nondescript (single, 
populations) - 
Motion direction 
detection - 
Chen et al. 
(2014) 229 
Horn-Schunk  
optical flow 
[7, 20 fps] 
Human ESC derived 
CMs (sheet) 
E-4031, isoprenaline Duration, frequency, 
synchronicity, 
orientation, 
acceleration 
 
Motion direction 
detection: polar 
coordinates 
Contractile duration 
1.16+/-0.06 s, 1.13+/- 
0.03 s 
Hayakawa et 
al. (2014) 227 
Block matching (MAE) 
[150 fps] 
Human iPSC 
derived CMs 
(monolayer) 
Isoproterenol, E-4031, 
verapamil 
Velocity, 
deformation 
distance, total 
duration, frequency 
Peak contraction speed 
8-15 μm/s, peak 
relaxation speed 4-10 
μm/s 
Huebsch et 
al. (2015) 16 
Block matching (MAD) 
[14 fps] 
Human iPSC 
derived CMs (sheet) 
Isoproterenol Velocity, frequency 
 
Motion direction 
detection: beating 
centers 
Peak contraction 
velocity 80 μm/s, peak 
relaxation velocity 35 
μm/s 
Maddah et 
al. (2015) 230 
Relative correlation of 
intensity vectors 
[50 fps] 
Human iPSC 
derived CMs. 
(monolayer, sphere, 
single) 
Norepinephrine, 
cisapride, quinidine, 
verapamil, E-4031, 
sotalol, nifedipine, 
aspirin 
Frequency, duration 
- 
Lee et al. 
(2015) 17 
Horn-Schunk  
optical flow 
[15.6, 8.6 fps] 
Human iPSC 
derived CMs 
E-4031, verapamil, 
blebbistatin 
Duration, frequency, 
amplitude, time from 
peak to baseline, 
time from baseline 
to peak, area under 
curve 
 
Motion direction 
detection 
- 
Ribeiro et al. 
(2017) 231 
Block matching  
(cross-correlation) 
[30 fps] 
Human iPSC 
derived CMs (single) 
Caffeine, isoproterenol, 
omecamtiv mecarbil 
Average 
displacement, 
velocity, spatial 
asynchronicity, 
temporal 
asynchronicity 
 
Motion direction 
detection 
Contraction 1.09 μm, 
0.78 μm; peak 
relaxation velocity 3.78 
μm/s, 2.87 μm/s; peak 
contraction velocity 
6.85 μm/s, 3.53 μm/s 
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In 2009, Kamgoué and colleagues calculated intracellular strain fields from single 
adult and neonatal rat CMs. A cross-correlation measure was calculated for the image 
pairs and the propagation of strain waves and shortening of CMs was quantified. 
Additionally, they developed a test set of artificial images to verify the method. In 
essence, they were among the first to apply image correlation analysis to single CMs. 
12 
Hayakawa and colleagues developed a method for extracting CM beating 
parameters and assessing wave propagation in neonatal rat CM monolayers. The 
monolayers were imaged using phase-contrast microscopy with a frame rate of 125 
fps. For vector calculation, MAE was used. Additionally, they performed 
simultaneous Ca2+ measurements and studied the effect of several drugs and agents 
that influence the beating. K+ channel blockers (E-4031, dl-sotalol, terfenadine), gap 
junction inhibitors (18-β-glycyrrhetinic acid, 1-heptanol), autonomic agents 
(acetylcholine, epinephrine) and propranolol were applied. 14 They later expanded 
their studies with hIPSC-CMs using the same method, and compared the findings 
with traction force microscopy, field potential measurements and Ca2+ imaging. 
They found the video microscopy to correlate well with force development and 
showed that effect of different compounds can be detected using video imaging. 227 
The method had later been used in a software tool by Sala and colleagues, used in 
characterization of LQT and hypertropic cardiomyopathy. They studied the effect 
of isoprenaline and nifedipine on contraction amplitude, as well as relaxation and 
contraction duration. 232 
Liu and colleagues introduced a real-time automatic CM analysis method and 
characterized the beating signal by studying its spectral properties 228. Their cell data 
consisted of dense CM populations and single CMs. The cellular background was 
not reported. As opposed to PIV methods, they used Thirion’s demons image 
matching method 233 for the generation of the vector fields. In short, the demon 
based algorithm tries to align objects by non-rigid models and estimating their 
deforming force vectors. In their later work 18, they improved their method by 
addressing the problems related to accuracy of motion estimation and that the 
method assumed CMs to be connected and beat with the same pattern. They 
developed a method, which segmented images into clusters that have differing 
beating characteristics. 
Chen and colleagues demonstrated the use of an integrated platform in CM 
studies with optical methods. They aligned clusters of CMs using shrink-wrap film 
and assessed their beating parameters. In addition, they applied E-4031 and 
isoprenaline to evaluate the performance of the platform. They studied H9 human 
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ESC-CMs, recorded their beating at 7 fps and 20 fps, and analysed their beating using 
a correlation based open-source software built by Sun and colleagues 234. A number 
of characteristics were calculated: duration, frequency, synchronicity, orientation and 
acceleration of contractions. As opposed to previously presented methods evaluating 
the magnitudes of vectors, they assessed the recorded series of images with 
categorical values in a grid to determine areas beating together. 229 The method was 
later used in conjunction with machine learning methods to show the feasibility of 
automated high-throughput drug effect analysis. hIPSC-CM response to E-4031, 
verapamil and blebbistatin was assessed. 17 
Huebsch and colleagues applied a block matching algorithm to analyze hIPSC-
CMs. In their method, MAE is used to generate the vector fields from 14 fps videos. 
They defined beating centers as regions where the motion originates by calculating 
the net movement toward and away from a smaller selected subregion. A beating 
center is a region where the difference between inward movement and outward 
movement is maximized. They validated the results of the motion analysis by 
electrophysiological methods. In one set, motion analysis was conducted with a 
concurrent MEA measurement. In another test set, a concurrent patch clamp 
measurement was done. In addition, they analyzed the Ca2+ flux using GECI 
GCaMP6f and performed motion analysis on the videos. Further, they assessed the 
CM response to isoproterenol with the developed method. 16 
Maddah and colleagues presented a CM analysis platform based on video 
microscopy and image analysis 230 using a method they developed earlier 15. Their 
analysis pipeline consists of recording CM cultures with a camera on 24 fps 
acquisition and segmenting them to regions of beating cells, non-beating cells and 
background. The beating signal is formed by calculating a correlation coefficient of 
the frames with respect to a resting-state reference image. Finally, the signals are 
characterized and regions are clustered to identify areas with similar and differing 
beating characteristics. Additionally, they characterized CM drug response using 
cisapride and norepinephrine. In the later study, regular hIPSC-CMs and GECI line 
(GCaMP) IPSCs were analysed using the platform. They also performed 
comparisons with existing methods: video analysis was applied simultaneously with 
patch clamp. Additionally, they performed test sets with video analysis followed by 
calcium imaging, using quinidine and blebbistatin. They also expanded on their 
previous study of drug responses by adding E-4031, verapamil, sotalol, nifedipine 
and aspirin, in addition to the ones mentioned earlier. 
Ribeiro and colleagues used cross-correlation based block matching to analyze 
hIPSC-CMs. The aim was to analyze the effect of cell shape and substrate properties 
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to contractility. They used micropatterned surfaces to shape the CMs to more 
physiological form. They found these factors to increase cellular mechanical output. 
In addition, directed calcium flow, mitochondrial distribution, more mature 
electrophysiology and T-tubule formation were found to increase contractility. 231 
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3 AIMS OF THE STUDY 
The aim of the study was to develop a non-invasive video-based analysis method for 
characterizing CM biomechanics and to assess its functionality and performance. 
This involved validation of the tool, conducting comparative studies and 
evaluating relevant biological problems using the method. To reach this goal, the 
following study aims were prepared. 
1. Develop a tool for quantifying hiPSC-CM beating dynamics in vitro, assess the 
imaging protocol and determine the method accuracy using artificial data sets 
(Studies I, II) 
2. Compare and validate the measurement results with patch clamp, calcium 
imaging and microelectrode arrays (Studies I, III, IV)  
3. Demonstrate the use of the method on diseased cells using LQT1 and CPVT 
disease specific hiPSC-CMs, determine beating phenotypes between populations 
and compare them with respective electrical phenotypes (Studies III and IV) 
4. Perform simultaneous contraction and calcium imaging measurements (Study 
IV) 
5. Develop a software tool for use in cardiomyocyte studies (Studies I-IV) 
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4 MATERIALS AND METHODS 
4.1 Generation of stem cell lines 
The iPSC cell lines used in the studies were generated in BioMediTech, University 
of Tampere with permission from the ethical committee of Pirkanmaa Hospital 
District (R08070). Written consent for the research was also obtained from all the 
skin biopsy donors. 
The cell lines used in the studies are listed in Table 3, along with the mutations. 
The wild type (WT) cell lines UTA.40602.WT and UTA.04607.WT are treated as 
control cell lines in the studies. The LQT1 is studied using two founder mutations 
of the KCNQ1 gene with two cell lines each: G589D (also referred to as KCNQ1-
FinA: UTA.00208.LQT1 and UTA.00211.LQT1 – here in brief LQT1A) and ivs7-
2A>G (also referred to as KCNQ1-FinB: UTA.00102.LQT1 and UTA.00118.LQT1 
– here in brief LQT1B). CPVT is studied using two mutations of RYR2 gene with 
one cell line each: exon 3 deletion (UTA.05605.CPVT – here in brief CPVTa) and 
V4653F (UTA.05404.CPVT – here in brief CPVTb). 
Table 3.  Cell lines and mutations used in each of the studies. 
Cell line Mutation Referred to as Study 
UTA.04602.WT None (WT) WT/Control I, II, III, IV 
UTA.04607.WT None (WT) WT/Control I, III 
UTA.00208.LQT1 KCNQ1-FinA: G589D LQT1A III 
UTA.00211.LQT1 KCNQ1-FinA: G589D LQT1A III 
UTA.00102.LQT1 KCNQ1-FinB: ivs7-2A>G LQT1B III 
UTA.00118.LQT1 KCNQ1-FinB: ivs7-2A>G LQT1B III 
UTA.05605.CPVT RYR2: exon 3 deletion CPVTa IV 
UTA.05404.CPVT RYR2: V4653F CPVTb IV 
The WT cell lines were established from primary dermal fibroblasts obtained with a 
skin biopsy from a healthy 55-year-old female. The LQT1 patient with G589D 
mutation is a 46-year-old female and the one with ivs7-2A>G mutation a 51-year-
old female. Both patients were on E-blocker medication. The CPVT patients were 
described in an earlier study 163. The obtained primary fibroblasts were cultured 
under fibroblast culturing conditions. The WT and disease specific iPSC lines were 
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established using lentiviral infection, followed by retroviral infection. The full 
protocol of establishing the iPSC cell lines has been described earlier 69,92. 
4.2 Cardiomyocyte differentiation and characterization 
The hiPSCs were differentiated into CMs by co-culturing with murine visceral 
endoderm-like (END-2) cells (Humbrecht Institute, Utrecht, The Netherlands). 
After a minimum of 14 days, beating colonies were dissociated mechanically, treated 
with collagenase A (Roche Diagnostics, Mannheim, Germany) and plated on 0.1 % 
gelatin. In studies I-III, the dissociated cells were plated on standard cell culture 
multi-well plates and in Study IV, the CMs were plated on glass coverslips. 
4.3 Video-image based contraction analysis 
Analysis of the video data represents the core part of the study. 
4.3.1 Video recordings 
Beating cells were identified visually using a microscope and spontaneous beating 
was recorded on video without pacing. In the studies I and III, a Nikon Eclipse 
TS100 phase contrast microscope (Nikon Corporation, Japan) and an OPTIKA 
DIGI-12 digital video camera (OPTIKA Microscopes, Italy) were used. The 
duration of recorded videos was 30-60 seconds, with a 720x480-pixel resolution, 30 
fps. In Study II, IGV-B1620 (IMPERX, FL, USA) was used with Nikon Eclipse 
TS100 phase contrast microscope (Nikon Corporation, Japan) to record videos at 
60 and 120 fps. Study IV included similar video recordings, but overall featured a 
more complex imaging protocol, described in 4.4.3. 
4.3.2 Video analysis process 
During this thesis project, a video analysis method and software tool was gradually 
developed and improved. In brief, the method uses particle image velocimetry based 
block matching method for calculation of velocity vector fields from consecutive 
video frames. It uses a beating focus point based approach, defined in detail later in 
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this section, for determining directional components from the vector fields and 
calculates beating signals, characterizing the motion of the cell.  
The flowchart of the analysis is illustrated in Figure 6.  As the method was developed 
during and between the individual studies, several phases shown were not present 
and used at first, as they had not yet been developed and were instead done manually. 
 
Figure 6.  The stages of video analysis process with the development of automation and other 
features, and their use in studies. While the indicated features were present during the 
studies mentioned, the features were not all used for the indicated studies. For instance, the 
online database was not used in deriving results in Study IV. 
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The overall analysis flow starts from the recorded video of cardiomyocyte beating. 
The block matching window size and the analysis region are set manually (stage 1). 
This allowed the calculation of velocity vector fields for multiple cells within the 
same video. Although determining a proper window size and analysis region could 
be made automatic, setting these manually enabled flexible use in different 
applications. After the analysis, the cells were segmented semi-automatically using a 
texture-based algorithm using greyscale entropy, cell size and the distribution of 
greyscale values within the analysis region (stage 2). Within these segmented cells, 
the beating focus point was estimated based on the velocity vector gradient within 
the cell during a contraction (stage 3). Based on the ROI and the beating focus point, 
the directional signals are calculated (stage 4). Signal peaks are then detected based 
on estimated peak distance, and frequency and magnitude distribution of the signal. 
Possible signal lowpass filtering is applied to facilitate peak detection (stage 5). An 
averaged waveform template is calculated based on a set correlation factor (stage 6): 
the signal is divided into beat cycles, and the template is initiated with a beat cycle, 
and the rest of the beat cycles are either averaged or discarded depending on the 
correlation with the initiated template, as presented by Pradhapan and colleagues 235. 
The template or the whole signal is then parametrized to extract the start- and end-
points of contraction and relaxation movement (stage 7). A summary of the results 
is then provided, and uploaded to a result database (stage 8). 
4.3.2.1 Image velocimetry 
In the studies, MATLAB PIV toolbox mpiv was used to calculate velocity vector 
fields between video frames using MQD method 236. The analysis methodology was 
developed iteratively between the studies and while the underlying mechanics stay 
the same, the method has become more refined. 
Adjacent sub-window overlap ratio of 0.5 was used. A default sub-window size 
of 32 pixels was used and vector resolution was improved with recurrent calculation, 
reducing the window size by half. Choosing an optimal sub-window size depends on 
the image resolution, cell size and the desired resolution of the velocity vector field. 
The calculated vector fields typically were not complete as stray vectors were 
eliminated. Median filter was applied to the vector field and it corrected using kriging 
interpolation to determine missing vectors. Finally, the field was smoothed using a 
weighted 3x3 kernel as a low-pass filter. An example of a velocity vector field 
determined from cardiomyocyte contraction is shown in Figure 7.  
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Figure 7.  A velocity vector field measured during a CM contraction. In contrast to an adult CM with a 
primary axis of contraction, hiPSC-CMs typically have more fusiform beating patterns 
directed towards the center of the cell.  
The parameters related to maximum possible displacement and stray vector 
elimination threshold were subject to small alterations depending on the cell/cell 
cluster size and application. 
4.3.2.2 Derivation of beating signals 
Beating signals were calculated from velocity vector fields. While the time axis for 
the signals is easily defined due to frame rate, a meaningful measure of movement 
magnitude is not easily accessible and dependent on the camera and the 
measurement optics. Here, the absolute magnitude of motion was not deemed 
interesting due to a number of reasons: the cell sizes varied, their maturity was not 
constant resulting in fusiform beating patterns, the cells were not uniformly attached 
to the culture plates and ultimately the fundamental question of how to select the 
region of interest properly remained unanswered. 
First, a region of interest was determined. During the first studies, it was selected 
manually based on observed motion. Later on, semiautomatic methods including 
texture segmentation based on local entropy were used to determine the cell location 
and the textures that typically exhibit movement within a cell. Due to the differences 
in contractile behavior and morphology between mature CMs and human iPSC 
derived CMs, the cells did not have predetermined directionality in their beating. The 
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fusiform beating behavior caused the contraction to head towards the center of the 
cell from all directions. In order to differentiate the directional components between 
contraction and relaxation, a beating focus point was determined. At first, it was 
determined manually and later automatized by determining velocity vector field 
gradient maxima. 
In order to quantify the fusiform nature of beating, the region of interest was 
divided to eight sectors around the beating focus point. The velocity vectors in that 
region were divided to radial and tangential components. In the studies I and III, the 
division to components was done with respect to the midline of the sector whereas 
in studies II and IV, with respect to their individual location vector. The division is 
illustrated in Figures 8A and B, respectively. 
 
Figure 8.  The sector division approaches used in studies for determining radial and tangential 
components of motion. Approach A) uses sector midline as a reference, whereas approach 
B) uses the location vector of each individual vector. 
With this process, 16 different beating signals were formed – two from each of the 
eight sectors. The radial signals represent the movement towards and away of the 
beating focus point, and tangential signals the movement perpendicular to that. The 
positive and negative signs for the signals were not set consistently. 
4.3.2.3 Signal post-processing 
When possible, the signals were used unfiltered. This was done to preserve the signal 
shapes with as much detail as possible, as the signal/noise distribution was not 
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immediately known. In studies I and IV, motion signals integrals with respect to time 
were calculated. This way the resulting displacement signals could be compared with 
other measurement modalities. In Study II, the signals were filtered using a 20-point 
Gaussian window. In Study IV, the signals were first filtered using zero-phase digital 
filtering with a third order Butterworth lowpass filter at normalized 0.25 frequency. 
The baseline was corrected with linear detrending. 
4.3.2.4 Signal characterization 
In order to characterize the motion signal, time characteristics of different phases 
were determined: duration of contraction (phase 1), duration when cell stays 
contracted (phase 2) and duration of relaxation (phase 3). In addition, the duration 
when the cell is relaxed was measured. As the analysis continued, it became apparent 
that an additional phase 4 was required for the parameterization due to motion 
observed after relaxation. Phase 5 indicated the duration cell remained relaxed. The 
phases are illustrated in Figure 9.  
 
Figure 9.  An illustration of the beating motion signal featuring all specified phases. Phase 1 indicates 
the cell is contracting, phase 2 the duration cell remains contracted, phase 3 the cell relaxes, 
phase 4 the motion after the first relaxation peak, and phase 5 when cell remains relaxed. 
In healthy control-type cells, typically only phases 1, 3 and 5 were present. 
 
4.3.2.5 Correlation based averaged waveform templates (II and IV) 
Averaged waveform templates were calculated to determine parameters 
characterizing the cell beating. These templates were calculated using a method 
presented by Pradhapan and colleagues 235.  
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The template was first initialized by selecting a beat at measurement mid-point. 
Cross-correlation with the other beats was then measured. The beats with a 
minimum cross-correlation value of 0.8 or greater were selected and averaged, to 
remove waveforms that visually did not correspond well to the template. The 
templates were synchronized based on the peak of contraction velocity. This process 
allowed the rejection of erroneous beats and more consistent averaging. The cross-
correlation value was lowered in Study IV to 0.5 to disregard only the most erroneous 
peaks due to the lower number of total beats. The effect of frame rate and the 
number of beats was examined in Study II, as described in 4.3.3. 
4.3.3 Artificial data sets (I and II) 
Artificial data sets were included in studies I and II. In Study I, a still frame of a CM 
was distorted to produce a video imitating a beating CM. Pinch and spherize filter 
237 was used to generate distortion fields of varying magnitudes to a region of interest. 
In essence, each point of the region of interest was mapped to a virtual half-sphere 
and a new distance to the beating focus point was set based on the desired distortion 
factor. The known distortion field was then compared with the results obtained using 
video analysis. The effect of noise to the analysis was further tested: speckle noise of 
different variances was applied to the images, the resulting videos were analyzed and 
the analysis result correlation calculated. Speckle noise was selected because sporadic 
appearances of bright and dark pixels presents a challenge for PIV. The noise was 
calculated using the equation below, where J represents the resulting image, I 
represents the original image, V the set variance and IR the random noise between 
values -0.5 and 0.5, using a mean of 0. 
ܬ = ܫ + √12ܸܫܫோ 
 
In Study II, the effect of sampling frequency to the formation of templates was 
examined. As described in 4.3.1, videos at 120 fps were recorded. The videos were 
decimated to 60 fps and 40 fps by omitting frames to create videos with lower 
framerates. The videos were then analyzed using the present method, and the 
resulting templates were resampled for comparing templates formed with different 
templates. 
 63 
4.4 Reference in vitro measurements 
In addition to the video image-based method, the cells were analyzed using 
measurements that quantify their electrical and ionic activity. The measurements 
were conducted both concurrently and asynchronously with the video-based analysis 
method. The results were used to determine cellular phenotypes in both control and 
disease-specific genotypes, as well as compare the biomechanical signals with signals 
from electrical and ionic activity measurements. 
4.4.1 Patch clamp measurements (I and III) 
Patch clamp measurements were conducted in Study I and III. In Study I, patch 
clamp was used as a reference method for simultaneous measurement with video 
measurements in two single CMs. Standard current clamp configuration was used in 
perforated patch mode to measure CM action potentials while recording light 
transmission video. TTL synchronization pulses were used to synchronize the video 
data with current clamp data and compare the obtained video signal with the 
membrane potential signal. Similarly in Study III, the same measurement mode was 
used to record action potentials for both simultaneous and standalone 
measurements. Action potential characteristics (APD90, APD50 and APA) were 
measured to determine whether the cells were ventricular-, atrial- or nodal-like. In 
addition, patch clamp was used simultaneously with video imaging to compare the 
electrical and mechanical phenotypes of WT and LQT specific cells. 
LQT-specific CM electrophysiology was studied by blocking delayed rectifying 
K+ currents in ventricular-type CMs, mimicking the LQTS conditions with abnormal 
K+ current dynamics. The slowly activating component IKs was blocked using 
JNJ303 at 300 nM concentration. The rapidly activating component IKr was blocked 
using E-4031 at 100 nM. APs were measured at baseline, exposure and after wash-
out. 
The action potentials were recorded using Axon Axopatch 200B (Molecular 
Devices, CA, USA) patch clamp amplifier, connected via AD/DA Digidata 1440 
(Molecular Devices, CA, USA) to an acquisition computer, digitally sampled at 20 
kHz and filtered at 5 kHz using a low pass Bessel filter. In concurrent video 
measurement, ANDOR iXon 885 CCD camera (Andor Technology, Belfast, 
Northern Ireland) was used. 
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4.4.2 Calcium imaging (III) 
Ratiometric calcium imaging was used in Study III to assess the Ca2+ handling in 
LQT-type cells. The CMs were plated on glass coverslips and loaded with 4 μM Fura-
2 AM (Life Technologies Ltd, UK). Andor iXon 885 CCD camera and inverted 
Olympus X71 microscope were used in imaging. Camera was synchronized with 
Polychrome V light source to excite the cells at 340 nm and 380 nm wavelengths. 
The emission was detected at 505 nm. The 15 s recordings were categorized by 
amplitude stability, arrhythmias due to multiple peaks and smaller amplitude events. 
4.4.3 Concurrent calcium imaging and video measurements (IV) 
Study IV involved a simultaneous measurement of calcium and video imaging. To 
determine the feasibility of measuring motion from a video with calcium 
fluorescence, a protocol for alternating between measurement modalities was 
devised, as described below. The CMs were plated on glass coverslips and loaded 
with 4 μM Fluo-4 AM (Life Technologies Ltd, UK). Two light sources, Polychrome 
V and Olympus TH4-200, were used to create four different lighting profiles as 
shown in Figure 10.  
 
Figure 10.  Concurrent calcium and video measurement lighting profiles. The fluorophore excitation was 
synchronized with the video recording so the frames alternated between fluorescent imaging 
and only visible light. Mid-recording the background light intensity was increased to obtain 
transmission video images with visible light. Four different signals were calculated: PIV from 
the transmission frames, CaPIV from the fluorescent frames, Ca(dark) from the fluorescence 
frames without background light and Ca(bright) with fluorescent light. Image from Study IV. 
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Two imaging channels were used: Andor iXon 885 CCD camera was used in imaging 
and was synchronized with Polychrome V light source to excite calcium at 488 nm 
every other frame while the other frame remained unilluminated. TH4-200 light 
source was used mid-measurement to apply the background light, while still being 
able to discern calcium fluctuations. Olympus IX71 inverted microscope was used 
in the measurement. Both fluorescence and video signals were recorded through 
Olympus U-MF2 Alexa 488 bandpass filter cube (excitation 470-495, emission 
525/50 nm). Frame rates and resolutions varied; frame rates of 46-114 fps were 
acquired, resulting in 23-57 fps per channel. 
The process generated four different signals from the same region of interest: 
calcium transient signal with and without illumination (Ca (bright) and Ca (dark), 
respectively), and PIV signal with and without calcium excitation (PIV and CaPIV, 
respectively). Motion signals were measured as described in 4.3.2.2. The motion 
signals were integrated with respect to time to produce contraction signals, and linear 
detrending was used to correct the baseline. 
Both calcium and contraction signals were characterized by determining 
parameters describing waveform widths and amplitudes. Durations at percentages 
of the maximum peak height were defined for 10 %, 25 %, 50 %, 80 % and 90 %, 
as shown in Figure 11A. The time difference between contraction and calcium peaks 
were measured by calculating the time difference between the maximum rates of 
change in both onset and offset of each waveform, as illustrated in Figure 11B. To 
assess the effect of fluorescence to motion signal magnitude, symmetric mean 
absolute percentage error was calculated between PIV and CaPIV peaks for all 
signals. 
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Figure 11.  Parameters calculated in concurrent measurement of calcium and contraction. A) Duration 
parameters defined at 10%, 25%, 50%, 80% and 90% of maximum peak height. B) Time 
differences between maximum rates of change in calcium (blue) and contraction (red) 
signals. The time interval is defined positive when contraction follows calcium. The signals 
are scaled and fitted for illustration. Figure A is adapted from Study IV. 
4.5 Statistical analysis 
The statistical analysis was performed using MATLAB R2014a. In Study I and II, 
mean values and standard deviations (SD) were calculated for the determined 
parameters. In Study III, two-sample t-test was used in comparing two individual 
experiments and one-way ANOVA was used when comparing multiple experiments. 
Baseline and drug effect were compared using paired sample t-test. Standard error 
of mean was used in place of standard deviation. In Study IV, a two-sample t-test 
was used to determine the statistical difference between the measurement modalities. 
Linear regression was used and coefficient of determination was calculated in 
mapping parameters against each other. To demonstrate the variability of the cells, 
population SD was calculated instead of sample SD. Symmetric mean absolute 
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percentage error was used in determining differences in velocity magnitudes. In all 
studies, p-values below 0.05 were considered significantly different. 
Here in this thesis, additional measures of standard error of mean are calculated 
to make comparisons easier between the studies. 
4.6 Analysis tool interface development 
The tool was to be used both as standalone and as augment to other studies. Cell 
biologists actively participated in determining the tool capabilities and suggesting 
features. As such, it was subject to constant changes when new needs rose. Initially, 
the software was little more than a processing script to extract beating signals. 
Manual work was required to extract signal parameters. During a study, the tool had 
typically gone through a number of adaptations many of which were not 
implemented in the study at question, as it would have required repeated re-analyses 
of the same data. 
The aim of the software tool was to provide a means for biologists to use 
contraction analysis as a low threshold method. For this purpose, a graphical user 
interface (UI) was to be developed to make the use of the tool convenient and 
intuitive. Semiautomatic operation was considered necessary for providing users 
with control over the analysis, while keeping the user experience streamlined and the 
interface uncluttered. 
A number of requirements was set for the tool, and other features were added 
along the way. The software was to analyze cells one at a time by determining cell 
location, region of interest and beating focus point. It was to calculate the velocity 
vector signals for all sectors and represent them for the user. In addition, it was to 
calculate the waveform templates and calculate time intervals characterizing the 
signal. The user was to be able to upload the results of the analysis to an online 
database and generate result reports in PDF format. 
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5 RESULTS 
The results presented here are divided in categories: the results from the validation 
of the method on artificial data and on control-type cells, results from patient specific 
cells, and finally the video analysis tool resulting from the study. 
5.1 Video analysis method validation 
5.1.1 Cardiomyocyte beating velocity signal characterization (I-IV) 
The MQD method estimates where a certain windowed region has moved between 
the two frames, resulting the distance and direction for each window. Using the 
protocol described in 4.3.2-4.3.2.3, signals characterizing the CM beating were 
obtained. 
The method enabled successful quantification of beating from cells where the 
beating resulted in movement of cell textures and the moving area was large enough 
to support 16x16 windowing. Movement consisting of primarily Z-directional 
movement manifested itself as changes of pixel brightness in the cell. Without X/Y-
directional movement, measuring the motion was difficult and occasionally 
impossible. While the changes in pixel intensity are visible to human eye, it was not 
detectable using the PIV block matching method. These cell videos were not 
included in the analysis.  
The beating signal shows the motion magnitude on an arbitrary scale. For 
illustration, the magnitude is shown linearly normalized to 0-1 interval. A typical 
beating signal is shown in Figure 12. The signal illustrates the contraction cycle of 
the cell with two peaks in opposite directions: a contraction and the relaxation. 
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Figure 12.  A typical beating signal as a function of time. An upward peak represents contraction and a 
downward peak relaxation. Zero level represents the baseline, with amplitude normalized to 
maximum contraction velocity. 
5.1.2 Validation of movement (I) 
To validate the method, artificial video data using a known displacement field set 
was created, a protocol described in 4.3.3. Correlation coefficients between the 
signals obtained from artificial data and the known displacement velocity was 
calculated. The results varied between sectors and directions, with mean value of 
0.95 for all sectors. The extent of contraction was not uniform from the beating 
focus point, as the cell was not uniformly round. Correlation of entire signals with 
differing amplitudes results in lower correlation figures. However, as the changes 
were done for each frame, measures such as time to peak and transient widths would 
not have shown any differences.  
The effect of noise to the measurement was tested using speckle noise. The 
correlation between the set displacement field and the one measured with different 
variances was calculated for three sectors to cover different parts of the cell. Figure 
13 illustrates the decline of mean correlation to the known motion with respect to 
noise level as maximum percentage change in pixel intensity. In essence, a 0.003 
variance resulted in maximum pixel value changes of ± 10 % and 0.015 variance 
changes of ± 22 %. 
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Figure 13.  Mean correlation of variances as a function of speckle noise percentage. A correlation of 
0.9 level can be achieved even at 9 % noise percentage level. Data adapted from Study I. 
As a reference, the pixel value fluctuation in a typical video recording was measured 
from a 300 frame recording used in Study I, in an area without cells. The values were 
found to be between ± 0.4-0.6 %. 
5.1.3 Template building (II) 
In Study II, the effect of frame rate and number of samples to forming the templates 
was studied as described in 4.3.2.4 and 4.3.3. The original 120 fps videos and the 
derived videos decimated to 60 fps and 40 fps videos were analyzed using templates. 
The correlation of template signals from 60 fps and 40 fps videos with resampled 
template signals from 120 fps videos were calculated. Halving the framerate to 60 
fps decreased the mean correlation in the measured cells in three sectors to 0.97, and 
dividing into three to 40 fps decreased it to 0.95. The correlations between resampled 
120 fps templates and 40 fps templates was found to be poor in two videos. The 
effect was found in videos with higher frame rate. 
The effect of number of beats to the template quality was assessed visually. 
Starting at 20 beats, the number of beats included in the calculation of the templates 
were decreased one by one. It was determined that the signal quality remained similar 
until 12 beats (60 % of the beats) were included. At six beats (30 %), the template 
quality was visibly poor in comparison with the original. 
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5.1.4 Concurrent video and patch clamp measurement (I) 
In the concurrent video and patch clamp measurement, described in 4.4.1, the 
contraction velocity signal was integrated with respect to time to obtain position 
data. It was compared with the current clamp data to measure the time difference 
between AP and contraction peaks. The time difference of all beats in the 
measurement consisting of control cells in Study I was found to be 306 ms with a 40 
ms SD, which is in line with a later study 232, as well as with previously reported 
values for rabbit ventricular myocytes 41. 
5.1.5 Effect of fluorescence on video measurement accuracy (IV) 
Brightfield video and calcium imaging was recorded in subsequent video frames. 
This procedure allowed the near-simultaneous assessment of the accuracy of the 
MQD based PIV method in the presence of fluorescent dyes. Transient duration 
parameters at widths 10, 25, 50, 80 and 90 % did not show any statistically significant 
differences between the signals measured in the presence of absence of fluorescent 
dyes, as can also be seen in Figure 14. As stated in 5.1.1, assessing the absolute 
magnitude of motion does not necessarily offer relevant information due to the 
difficulty of inter-cell comparison. However, the magnitude of motion of the same 
cell can be compared. When comparing the velocity amplitudes of the signals with 
and without fluorescence in all recordings involved in the study, a 5 % symmetric 
mean absolute percentage error was found.  
 
Figure 14.  Typical contraction signals with and without fluorescence. Blue shows the signal in the 
presence of fluorescence and red the signal in its absence.  
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5.1.6 Contraction-calcium dynamics measurement 
Due to the negligible differences in video measurement accuracy caused by 
fluorescence, contraction and calcium could be measured simultaneously. A typical 
signal from a concurrent measurement is shown in Figure 15, with calcium shown 
in blue and contraction in red. Contraction follows calcium with a delay and the 
contraction transient has a steeper fall than that of calcium, a finding that can also 
be interpreted from previous studies 16. 
 
Figure 15.  A typical calcium and contraction transient pair in a concurrent measurement scaled to fit 
on an arbitrary magnitude scale. Calcium shown in blue and contraction in red. 
The contraction and calcium transients were characterized using peak width 
parameters as described in 4.4.3. The signals were obtained from brightfield video 
frames with fluorescent calcium present. The peak width parameters in WT cells are 
shown in Figure 16.   
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Figure 16.  Fridericia beat rate corrected contraction and calcium transient characterization parameters 
at 10 %, 25 %, 50 %, 80 % and 90 % of the peak height maximum in WT cells. The transients 
at the peak 10 % have nearly the same width. The error bars show standard error of mean. 
The mid-transient 50 % values show a greater disparity as calcium transient width reaches 
600 ms – a near-baseline value for contraction. Data adapted from Study IV. 
5.2 Cell line specific studies 
5.2.1 Motion signal characterization of wild type cardiomyocytes (I) 
Motion signals obtained from wild-type cells were analyzed in Study I. The measured 
time parameter values were measured as such, without regard to beating rate. In our 
later study 171, Fridericia QT correction was used to account for different beating 
frequencies. When the same correction is applied to the results of Study I, the phase 
durations are easier to be compared with previously reported results, as the effect of 
different beating rate is decreased. Here, the results of the Study I are presented as 
QT-corrected and shown in Table 4.  
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Table 4.  Beating frequency corrected phase durations in WT cells. Data adapted from Study I. 
Cell 
(n = 13) 
Beats per minute (BPM) Phase 1 (ms) Phase 2 (ms) Phase 3 (ms) Phases 1-3 (ms) 
1 12.0 264 0 334 609 
2 18.2 282 0 411 693 
3 22.8 232 0 322 554 
4 23.6 264 1 328 592 
5 24.1 121 0 149 270 
6 24.6 317 6 397 720 
7 26.0 135 0 262 397 
8 26.3 171 10 451 632 
9 29.1 177 0 250 427 
10 36.5 226 1 274 501 
11 41.8 192 3 262 456 
12 43.1 245 0 323 569 
13 66.3 216 7 326 549 
 
Mean 27.3 218.9 1.7 313.6 536.1 
SD 9.1 60.2 3.1 82.2 124.9 
SME 2.6 17.4 0.9 23.7 34.7 
5.2.2 LQT patient specific cardiomyocytes (III) 
5.2.2.1 Motion signal characterization 
Typically, the relaxation movement followed the contraction movement with a delay 
of 0-2 frames in Study I, indicating a delay of 0-67 ms with 30 fps in individual beats. 
However, already a visual observation of LQT-type cells can reveal atypical beating 
behavior when compared to wild type cells. In LQT1A (G589D mutation) type cells, 
the cell stayed contracted for a prolonged time before relaxing. The LQT1B (ivs7-
2A>G mutation) type cells exhibited similar behavior, but also included twitching 
motion after the cell had seemingly relaxed. This behavior in mechanical phenotype 
was previously unreported and was a new finding. As described earlier, an additional 
phase 4 indicating the incomplete relaxation was required to characterize the beating. 
Typical signal waveforms of both LQT phenotypes were presented in Study III. 
Here, integrated waveforms of both are illustrated as well in Figure 17, showing how 
the previously reported waveforms relate to the integrated contraction curves used 
in later studies. While the characterizations “relaxation duration” and “incomplete 
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relaxation” seem misleading when considering the integrated contraction signal, the 
unintegrated motion signal represents better the actual visual observation. 
 
Figure 17.  Typical WT and LQT motion signals (above) and integrated contraction signals (below). 
Subfigures A-C represent the beating signals from WT, LQT1A and LQT1B cells, 
respectively. LQT1A cells exhibit a prolonged interval between contraction peak and 
relaxation peak in motion signal when compared to WT, where relaxation occurs shortly 
after contraction. LQT1B cells show multiple, smaller relaxation-associated peaks. 
In Study III, the WT cell lines used as control cells did not exhibit abnormal 
behavior. 17/24 CMs of type LQT1A exhibited phase 2, with two of these cells 
exhibiting also phase 4. Phase 2 was present also in LQT1B type cells (17/25), 
although its duration was not as long as in LQT1A type cells. 15 out of these 17 
exhibited phase 4. Control-type beating patterns were seen in the remaining cells of 
both LQT-specific cell lines. These results of these time parameters were presented 
in Study III similarly as in Study I without beat rate correction. Table 5 illustrates the 
durations of the phases with Fridericia beat rate correction. 
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Table 5.  Durations of beat phases in wild type, G589D and ivs7-2A>G genotypes in milliseconds, ± 
standard error of mean. Both control-like and abnormal beating phenotypes were observed 
in the patient specific cell lines. (*) indicates p<0.05 and (**) p<0.001 in two-way t-tests. Data 
adapted from Study III. 
 
 Phase 1 (ms) Phase 2 (ms) Phase 3 (ms) Phase 4 (ms) Phases 1-4 (ms) 
Control 
(n = 11) Normal 220 ± 18 3 ± 1 320 ± 15 0 543 ± 40 
       
G589D 
(n = 7) Normal 223 ± 24 12 ± 4 285 ± 12 0 520 ± 36 
(n = 17) Abnormal 204 ± 20 132 ± 22* 256 ± 21 26 ± 25 620 ± 61 
       
ivs7-2A>G 
(n = 8) Normal 188 ± 23 4 ± 2 288 ± 31 0 480 ± 54 
(n = 17) Abnormal 228 ± 25 35 ± 11 301 ± 21 254 ± 41** 818 ± 64 
5.2.2.2 Electrophysiological measurements 
In addition to the mechanical phenotype, the LQT phenotype was studied using 
patch clamp and calcium imaging in Study III. The APD50s in LQT1A- and 
LQT1B-type ventricular-like CMs were 458.5 ± 57.4 ms and 416.1 ± 221 ms, 
respectively. When compared to control-type ventricular-like CMs, APD50 was 
291.8 ± 21.5 ms, indicating a statistically significant difference, as was expected. In 
LQT1A type cells, spontaneous EADs were detected, but not in LQT1B type cells 
or WT cells. In calcium imaging, LQT1A type cells exhibited more severe 
abnormalities. Both disease genotypes displayed double peaks and small amplitude 
arrhythmias in calcium transients more than in WT cells. Calcium transients from 
LQT1A type cells had more double peaks, small amplitude arrhythmias as well as 
longer calcium transient duration than those from LQT1B type cells. Typical signals 
from the measurements are shown in Figure 18.  
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Figure 18.  Typical motion signals (top row), patch clamp recordings (middle row) and calcium 
transients (bottom row) from A) WT cells, B) LQT1A and C) LQT1B cells measured from 
different cells in non-simultaneous measurements. The most typical abnormality in LQT1A 
cells were prolonged contraction in motion signal and double peaks in calcium signal. In 
LQT1B, the most typical abnormality were interrupted relaxation in motion signal and spikes 
in calcium transient. The action potentials in both LQT1A and LQT1B were prolonged. Image 
adapted from Study III. 
The effect of K+ channel blockers was studied on WT and LQT1 type cells using 
patch clamp and calcium imaging. JNJ303, an IKs blocker, had a prolongation of 
APD50 and APD90 in WT cells (31% and 28%, respectively). However, it had little 
effect on LQT1A type cells (7.7% and 8.7%, respectively) and no effect on LQT1B 
type cells. The effect was reversible with wash-out. E-4031, an IKr blocker, prolonged 
APD50 and APD90 in WT cells (30% and 74%, respectively). No EADs were 
detected. In LQT1A type cells, the APDs were significantly prolonged (70% and 
314%). In LQT1B type cells, the prolongation effect was even larger (412% and 
771%). While the APDs were recovered by wash-out, the maximum diastolic 
potential was only partially recovered. 
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5.2.3 Simultaneous measurement of motion and calcium in CPVT cells (IV) 
Using the protocol described in 4.4.3, two CPVT lines were characterized with 
concurrent motion and calcium measurements. Widths of integrated motion signals, 
i.e. contraction signals, and calcium transient widths were calculated from all lines. 
The resulting values are listed in Table 6, and an example of the transients are 
illustrated previously in Figure 15.   
Table 6.  Beating rate corrected motion and calcium signal parameters. Mean transient widths at 
different peak heights ± SD. Data adapted from Study IV. 
 
Motion Calcium  
WT (ms) CPVTa (ms) CPVTb (ms) WT (ms) CPVTa (ms) CPVTb (ms) 
10% 157 ± 54 208 ± 109 150 ± 54 228 ± 77 239 ± 90 156 ± 98 
25% 236 ± 84 289 ± 116 222 ± 114 355 ± 102 390 ± 149 237 ± 157 
50% 328 ± 115 389 ± 145 297 ± 129 549 ± 140 531 ± 176 341 ± 174 
80% 473 ± 138 581 ± 109 414 ± 102 899 ± 232 707 ± 202 457 ± 202 
90% 606 ± 230 857 ± 302 536 ± 166 1132 ± 302 860 ± 267 527 ± 273 
When compared to WT, CPVTa and CPVTb motion and calcium transients appear 
to be similar in width. Although not directly comparable, the values for WT 90% are 
similar to the results obtained in studies I and III. The values characterizing WT 
calcium transient at 90% in Study III, however, were nearly 500 ms lower than the 
non-BPM corrected ones obtained in Study IV, indicating a large variability in the 
cells. 
The means of contraction related parameters did not show statistically significant 
differences between cell lines even without BPM correction, although CPVTa came 
close in 80%-90% parameters (p<0.1). In calcium related parameters, CPVTb 
showed statistically significant differences in 25%-90% parameters with BPM 
correction with background light on and 50%-90% without background light, while 
the calcium parameters not corrected for BPM only showed differences in 80%-90% 
parameters. Statistically significant differences were found between the 
corresponding contraction parameters and calcium parameters in WT, but not in 
CPVTa or CPVTb, even when adjusted for BPM. 
Linear regression was used to assess the similarity of the different measured 
signals. The coefficient of determination (R2) was used as a measure to characterize 
signal similarity using the BPM correction. The results are listed in Table 7.  
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Table 7.  Coefficients of determination in linear regression of the measured characteristics in all 
signal pairs. 
 
PIV / CaPIV  PIV / Ca(bright)  CaPIV / Ca(bright) 
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb 
10% 0.98 1.00 0.99 10% 0.70 0.07 0.40 10% 0.73 0.07 0.50 
25% 0.94 0.99 1.00 25% 0.70 0.50 0.94 25% 0.69 0.50 0.94 
50% 0.97 0.99 1.00 50% 0.58 0.65 0.77 50% 0.56 0.59 0.77 
80% 0.97 0.81 0.98 80% 0.46 0.04 0.55 80% 0.47 0.01 0.51 
90% 0.54 0.99 0.88 90% 0.53 0.09 0.30 90% 0.56 0.05 0.21  
 
Ca(bright) / Ca(dark)  PIV / Ca(dark)  CaPIV / Ca(dark) 
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb 
10% 0.91 0.89 0.46 10% 0.55 0.08 0.97 10% 0.55 0.08 0.99 
25% 0.93 0.77 0.85 25% 0.63 0.54 0.89 25% 0.58 0.55 0.85 
50% 0.93 0.97 1.00 50% 0.46 0.66 0.78 50% 0.42 0.60 0.77 
80% 0.95 0.95 0.99 80% 0.36 0.03 0.60 80% 0.37 0.01 0.59 
90% 0.92 0.80 0.98 90% 0.49 0.00 0.37 90% 0.50 0.00 0.25 
High coefficients were found in categories representing the same type of 
measurement, i.e. PIV/CaPIV and Ca(bright)/Ca(dark). There was a limited 
connection between calcium and motion in WT and CPVTb, and overall a poor 
connection in CPVTa. As the Ca(dark) measurements were not concurrent with 
Ca(bright) and motion measurements, the coefficients are typically smaller than for 
concurrent measurements due to variability between waveforms. 
Mean time differences between calcium and contraction maximum rise and fall 
velocities were calculated to assess the synchronicity of calcium and motion. Beating 
rate correction was used. The mean time differences and standard error of means 
for the three cell lines used are listed in Table 8.  
Table 8.  Mean time differences between maximum onset and offset rates of motion and 
calcium transients ± standard error of mean for the three cell lines. 
 
Onset (ms) Offset (ms) 
WT 109 ± 20 24 ± 15 
CPVTa 159 ± 29 20 ± 34 
CPVTb 70 ± 23 63 ± 17 
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Positive value indicates calcium transient reaching its maximum velocity in onset and 
offset before motion. One CPVTa-line cell showed contraction reaching its 
maximum fall velocity after calcium. This behavior was not seen in other cells.  
Although the differences between cell lines are not statistically significant, the 
values show signs of dissimilar contraction-calcium coupling dynamics. CPVTa has 
differing values based on results presented in Tables 7 and 8, where the possible 
disconnection between contraction and calcium modalities manifested itself as 
differing transient shapes and time differences. 
5.3 Video analysis tool 
The method was used in a video analysis tool, developed during the course of the 
studies. It is based on the MATLAB implementation of the method. A graphical UI 
was developed and using MATLAB deploytool, an implementation of the software 
enabled biologists and researchers studying cardiomyocytes to use it in their studies. 
At first, the analysis method was first ran from MATLAB command line as a 
combination of scripts. A UI was developed as the need for more analyses increased 
and the tool was to be used by other researchers, with background mainly in biology. 
A processing queue of videos made it easier and faster to handle large numbers of 
samples. After processing the videos, for analyzing vector field results the option of 
selecting the region of interest either manually or automatically using texture-based 
filtering was created. Similarly, an option for either manual selection or gradient-
based selection was devised for beating focus point. 
The UI enabled easy viewing of all 16 signals, as shown in Figure 19 illustrating 
the UI. The signal could be cropped to exclude portions with shaking or other 
undesirable portions to facilitate parametrization. The parametrization could be 
done either automatically by using the template method based on the signal peaks, 
or manually by selecting points of interest from the signal. The results of the analysis 
could then be saved to a report. For storing analysis results, an online database with 
a web-based UI was acquired. The database was set up to categorize the results by 
saving key metadata of the results: date of recording, time, plate index, cell line, 
genetic background, drug and concentration, data on cell environment, date of 
analysis, analysis operator and software version, as well as a packed video with its 
own metadata including duration. 
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Figure 19.  Video analysis tool UI. The user can view measured signals from different areas of the cell. 
The software uses peak detection algorithms for initializing parametrization. The user can 
view the signal simultaneously with the video, crop the signal, adjust various settings, such 
as modify the peak detection settings, flag extra peaks, and remove recording artefacts such 
as vibration. 
The web-based UI allowed reviewing of results and signals, searching with filters for 
results and downloading them. It also enabled uploading of original videos after 
directly recording, making it simple to link the analysis results directly to the original 
video and allowing multiple analyses of the same original recording. 
For the purpose of calculation speed, a C++ version of the calculation of vector 
fields was developed. It has support for the use of NVIDIA parallel computing 
model CUDA, which allows the use of graphics processing units in calculation of 
the vector fields, which is computationally the most intensive task. The process 
shortened the time required for analysis drastically, as the velocity vector field 
calculation is computationally the most demanding task. 
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6 DISCUSSION 
The aim of this thesis was to develop a novel method and tool for quantifying CM 
contraction-relaxation biomechanics using video microscopy. Its accuracy and 
functionality was validated and an analysis tool using the method was devised. The 
results obtained and shown in 5.1.1 and 5.1.2 show that the analysis method, based 
on block matching motion estimation, can quantify the beating of single dissociated 
CMs. The motion estimation from brightfield and phase contrast videos is non-
invasive, non-destructive and label-free. In addition, it is easy to perform and can be 
automated. The method can be used either standalone or as a complement to other 
studies. When complementing traditional electrophysiological measurements, it can 
be used either simultaneously or separately. Video analysis combined with methods 
such as patch clamp, calcium imaging and MEAs, form a comprehensive view on 
CM functionality. The resulting tool can be used in quantifying cardiomyocyte 
biomechanics in research use, determine drug responses in pharmaceutical studies 
and characterize genetic cardiac diseases. 
 
6.1 Video microscopy based quantification of contraction 
6.1.1 Method development 
The method uses PIV-based block matching algorithm to estimate the motion in 
videos recorded using brightfield microscopy. It calculates velocity vector fields from 
the video frames and determines signals characterizing the beating of the CMs. The 
tool and method was constantly subject to changes, starting from the comparably 
primitive first versions to the late stages. In addition to the development and use of 
the method, the UI and user experience required attention. For publications, a 
version of the analysis tool had to be fixed and the study performed using this 
version for processing of results and writing the publications, even if the method 
had been considerably improved meanwhile. This was seen in Study III, which was 
performed at the same time as Study I, but published later than Study II. The reason 
for the publication dates is that Study III required Study I to be published, as the 
analysis method had not been reviewed and accepted by a journal focusing on 
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technology. Before submitting the first study to a journal, a patent application was 
filed in December 2012.  
The decision of dividing the signals to tangential/radial motion was done 
specifically to analyze hiPSC-CMs, which typically have an immature sarcomere 
structure. In contrast to adult cardiomyocytes, the beating is fusiform and there is 
no specific contraction axis. Thus, the radial and tangential axes can provide specific 
information on the timing of movement in different directions. The version used in 
Studies I and III used a sector midline approach for deriving the directional signals, 
and the tangential/radial motion based on a manually selected beating focus point. 
The obtained results were consistent with visually observed beating. However, the 
method as such was not very sophisticated and it was changed in Studies II and IV 
to calculate the velocity components against a unit vector from its location to the 
beating focus point. This change has an effect on the results, although subjective 
observations deemed it minor (data not shown). However, we did not study its 
magnitude in detail. As the motion direction is determined based on the focus point, 
the method is sensitive to erroneous focus point detection. If the focus point is off, 
the transients may have small erroneous peaks as motion related to relaxation may 
be detected as motion away from focus point instead of motion towards focus point. 
Determining the beating focus point was a novel approach, one which was later also 
used in another study by Huebsch and colleagues 16. The division to radial and 
tangential signals was important, as the twisting of the cells were not present in all 
sectors similarly. Chen and colleagues noted the vector directions to provide greater 
temporal and spatial resolution, especially regarding more complex beating patterns 
229. The incomplete relaxation motion shown in cell line with mutation ivs7-2A>G 
was not evident in all sectors and directions. This was also highlighted in Study II, 
where the relaxation movement of the cell began earlier in some parts of the cell 
than others. Therefore, simple averaging over all sectors or analyzing all areas at the 
same time may not be optimal. In general terms, high signal-to-noise ratio in motion 
signals are obtained from cell areas with high density of vectors with high magnitude. 
Thus, detection and recognition of abnormal motion is challenging, if it occurs in 
areas with low magnitude of motion. 
6.1.2 Estimation of accuracy 
The artificial beating video developed in Study I was a step towards defining the 
accuracy of the method. The radial symmetry of the pinch filter produced a feasible 
approximation of the beating motion. The motion analysis results from the analyzed 
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video with distortion were similar in shape to the actual distortion, but there were 
differences in magnitudes. The sector division around the center point produced 
regions of interest of different sizes and the distortion field extended outside the 
region of interest. Producing a more extensive test set would also allow comparing 
different block matching methods. Test images had been used previously by 
Kamgoué and colleagues to determine the accuracy of their algorithm for measuring 
CM contraction. They estimated the measured velocity vector field to have a 
maximum error of 15 % from the known displacement field 12.  
The effect of speckle noise to the artificial data set was determined to be a feasible 
estimate to assess the noise resistance of the method. The type of noise was selected 
based on its perceived difficulty for PIV. The granular nature of speckle noise indeed 
does challenge the method - while the method was in some sectors capable of 
handling even high variance noise, in some sectors the quality decreased greatly. In 
retrospect, a test with Poisson type noise would have been more informative as it 
would better mimic conditions present in low-light imaging – simulating a more 
typical imaging problem. In the study, the magnitude of noise variance was not an 
easily accessible metric: a seemingly small 0.003 variance already indicated ± 10 % 
changes in pixel intensity. Comparing the re-calculated results shown in 5.1.2 with 
the typical noise level of ± 0.4-0.6 % measured during a recording shows the method 
to perform well even under noisy conditions, and only lose accuracy under 
excessively high noise levels. 
6.1.3 Video analysis prerequisites 
In studies I and III, the videos were recorded using 30 fps. As the frequency 
corresponds to 33 ms per frame and the entire beat may last only 200 ms, every data 
point is significant in determining signal shape. Thus, it was important to study the 
conditions that provide a good basis for analysis with the method. Study II examined 
the possibility of using correlation-based averaged templates in contraction signals. 
These templates provided a way of producing one-glance signals by using selective 
averaging based on correlation. The template method was used in Study II to answer 
the question of required frame rate and the number of beats necessary for creating a 
reliable template. Both factors influence the quality of the template, and thus the 
reliability of the measurement. We found that for templates, going lower than 60 fps 
or 12 beats in a signal started to reduce the quality of the template, as indicated in 
5.1.3. In later scrutiny of the results it was found that the resampling of high fps 
templates and matching with lower fps templates had induced an error in the 
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calculation. This error was due to the template formation process: the number of 
frames included in the template before the contraction peak was not modified 
correctly for different frame rates. This resulted in substantially worse correlations 
for the frame rate comparisons, as the total number of frames included in a template 
relies on the beating rate. Thus, the results regarding the frame rate in Study II should 
be approached with caution: lower frame rates perform better than the obtained 
results would indicate.  
While the approach of using correlation to compare the quality of templates was 
a reasonable approach, it did not give a very solid foundation to make conclusions. 
However, the study provided us guidelines for further studies. On the other hand, 
in Study IV the findings related to frame rate were not followed stringently due to 
practical reasons related to the study aims and equipment at hand. Furthermore, in 
this study, the minimum correlation was set much lower, effectively turning cross-
correlation templates into simple averaging as only the most erroneous peaks were 
disregarded. Also, due to the prevalent double peaks in data, the maximum rate of 
change was deemed a more suitable metric for synchronizing the templates than the 
contraction peak. Nevertheless, despite the low framerate in the studies I and III, we 
were able to establish statistically significant differences between cell lines. 
Huebsch and colleagues found 14 fps to be sufficient for determining CM 
baseline function by comparing against a recording with 100 fps 16. The measured 
parameters did not include separate contraction and relaxation times, as the analysis 
was more focused on the beating rate. They did note the low fps to underestimate 
the movement speeds. Sala and colleagues suggest frame rate of 70 fps or more for 
detailed analysis 232. The other research groups listed in Table 2 in 2.8.3 have typically 
either used frame rates below 30 fps and even below 15 fps, or very high frame rates 
up to 150 fps.  
Based on our studies, we could obtain meaningful measurement data with 20 fps 
in Study IV. Despite the erroneous results obtained in Study II regarding the 
template quality and frame rate, suggestions regarding the frame rate can be derived 
from the cell characterization in studies I and III, shown in 5.2.1 and 5.2.2.1. In these 
studies, the frame rate was 30 fps, and the borderline abnormal beating behavior had 
average durations in the range of 30 ms. As this is effectively the duration of one 
frame at 30 fps, the accuracy and reliability of results would benefit greatly from a 
doubled frame rate of 60 fps, or more. As the error in Study II regarding template 
creation caused the templates to contain extra baseline frames, the comparisons 
produced strictly worse results than what correct calculations would provide. This is 
partly confirmed by the frame rates used by other research groups: frame rates in 
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range of 15-30 have been used regularly as shown in Table 2. Although our studies 
did not include pharmaceutical studies, it is reasonable to suggest that high time 
resolution is meaningful when comparing effects of pharmaceutical substances on 
the same cells. Frame rates of >100 fps have been used in this context, as shown in 
Table 2.   
A key aspect of a successful measurement of motion relies on the obtained image 
quality. Captured video data, when uncompressed, represents gigabytes of data. If 
the videos are compressed with lossy frame-by-frame algorithms, the quality of the 
videos may suffer, and the analysis results become less reliable. In particular, high 
JPEG compression may induce a checkerboard pattern, referred to as Gibb’s 
phenomenon, which may drastically affect the PIV measurement. For best results, 
lossless video compression is recommended. 238 
 
6.1.4 Concurrent measurements with other modalities 
The effectiveness of video analysis was determined by using it alongside other 
measurement methods. Video analysis was used concurrently with patch clamp in 
Study I, where it served as a validation with gold standard of cellular 
electrophysiology to show the procession of AP to contraction. The signals were 
recorded simultaneously to measure the time difference between peaks. To our best 
knowledge, this was the first combined measurement of patch clamp and video 
microscopy motion analysis of hiPSC-CMs. The video based method was capable of 
measuring the contractile activity even though the pipette was blocking a large part 
of the cell area. Inserting the pipette visually dampened the beating slightly, but the 
exact effect was not measured. A time difference of 306 ± 40 ms SD between the 
peaks of PC and motion signal was detected, as indicated in section 5.1.4. The 
developed method fared well, as the results show similar delay as previously reported 
for rabbit ventricular myocytes. Later in a similar study using video microscopy 
analysis and patch clamp by Sala and colleagues, a time difference in the same range 
was obtained 232. 
In Study III, the calcium measurements and contraction measurements were 
done separately. A concurrent measurement of calcium and contraction on the LQT 
phenotype would have provided a more detailed view on the disease. For this 
purpose, it was important to determine a way to measure them simultaneously. Study 
IV implemented a concurrent motion measurement with calcium imaging. Similar 
studies had previously been done by Hayakawa and colleagues, and Huebsch and 
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colleagues. The former group separated phase contrast and fluorescence images by 
evaluating the oscillation minima of the fluorescence intensity. The latter group 
normalized pixel intensity within subwindows to induce tracking of textures rather 
than intensities. 14,16. We showed that using MQD, the measurement can be done 
directly without such corrections with high accuracy, with only a minor difference in 
baseline, as demonstrated in Study IV and section 5.1.5. Part of the observed error, 
especially related to the signal peak height between the motion signals from 
brightfield and combined brightfield-calcium imaging, can be explained by the time 
difference between the frames with and without fluorescence. The lowest frame rate 
for the individual channels was 23 fps, indicating a nearly 22 ms difference between 
brightfield and combined brightfield-calcium imaging. If the cells used in the study 
had had faster contraction mechanics, the frame rate effect would have been even 
greater. With a higher frame rate, a more detailed view on the differences between 
imaging systems would be obtained.  
The photobleaching of fluorophores in a simultaneous measurement can affect 
the measurement. As we were performing a simultaneous measurement, this was not 
a core research question in this study. The phototoxicity effects should be considered 
when using the method for measuring contraction-calcium dynamics, and a more 
detailed study with different background light levels would be essential. 
 
6.1.5 Signal parameterization 
At the onset of the first studies, little was known on the hiPSC-CM beating 
characteristics. Furthermore, the parameters to measure from the signals were not 
established. The observed differences in beating between dissociated WT and LQT 
specific CMs formed the basis of signal interpretation: WT cells were observed to 
relax shortly after contraction, and prolonged contraction present in LQT specific 
CMs was determined to be abnormal. Thus, our first parametrization only 
differentiated between contraction and relaxation, and more parameters were 
required. We added parameters regarding contraction-relaxation delay and 
incomplete relaxation to account for the LQT abnormality. Later, we characterized 
the motion using contraction signal, the integral of motion with respect to time. It 
enabled easier comparison between different modalities, such as calcium imaging 
and patch clamp.  
As there was considerable variation of beating rate between the measurements in 
studies I-IV, the contraction and relaxation times were not easy to compare. To 
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facilitate the evaluation of the results, Fridericia QT correction was applied to all 
results here. While generally used for clinical QT correction, it provided more 
uniform results that allowed greater comparability, as shown in 5.2.1 where we 
reanalyze the results of Study I using the correction. A beat rate correction is 
necessary, as the APD and Ca2+ transient durations in CMs are rate-dependent and 
thus the contraction duration, which depends on these functions, is rate dependent 
as well. This effect can be seen when comparing the results of Study I and III to 
Table 4 and Table 5, respectively. The corrected results demonstrated better the 
control/disease phenotype when comparing the time parameters, especially when 
considering the sum of phases I-IV. While the beat rate corrections, developed for 
ECG interpretation, do appear to function with single cells, it is likely they are not 
optimally suited for single cell motion studies. The correction to beat duration has 
been previously used in video microscopy contraction analysis by us 171, and by 
Maddah and colleagues 230. 
6.2 Cellular studies 
6.2.1 LQT phenotype 
Study III presented the characteristics of LQT-specific CMs with two mutations. 
The mutations expressed different mechanical and electrophysiological phenotypes, 
as shown in 5.2.2.1. The LQT1A (G589D mutation) mechanical phenotype showed 
a prolonged duration between the contraction and relaxation movements in contrast 
to the wild type cells as expected in LQT genotype. In LQT1B (ivs7-2A>G 
mutation) phenotype, the prolongation was present in some cells, but the more 
pronounced difference was seen in the incomplete relaxation sequence, where it 
manifested as a twitching motion in relaxation. These differences in beating behavior 
when compared to WT cells were previously reported only on whole heart level, 
where the prolonged APD resulted in prolonged regional ventricular contraction 239. 
However, the twitching motion related to LQT1B type cells had not previously been 
reported.  
These effects were seen typically in dissociated single cells or clusters of 2-3 cells, 
and their beating patterns were atypical: the contractile motion was not always 
directed towards a single point. The motion was twisting and fusiform. Combined 
with the 20x magnification, small resolution and a 16x16 window size, measuring 
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these cells was not a simple task. In addition, the way cells are adhered to the plates 
can affect the results, as a loose cell edge may increase the motion in some areas. 
Yet, signals that matched the visually observed phenomenon were able to be 
determined and the results were evident even when averaged over three different 
sectors, reducing the bias of manual selection. 
In LQT1A cells, the duration of interval between contraction and relaxation was 
measured from the end of contraction movement and start of relaxation movement. 
The velocities in contraction ending and relaxation beginning are small, making the 
question of determining these points relevant for accurate characterization. It can be 
argued what constitutes as a prolongation between the two time points, when it can 
be difficult to determine the point of zero movement from a noisy signal and thus 
the duration of the actual interval. However, the parameters were measured manually 
using the same criteria by the same observer. A repeated study on the same cell lines 
with a camera with higher frame rate could present a better view on the subject. The 
twitching motion in LQT1B cells was considered as incomplete relaxation. In effect, 
the cell relaxed in two phases in the video recordings. For LQT1B there was less 
room for interpretation than for LQT1A, as the mean pause between the relaxation 
movements was as long as 12 frames. However, defining the exact frames in a noisy 
recording was subjective, and thus created a source of error. 
The Ca2+ transients measured from LQT type cells had abnormalities consisting 
of double or more peaks, as well as spikes with small amplitude, as shown in Figure 
18 in 5.2.2.2. These effects were seen in WT cells as well, although they were more 
prevalent in LQT type cells. In LQT-type cells, these effects were more pronounced 
in LQT1A cells, which exhibited both features. In LQT1B, small upward spikes 
during calcium transient were the more prevalent than the double peaks. These 
spikes are a less pronounced feature than the double peaks. In both LQT-type 
mutations, the cell lines showed significantly prolonged APs in patch clamp study. 
EADs were present in 5/30 of the LQT1A-type cells, but not in the LQT1B-type. 
Although the APD prolongation was more severe in LQT1A type cells than in 
LQT1B type cells, inducing the prolonged state of contraction, the latter were more 
susceptible for ion channel blockers, as shown in 5.2.2.2. These factors may be 
associated with the interrupted relaxation sequence. Mechanically, the LQT1B type 
cells seemed to exhibit more problems in the beating behavior due to the presence 
of both prolongation of contraction-relaxation interval and the incomplete 
relaxation. The patients from which the cell lines were derived exhibited similar 
clinical long QT symptoms, although the LQT1B patient did have a longer QTc 
time. It could thus be possible for the heart to have mechanisms that compensate 
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for the phenotypes of the cell models. In addition, the abnormal beating behavior 
was not present in all of the cells, which could indicate that the healthier cells 
compensate for the abnormal ones when beating in syncytium. It could also mean 
that the prolongation has more symptomatic effects. When considering the 
recalculated contraction profiles in section 5.2.2.1, the calcium transients are more 
in line with the contraction waveforms. They show the LQT1A-specific cells to have 
more drastic abnormality in waveform than LQT1B, when compared to WT cells, 
which supports findings in patch clamp and calcium imaging that showed longer 
APD and double peaks, respectively. However, the total mechanical activity times 
calculated from the onset of contraction to the end of incomplete relaxation were 
longer in LQT1B than in LQT1A. It is uncertain if the activity is related to EADs 
manifesting themselves as aftercontractions, as EADs were not detected with patch 
clamp in LQT1B. However, patch clamp is by design an invasive measurement and 
thus it may affect the behavior of cells by disrupting activity that can be detected 
using other methods. The mechanical phenotype of LQT1 has later been analyzed 
also by Sala and colleagues 232 using the method presented by Hayakawa and 
colleagues 14,227. In their study, the disease phenotype was visible as prolonged 
duration of contraction, similarly as our findings indicated in LQT1A-type cells 232. 
They did not report LQT1B-type behavior. Aftercontractions similar to the ones we 
detected, however, have been reported by Nguyen and colleagues in studies 
involving dofetilide, a hERG channel blocker, where the compound caused 
aftercontractions and prolongation of total mechanical activity 240. 
6.2.2 Contraction-calcium dynamics 
In Study IV, we found the contraction to follow the calcium transient after a short 
delay, as expected. Contraction and calcium appear to have a close association, as 
was shown in 5.1.6 and 5.2.3. The motion and calcium signals showed independent 
behavior, which indicates that they provide complementary information. Although 
they share characteristics due to calcium inducing the contraction, a study that uses 
both modalities can give a more thorough view on cellular function. The measured 
onset- and offset-times indicate that there is considerable variation between the cells. 
Although the calcium and contraction measurements were done from the same 
region of the cell, the measured motion is a product of the local calcium driven 
motion and the deformation of the cell driven by other regions of the cell, which are 
both affected by the way the cells are adhered to the well plate. Thus, these aspects 
do not affect the calcium signal and the contraction signal in the same way. 
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The study implies that previously recorded calcium imaging data can be analyzed 
afterwards for determining the contraction movement. This enables revisiting 
previous studies to gain information on the calcium-contraction coupling, and how 
abnormal calcium transients translate to contractility. 
6.2.3 CPVT phenotype 
The CPVT phenotype was analyzed in Study IV as a demonstration of the 
simultaneous calcium-contraction measurement. Two different mutations were 
considered: exon 3 deletion (CPVTa) and V4653F mutation (CPVTb) in RYR2 gene. 
Unfortunately, the number of videos recorded was small and the video durations 
were short, as this study was not the main aim of the cell measurements performed 
by our collaborators. Despite the low sample size, the results did indicate towards 
CPVT not displaying an abnormal biomechanical phenotype at baseline conditions. 
This result is in agreement with previous studies, where the abnormal 
electrophysiological phenotype is revealed only when the beating rate is increased. A 
difference was discovered in linear regression of near-baseline calcium/contraction 
parameters for the cell line carrying the exon 3 deletion mutation. This difference 
would indicate a greater disconnection between calcium and contraction mechanics. 
This is in line with the exon 3 deletion mutation having a more severe clinical 
outcome than the V4653F mutation 163. However, due to the limitations of the 
number of the cells and recorded videos, and the absence adrenergic stimulation, we 
cannot obtain a solid foundation for this conclusion and a more detailed Study is 
required. 
6.2.4 The effect of cell culture and dissociated to single cells 
In our studies, dissociated CMs were used. The abnormal beating behavior was 
present in LQT specific CMs, and there is reason to expect dissociated CMs to 
exhibit more LQTS type behavior: DAD/EADs might not cause arrhythmias as the 
neighboring cells may act as current sinks 36. 
While the prolonged contraction was deemed abnormal in dissociated CMs, the 
contraction time for monolayers and large clusters appears to be longer for control 
cells 241 when compared to our results with dissociated single cells. Therefore, the 
parameters for abnormality depend on the cell culture. Further, the delay indicating 
the time when the cell stays contracted, could be characteristic to more mature cells, 
as it could be a feature of stronger sarcomere cooperation. Thus, sensitivity in studies 
with dissociated CMs may be higher than with larger clusters or monolayers, as the 
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more complex structures form a very different electrical and mechanical 
environment, which likely equalizes intercellular differences. Due to these reasons, 
foresight is advised when comparing analysis results of CM biomechanics from 
different cultures. 
Even though single cells are more sensitive to displaying abnormal behavior, it is 
unclear whether dissociated cells are the optimal choice for drug testing or if larger 
populations should be used, due to myocardium acting as a syncytium. Further 
considerations include cardiac 3D structures, which have shown to exhibit functional 
differences in cultures 242. Based on our observations, dissociated cells appear to 
offer greater sensitivity for characterizing LQTS as healthy nearby cells can 
overcome the abnormality in other cells. Greater sensitivity of dissociated cells has 
been reported by other groups as well 243. Nevertheless, monolayers and large 
clusters can be analyzed as well using the method. They may have multiple beating 
areas and by extension, multiple focus points and can thus provide multiple signals. 
Further, the beating areas may be asynchronous and the interplay of contractile 
activity at their boundaries is a candidate for future research.  
6.3 Feasibility of video analysis in different studies 
6.3.1 General cardiomyocyte studies 
The video analysis tool provides an easily accessible tool for CM studies. These 
studies typically involve using a microscope, as the beating of CMs is an integral part 
of their function. Thus, recording a video of this beating motion is a low effort 
procedure, as the cells are already being observed visually. As discovered in Study I, 
the camera requirements for recording a video are low: a camera attached to the 
microscope ocular suffices and smartphone video recording capability has been 
suggested to be sufficient 232. When the analysis of recorded video data is easily 
available, the motion analysis provides relevant data on cellular biomechanics and 
functionality can be linked with any CM study. Video analysis can also be used to 
monitor the cells in long-term cultures, when cameras are incorporated in culturing 
environment. 
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6.3.2 Genetic cardiac disease studies 
We demonstrated the characterization of CM beating abnormalities caused by LQTS 
in Study III and found different mechanical beating phenotypes. By analyzing CMs 
derived from individuals with genetic cardiac disease, in addition to motion 
abnormalities, the ratio of abnormally beating cells to control-like cells could provide 
a metric for assessing the status of the patient. Single dissociated CMs appear to 
provide greater sensitivity in detecting abnormal cell behavior. For this purpose, 
video analysis is a suitable method due to its non-invasive nature and good enough 
resolution to analyze such cells. Electrophysiological measurements would be 
required for more accurate results on normally beating cells, but abnormally beating 
cells alone would indicate susceptibility for arrhythmias. 
6.3.3 Pharmaceutical studies 
Video analysis method can be a feasible platform for drug screening in CM cultures. 
In contrast to more invasive analysis methods, the effect of the drug can be 
interpreted without interference from measurement agents. In addition, the method 
can be automated and it is scalable, paving way for high throughput screening. The 
method is well suited for early-phase safety assays, where the substances that cause 
abnormal beating can be omitted from more labor extensive electrophysiological 
studies. Due to their method of operation, cancer drugs in particular would benefit 
from the screening of abnormal mechanical function.  
While not included in this thesis, we have used the method in these studies to 
analyze the effect of E-4031 on the contraction duration parameters, as well as the 
contraction intensity and showed that motion analysis could detect dose-dependent 
decrease of magnitude from 30 nM level onwards 171. One of the key advantages of 
video analysis is that due to the possibility of repeated measurements in long term 
cultures, toxicity related to long term drug exposure can be detected 244.  
Human iPSC derived CMs have the potential to decrease the number of animal 
experiments required in drug discovery. Further, there are a number of differences 
between human CM physiology and animal models. 245 New methods, such as the 
one presented in this thesis, make these hiPSC-CM models more feasible to use and 
in turn make drug discovery more ethical. The results of Study IV could also be 
applied animal studies, decreasing the number of animals required, as contraction 
could be measured directly from calcium data. This translates into reduced costs and 
more ethical research. 
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6.3.4 Previous video analysis use 
In addition to the publications included in this thesis, the tool has been used in a 
number of studies and master’s theses, with the name BeatView and CellVisus. 
Optogenetic dyes have been assessed simultaneously with contraction measurement 
by Björk, Ojala and colleagues 171. CM functionality was measured in development 
of a fluorimetric oxygen sensor by Välimäki and colleagues 246. The imaging and 
measurement capability of a portable live-cell imaging system was demonstrated with 
a CM measurement by Rajan and colleagues 247. The impact of indirect temperature 
control for the portable imaging system on CM functionality was assessed by Mäki 
and colleagues 248. 
6.4 Video analysis tool 
The software tool developed during the presented studies was built in several stages, 
depending on the needs of the studies performed and the needs of the users. The 
resulting tool presented in 5.3 has been evaluation in various development stages 
and in use by cell biologists in Tampere University Heart Group since 2013 in its 
different forms. It allows the users to measure the cellular function prior to studies 
that are more laborious. Recently, it has also been used as a standalone method, as 
mentioned in 6.3.4. 
The use of the developed online database in gathering results ultimately leads to 
vast amounts of data characterizing the cardiomyocyte biomechanics. The possibility 
of filtering the experiments, data and results based on selected criteria enables 
pooling of results from different studies. As the database also saves the original 
videos and software version numbers, the database can be used to recalculate the 
data using newer software versions. The web-based interface enables directly 
uploading video recordings from measurement computers, subsequent easy 
downloading on analysis computers and the linking of the recordings with results. 
The current stage of automation in the software removes user-induced bias in 
parametrization of the signals. However, as unsupported arrhythmias and beating 
characteristics emerge, user intervention is required. With the use of the result 
database, the software can be modified to better parameterize the signals as defined 
by the researchers with most experience on the specific arrhythmias. 
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Barring unsupported arrhythmias requiring user interaction, the overall analysis 
process duration depends largely on the computer processing power. Changing the 
analysis process from MATLAB-based mpiv to the in-house developed C++ version 
using CUDA cut the processing times drastically. Due to this development in 
computing power, even real-time analysis can be achieved with typical imaging 
resolutions on desktop computers with dedicated graphics cards that support 
CUDA. 
The software is currently closed source. Its licensing terms are currently in 
internal discussion. 
6.5 Study limitations and biasing factors 
In contrast to other methods, video analysis requires actual movement from cells. 
Thus, the beating motion may be a biasing factor as only cells with visible beating 
were selected for the analysis. The calcium cycling required for calcium imaging may 
still be present even if the beating motion is weak, or nonexistent. The cells have to 
be sufficiently strong to beat in the first place, ignoring the weaker cells. As the CM 
induction process generates mixtures of subtypes: atrial, ventricular and nodal, there 
may be a bias towards a specific type of cells in the video recording selection process. 
Unfortunately, the most accurate methods for determining chamber specificity from 
CMs are with microelectrodes, and patch clamp the only measurement capable of 
determining the ionic activity. Thus far, the possibility of determining chamber 
specificity of CMs using contractility has not been studied. Further, the question of 
cell density is relevant also in this regard: there has been debate and doubt cast on 
its effect on determining the chamber specificity of cells based on their action 
potential morphology in single cells 137–139. This complicates the use of MEAs in 
conjunction with video analysis, as MEAs are not well suited towards measuring 
single cells. 
In studies I and III, the parametrization was done manually by the same observer, 
using the same criteria. However, the analyst had a priori information on the cell 
genotype, thus allowing room for possible bias. The effect of this bias is not believed 
to be large, as visual observations by another analyst in these studies on the 
percentages of abnormally beating cells were in agreement with the parametrizations 
of the beating signals. The method produces a number of signals from different areas 
of the cell. Selecting the areas and signals for further analysis and parametrization is 
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not obvious due to cell attachment and the fusiform nature of beating of the stem 
cell derived CMs. In studies I and III, three signals from three sectors were selected 
and the parameters calculated from those were averaged. In studies II and IV, no 
abnormal beating behavior was detected, which is why this averaging was not done. 
Typically, the subjectively highest quality signals were the ones with largest motion, 
as they showed the highest signal-to-noise ratio.  
While the method itself is non-invasive, the cells are stressed by the measurement 
due to light needed for the video recording. However, in regular video recording, no 
high intensity light is applied and thus the effect is minimal. However, there has not 
been extensive research on the effects of long-term low intensity light or pulsed 
lighting. We did recognize the effect of laboratory lighting from fluorescent tubes in 
the video analysis, as the overall lighting of the room with a window changed during 
the day (data not shown). The effect was not substantial or systematic enough for a 
full report, but it is a factor that should be taken into account when comparing results 
from different laboratories in detail. 
All the studies suffered from small sample sizes. This diminished the importance 
of Study IV in particular, where the analysis of CPVT cell line was severely limited 
and was used only for demonstration. While only few cells were analyzed in Study 
II, the focus of that study was in the technique itself. The sample size also affected 
the nature of studies that could be performed, as they limited the possibilities to 
analyze further the parameters: for instance, we were not able to look into the 
intensity of contraction. With small sample size, the effect of cell adhesion plays a 
large role in contraction intensity and population-wide differences could be masked 
by differences between individual cells. With larger cell populations, we could also 
have taken the cell adhesion points into account, as suggested in master of science 
thesis by Muhonen in 2016 249. 
6.6 Future aspects and studies 
The work opens new venues of CM research. As the process of video recording and 
the entire video analysis procedure can be automated, the functionality of the cells 
could be measured periodically in incubators during their lifetime, and report the 
gathered statistics directly to researchers. The technology could also be implemented 
in microscopy stations, which could monitor the functionality of the cells in real time 
while any CM microscopy study is conducted, and inform the operator if the cells 
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exhibit abnormal behavior. As the method can be used in conjunction with other 
measurement modalities, such as Ca2+ and voltage indicators, the scientific 
community can gain a more complete view on the CM functionality on a single cell 
level, as already demonstrated by us 171. 
The biomechanics of other genetic cardiac diseases remain unexplored, as well as 
the effect of pharmaceutical agents on their biomechanical phenotype. A future 
study of motion-calcium coupling in CPVT cells should include adrenergic 
stimulation to induce arrhythmias. As the arrhythmias in LQT specific cell lines were 
detected using the method, it is a reasonable assumption that arrhythmias related to 
CPVT can be detected as well. In addition, a study of motion-calcium coupling in 
LQT cells could help understand the differing phenotypes. 
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7 SUMMARY AND CONCLUSIONS 
The aim of the thesis was to develop a video image-based analysis method for 
analyzing cardiomyocyte biomechanics, and to use it to characterize genetic cardiac 
disease. The following conclusions can be made based on the results of the studies. 
1. Cardiomyocyte video analysis in general, and the developed tool in particular, 
enables an accessible way to assess the biomechanics of cardiomyocytes. Video 
analysis provides an easy and fast way for cell biologists and scientists to 
determine biomechanical functional characteristics of the cells as a standalone 
method, or as a way to augment other types of measurements. 
2. Video image analysis has a number of advantages beneficial to high throughput 
applications, important for pharmaceutical research. The process described here 
requires little user interaction, allowing future full automation. The method uses 
no labels, is non-toxic and minimally invasive, allowing repeated measurements 
of the same cells at different time points. 
3. The biomechanical phenotype of long QT syndrome cell in human induced 
pluripotent stem cell derived cardiomyocytes was studied using the method. For 
the first time, abnormal mechanical beating was discovered and measured on a 
single cell level. Two different long QT genotypes exhibit differing 
characteristics in beating as well as calcium cycling and electrical properties. 
4. While the beating signals recorded with low frame rates can be parametrized, 
low frame rate and low number of beats will result in error in averaging of signals 
and the loss of detail. Especially for studies where small changes and the function 
of the same cell is followed, a high frame rate would allow better discrimination. 
5. Concurrent calcium-contraction measurement without additional image 
corrections allows the simultaneous ionic and motion analysis, and also the 
analysis of contraction from previously recorded calcium imaging data, given 
enough fluorescence to ensure visibility of the cell. 
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6. CPVT cells exhibit normal beating phenotype in baseline conditions. Further 
research is needed to confirm or reject the preliminary findings in this thesis 
related to disconnection of contraction and calcium transients near baseline. 
These conclusions signify that video microscopy-based measurements of 
cardiomyocytes have feasible future applications in cardiomyocyte studies and in 
pharmaceutical research, as they provide a minimally invasive and high-throughput 
capable complement to electrophysiological methods. 
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Abstract
Background: The functionality of a cardiomyocyte is primarily measured by
analyzing the electrophysiological properties of the cell. The analysis of the beating
behavior of single cardiomyocytes, especially ones derived from stem cells, is
challenging but well warranted. In this study, a video-based method that is
non-invasive and label-free is introduced and applied for the study of single human
cardiomyocytes derived from induced pluripotent stem cells.
Methods: The beating of dissociated stem cell-derived cardiomyocytes was
visualized with a microscope and the motion was video-recorded. Minimum
quadratic difference, a digital image correlation method, was used for beating
analysis with geometrical sectorial cell division and radial/tangential directions. The
time series of the temporal displacement vector fields of a single cardiomyocyte was
computed from video data. The vector field data was processed to obtain
cell-specific, contraction-relaxation dynamics signals. Simulated cardiomyocyte
beating was used as a reference and the current clamp of real cardiomyocytes was
used to analyze the electrical functionality of the beating cardiomyocytes.
Results: Our results demonstrate that our sectorized image correlation method is
capable of extracting single cell beating characteristics from the video data of
induced pluripotent stem cell-derived cardiomyocytes that have no clear movement
axis, and that the method can accurately identify beating phases and time parameters.
Conclusion: Our video analysis of the beating motion of single human cardiomyocytes
provides a robust, non-invasive and label-free method to analyze the mechanobiological
functionality of cardiomyocytes derived from induced pluripotent stem cells. Thus, our
method has potential for the high-throughput analysis of cardiomyocyte functions.
Keywords: Cardiomyocyte mechanic functionality, Velocity vector analysis, Minimum
quadratic difference method
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Introduction
The withdrawal of drugs already on the market is most commonly due to cardiac side
effects. Cardiac safety analyses are currently done using animals as model organisms
and/or ectopic expression of single ion channels in non-cardiac human cells [1]. These
applications do not provide an optimal platform to explore the conditions in human
cardiac cells. Unfortunately, human cardiomyocytes (CMs) have been very challenging
to study, since the myocardial biopsy is a high-risk procedure and primary CMs dedif-
ferentiate quickly and stop beating in cell culture conditions. Also, the available
methods to measure the functionality of a cardiomyocyte (CM) are challenging and do
not provide high throughput.
Moreover, recent developments in stem cell technology, namely the invention of in-
duced pluripotent stem (iPS) cells, have increased the need for new methods to
characterize cells derived from iPS cells. iPS cells can be obtained from any individual
by reprogramming already differentiated mature cells such as skin fibroblasts into a
pluripotent state [2]. Therefore, by using iPS cells it is possible to obtain genetically de-
fined human pluripotent cells that can be differentiated into the cell type of interest,
for example CMs [3]. Recently, it has been shown that human iPS cell-derived CMs
have proper electrophysiological properties and assays using these cells can provide a
reliable alternative to preclinical in vitro testing [4].
The functional measurement of single CMs has traditionally been laborious and time
consuming. There are a few tools available for the study of the electrical properties of
individual cells. Patch clamp is a commonly used method for analyzing the function-
ality of single CMs, but this technique requires special, relatively expensive instru-
mentation, and laborious manual work that requires highly skilled personnel [5].
Microelectrode arrays (MEA) provide a platform for the analysis of larger aggregates
of cells with less manual work. Due to the dimensions of the electrodes and the dis-
tances between the electrodes, however, they are not suited for single cell function-
ality studies [6]. Voltage sensitive dyes such as di-8-ANEPPS provide one solution
for the analysis of single CMs. This method, however, is based on fluorescence im-
aging and the dyes interact with some ion channels, e.g. the product of the human
Ether-à-go-go-Related Gene (hERG), and thus potentially alter the electrophysio-
logical properties of the cells [7].
The electrical functionality of single CMs does not directly reveal the mechanical
properties of the cells. Atomic force microscopy (AFM) can be used to quantify the
mechanical properties of CMs, e.g. force. However, AFM is not well suited for long-
term measurements because it interferes with the cell [8]. Cellular electric impedance
measured with well plate integrated electrodes is also used to measure the beating
characteristics of cardiomyocytes [9]. The spatial resolution of the method is, however,
not high enough to study the movements within the cell in detail. High-speed video
microscopy can be used to obtain information from the beating cycle. Such methods
quantify the movement of single CMs with no intervention. By analyzing the move-
ments of the cells, it is possible to receive data from the mechanobiological functional-
ity of the cell and to combine the data with electrical measurements to understand
electro-mechanical coupling. Traditional video-based CM analysis methods [10,11]
may not, however, be optimal for the study of single iPS cell-derived CMs. The sarco-
mere structure of iPS cell-derived CMs is not fully organized [12] and, therefore, their
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beating is less uniform with no main contraction direction. Thus, better methods are
required that are robust in the detection of movement signals from these types of cells.
Here, we propose a robust, non-invasive method for the analysis of the beating dynamic
of single CMs with no clear axis of contraction by using recorded microscope videos. The
method is based on digital image correlation (DIC), more specifically its subtype the mini-
mum quadratic difference (MQD) method that has been developed mainly for particle image
velocimetry (PIV). Further, we use sectorial derivation of movement directions. The aim is to
provide detailed physical information on the dynamics and timing of the contraction and re-
laxation of stem cell-derived CMs. The previous methods used to analyze video data [10,11]
are not well suited for the analysis of heterogeneous beating. Our method is specifically
aimed towards the use of CMs derived from iPS cells. We present validation tests of the
method using artificial displacement images and current clamp recordings from human iPS
cell-derived CMs. Since the CMs derived from the cell line used here have not previously
been fully characterized, we also briefly provide the biological characterization data.
Materials and methods
Ethics statement
The study was approved by the Ethical Committee of the Pirkanmaa Hospital District
(R08070). A written informed consent from participants has been obtained.
Cell culture
Primary fibroblasts were obtained from skin biopsy and cultured under fibroblast culturing
conditions: Dulbecco’s modified eagle medium (DMEM, Lonza, Switzerland) contain-
ing 10% FBS, 2 mmol/l L-glutamine and 50 U/ml penicillin/streptomycin. 293FT-cells
(Invitrogen, CA, USA) were maintained similarly with 1% non-essential amino acids
(NEAA, Cambrex, NJ, USA). Plat-E-cells (Cell Biolabs, CA, USA) and irradiated or
mitomysin C (Sigma-Aldrich, MO, USA) treated mouse embryonic fibroblast (MEF,
Millipore, MA, USA) cells were cultured in the same conditions but without antibi-
otics. iPS cells were cultured with MEF cells as feeders in KSR-medium: knockout
(KO)-DMEM (Invitrogen) containing 20% KO-serum replacement (KO-SR, Invitrogen),
NEAA, L-glutamine, penicillin/streptomycin, 0.1 mmol/L 2-mercaptoethanol, and 4 ng/ml
basic fibroblast growth factor (bFGF, R & D Systems Inc., MN, USA).
iPS cells
iPS cell lines were established from the dermal fibroblasts of a 55 year old female using
lentivirus infection followed by retrovirus infection into the fibroblasts. The following cells,
plasmids and reagents were used: 293FT-cells, Plat-E-cells, pLenti6/UbC/mSlc7a1-vector
(Addgene, MA, USA), ViraPower™ Packaging Mix (Invitrogen), Lipofectamine™ 2000
(Invitrogen), pMX retroviral vector (hOCT3/4, hSOX2, hKLF4 or hc-MYC, Addgene),
and Fugene 6 (Roche Diagnostics, Germany). The full and detailed protocol has been
described earlier [2,13]. Two iPS cell lines from the same individual were used for the
studies: UTA.04602.WT and UTA.04607.WT.
Characterization of iPS cells
Reverse transcription polymerase chain reaction (RT-PCR). Total RNA was col-
lected from the iPS cells at passage 6 and purified with a NucleoSpin RNA II -kit
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(Macherey-Nagel, Germany). cDNA conversion was carried out with a high-capacity
cDNA RT -kit (Applied Biosystems, CA, USA) using 200 ng of RNA. RT-PCRs were
carried out with Dynazyme II (Finnzymes Oy, Finland) using 1 μl of cDNA as a tem-
plate and 5 μM primers. As positive controls for exogenous primers, PCR was also
carried out using the transfected plasmids (hOCT3/4, hSOX2, hKLF4, and hc-MYC)
as templates. Primers and reaction conditions for iPS cell characterization [2] and
PCR-primers for different germ layer markers [13] have been described earlier. β-actin and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used as housekeeping
control genes. Immunocytochemistry for pluripotency. iPS cells at passage 8 were
fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich) and stained with anti-Oct3/4
(1:400, R & D Systems), anti-TRA1-60 (1:200, Millipore), anti-Sox2, anti-Nanog,
anti-SSEA4, and anti-TRA1-81 (all 1:200, Santa Cruz Biotechnology, CA, USA). The
secondary antibodies (1:800, Invitrogen) were Alexa-Fluor-568-donkey-anti-goat-IgG,
Alexa-Fluor-568-goat-anti-mouse-IgM, or Alexa-Fluor-568-donkey-anti-mouse-IgG.
Vectashield mounting medium with DAPI (4′,6-diamidino-2-phenylindole, Vector
Laboratories Inc., CA, USA) was used to stain nuclei. Karyotype analysis. A commercial
company (Medix laboratories, Finland) defined the karyotypes of the iPS cell lines by using
G-banding chromosome analysis according to standard protocol. Formation of embryoid
bodies (EBs). EBs were cultured without feeder cells in EB-medium (KO-DMEM with 20%
fetal bovine serum (FBS), NEAA, L-glutamine and penicillin/streptomycin) without bFGF
for 5 weeks. RNA isolation and reverse transcription from the EBs was performed as
described above. The expression of markers characteristic of ectoderm, endoderm, and
mesoderm development in EBs was determined using RT-PCR (see above).
Cardiac differentiation and characterization
CM differentiation was performed by co-culturing iPS cells together with END-2-cells.
END-2-cells were cultured as described earlier [14]. To initiate CM differentiation, un-
differentiated iPS cell colonies were dissected mechanically into aggregates containing a
few hundred cells and placed on the top of Mitomycin C -treated END-2 cells in KSR-
culture medium without fetal bovine serum, serum replacement, or basic fibroblastic
growth factor. Ascorbic acid (Sigma-Aldrich) was also added into the medium with a
final concentration of 2.92 mg/ml [15]. The differentiating cell colonies were monitored
by microscopy daily and the medium was changed after 5, 8, and 12 days of culturing.
After 14 days, the 10% SR was added to the medium and ascorbic acid was no longer
used. RT-PCR for cardiac markers. RNA was collected from beating cardiac cells and
transcribed into cDNA as described for the pluripotent cells above. The reverse tran-
scription polymerase chain reaction (RT-PCRs) were also carried out in a way similar
to that of the pluripotency markers and primers of cardiac markers that have been
described earlier [13]. Immunocytochemical staining. The spontaneously beating
areas of the colonies were mechanically excised and treated with collagenase A
(Roche Diagnostics) as described by Mummery et al. [14]. Seven days after dissociation, the
cells were fixed with 4% paraformaldehyde for immunostaining with anti-cardiac-troponin-
T (1:1500, Abcam, MA, USA), anti-α-actinin (1:1500, Sigma-Aldrich), anti-myosin-
heavy-chain (MHC, 1:100, Millipore), anti-atrial-myosin-light-chain (MLC2a, 1:300,
Abcam), and anti-ventricular-myosin-light-chain (MLC2v, 1:150, Abcam). The sec-
ondary antibodies (1:800, Invitrogen) were Alexa-Fluor-568-donkey-anti-goat-IgG,
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Alexa-Fluor-568-coat-anti-mouse-IgG, Alexa-Fluor-488-donkey-anti-rabbit, and Alexa-
Fluor-488-donkey-anti-mouse. Vectashield mounting medium with DAPI was used to
stain the nuclei. Dissociated CMs were prepared for video recording in the same way
as for immunocytochemical staining.
Video microscopy
Videos of the dissociated spontaneously beating single CMs were recorded using video
microscopy. Both iPS cell lines were used in the recordings and they gave identical results.
Thirteen CMs were video-recorded for 30 s at 30 frames per second under sterile condi-
tions. The CMs were visualized using a Nikon Eclipse TS100 (Nikon Corporation, Japan)
microscope and monochrome 8 bit videos were acquired with an Optika DIGI-12
(Optika Microscopes, Italy) camera mounted on the microscope. Additionally, two
CMs were videoed and their concurrent action potentials were acquired with current
clamp measurement for combined functionality verification. In this series, a high resolution
14 bit Andor XION 885 (Andor Technology, UK) camera mounted on an Olympus IX51
(Olympus Corporation, Japan) microscope was used. Transmission images were acquired
for 60 s at 50 frames per second using TILLvisION (TILL photonics GmbH, Germany).
Digital image correlation analysis
The term DIC refers to methods that acquire images and perform analysis for full-field
shape, deformation and/or motion measurements [16]. The images are divided into
small sub-regions where the grayscale values are cross-correlated between the consecu-
tive image frames to provide a displacement map that indicates the movements of the
scene [16]. Standard cross-correlation analysis emphasizes bright pixels due to the
multiplication of intensity values [16]. In CM images, however, all image pixels regard-
less of their grayscale value can contribute to the motion analysis. Therefore, the
weighting of bright pixels in the standard cross-correlation analysis is a clear disadvan-
tage. In this study, we removed this disadvantage by using the MQD method [17] that
puts equal weight to all image pixels. Additionally, MQD has been shown to be more
accurate than other PIV evaluation methods based on correlation [18]. The MQD
method was originally developed to evaluate PIV recordings. It uses a least-square
principle to obtain the velocity vector field across the image based on two consecutive
video frames [16]. Image sub-regions (i, j) are compared between the consecutive image
frames (I1 and I2) using the function (1):
Si;j dx; dyð Þ ¼
XN=2
x¼−N=2
XN=2
y¼−N=2
I1 iþ x; jþ yð Þ−I2 iþ xþ dx; jþ yþ dyð Þ½ 2; ð1Þ
where x and y are the indices to the pixels inside the sub-region of size [N, N]. The
sub-region in the second frame I2 is shifted in x- and y-directions by dx, dy to obtain a
value at point (dx, dy) in the quadratic difference map Si,j of sub-region (i, j). The com-
putational ranges of dx and dy can be freely selected to match the application. The lo-
cation of the minimum value in Si,j reveals the medial displacement of the scene inside
the sub-region (i, j). Due to small displacements between CM frames, the necessary
sub-pixel accuracy in displacement estimation is obtained by sub-pixel fitting on the
Ahola et al. BioMedical Engineering OnLine 2014, 13:39 Page 5 of 18
http://www.biomedical-engineering-online.com/content/13/1/39
minimum value (dx, dy) in Si,j with a 1-dimensional 3-point Gaussian interpolation fit-
ting function (2) to determine the correlation peak [19].
Δx ¼ ln S dx−1; dyð Þð Þ− ln S dxþ 1; dyð Þð Þ
2 ln S dxþ 1; dyð Þð Þ−2 ln S dx; dyð Þð Þ þ ln S dx−1; dyð Þð Þ½  ;
Δy ¼ ln S dx; dy−1ð Þð Þ− ln S dx; dyþ 1ð Þð Þ
2 ln S dx; dyþ 1ð Þð Þ−2 ln S dx; dyð Þð Þ þ ln S dx; dy−1ð Þð Þ½  ð2Þ
Cardiomyocyte analysis with MQD
Single CMs recorded on video were manually segmented for MQD analysis. The
non-moving parts of the cell were cropped outside of the region of interest to de-
crease processing time and noise. To obtain a cell-specific coordinate system for the
beating analysis, the beating focus point of the cell is selected by visual approximation from
the video and the region of interest is divided into 8 sectors, each comprising a 45-degree
sector from the beating focus (Figure 1A). This enables the analysis of the inconsistent beat-
ing patterns of iPS-derived CMs. For each velocity vector in a sector, two dot products are
calculated. First with regard to the center line of the sector, to calculate the approximate ra-
dial component, and second with regard to the normal of the center line, to calculate the
approximate tangential component (Figure 1B). The centerline normals pointing towards
sectors 1–4 were selected for sectors 1–4, and the normals pointing towards 5–8 for sectors
5–8. For each sector, the sum of these vector components was calculated. In total, 16
different signals, 8 radial and 8 tangential signals, were obtained from a video.
The analysis was conducted using open source Matlab algorithm mpiv [20]. A
16×16 px subwindow size with a 0.5 overlap ratio was used. The resulting vectors
were smoothed using a median filter. Possible stray vectors were determined and re-
moved if the vector was outside the range of 2.5 times the standard deviation from
the mean value. Kriging interpolation was used to assign values for vectors that did
not have applicable values. Finally, weighting was used to smooth the vector field
using a 3 × 3 kernel
1 2 1
2 4 2
1 2 1
as a low-pass filter.
Figure 1 Beating analysis framework. A: The cell is divided into 8 sectors, each being of 45°, with the
center point being at the observed beating focus point of the cell. The sectors are numbered in a clockwise
manner. B: The radial and tangential components of the velocity vectors in each sector are calculated with
regard to the sector centerline going through the beating focus point.
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Data verification
The proposed beating analysis was verified using artificial displacement images. We
modified still CM images so that they modeled the displacement of the pixels during
CM beating with known displacement. An image distortion filter [21] was modified
and used on a CM image to create artificial distortions that resembled the various
stages of a beating iPS cell-derived CM with no main contraction axis. The resulting
images were analyzed using the MQD method. Figure 2 illustrates the effect of the arti-
ficial distortion on an even grid image and on a CM image.
The artificial images for the video were constructed by stretching the cell with the
distortion γ. Each point (x, y) in the original image within a set radius from the deter-
mined beating focus was mapped onto a virtual half-sphere of radius R, and a new dis-
tance X to the beating focus point was set-based on the desired distortion factor γ, as
done in the original image distortion filter.
With this method, an image of a cell was modified with varying values of γ and com-
bined to a video to get artificial cell data resembling that of a beating cell. Artificial images
were created using 5 different γ values: −1, −2, −4, −7, and −10. The video was created
from a total of 51 frames representing two beats that comprised 10 still frames, 5 frames
with decreasing γ values, 5 frames with increasing γ values, 11 still frames, 5 frames with
decreasing γ values, 5 frames with increasing γ values, and finally 10 still frames. Figure 2A
shows an unmodified, original image of the cell and Figure 2B an image distorted using
the explained method with γ = −10. The values of X define the displacement that can be
compared with the results of the MQD analysis due to symmetry.
Figure 2 Artificial data set created from a cardiomyocyte image. An even grid and a cardiomyocyte
image are shown to illustrate the effect of the artificial deformation that was used to create the data set.
A: An even grid and a cardiomyocyte image without the artificial deformation. B: An even grid and a
cardiomyocyte image with the described deformation applied, γ = 10.
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Noise resistance testing
The noise resistance of the proposed method was tested by adding multiplicative
speckle noise to each frame of the generated artificial video data that was obtained
from modifying a CM image, as explained above. The cell size was 6796 pixels. Speckle
noise was added to each image using the equation J ¼ I þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ12  Vp  I  Ir , where I is
the original image, J is the resulting image, V is variance and Ir is uniformly distributed
random noise between values −0.5 and 0.5, with mean of 0. 8. The following noise vari-
ances were used: 0, 0.03, 0.05, 0.07, 0.09, 0.011, 0.013, and 0.015.
Beating analysis of cardiomyocytes
The analysis was carried out for the 13 CMs recorded on video. The time required for each
phase of beating was measured: the contraction, the time it stayed contracted, the relaxation
time, and the time it stayed relaxed. The beating frequency was also measured.
Current clamp measurement
To further verify the findings, the proposed video analysis was conducted from video
data recorded from iPS cell-derived CMs with concurrent current clamp measurement.
Action potentials were recorded using the Axopatch 200B patch clamp amplifier con-
nected to an acquisition computer via AD/DA Digidata 1440 (Molecular devices, USA).
The measurement was carried out at room temperature in gap free mode using the
standard current clamp configuration in perforated patch mode. The HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid)-based extracellular perfusate for
current clamp recordings comprised (in mmol/l): 143 NaCl, 5 KCl, 1.8 CaCl2, 1.2
MgCl2, 5 glucose, and 10 HEPES. The pH was adjusted to 7.4 with NaOH and the
osmolarity set to 300 ± 2 mOsm (Gonotec, Osmomat 030, Labo Line Oy, Finland).
The intracellular solution comprised (in mmol/l): 122 KMeSO4, 30 KCl, 1 MgCl2, and 10
HEPES. KOH was used to set pH to 7.15 and the osmolarity was set to 295 ± 2 mOsm.
Amphotericin B (Sigma-Aldrich) was used as a membrane perforation agent and was dis-
solved in dimethyl sulfoxide to a final concentration in the patch pipette of 0.24 mg/ml.
Current-clamp recordings were digitally sampled at 20 kHz and filtered at 5 kHz using the
lowpass Bessel filter on the recording amplifier.
Combining current clamp and video analysis
TTL synchronization pulses (1 pulse per frame) were delivered by the digital signal
processor-driven imaging control unit (programmed in TILLvisION) to synchronize
the transmission frames and current clamp data sampling. The pulses and current
clamp data were concurrently sampled using 2 channels in current clamp. The video
data obtained simultaneously with the current clamp measurement was processed
using the proposed method.
Results
Characterization of induced pluripotent stem cells
The generated iPS cells were first characterized by the morphology of the cell colonies and
the individual cells that exhibited similar characteristics to those of human embryonic stem
cells: compact and round in shape (Figure 3A), defined edges and distinct cell borders
(Figure 3B). The iPS cells also expressed endogenous pluripotent marker genes at the
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mRNA level that was shown by RT-PCR (Figure 3C). The expression of pluripotency
genes also at the protein level was demonstrated by the immunocytochemical staining
of different markers for pluripotent stem cells (Figure 3D). On the other hand, trans-
gene expression was turned off in the iPS cells (Figure 3E). To confirm the pluripotent
state of the iPS cells, an EB formation assay was carried out. The cells from the EBs
were shown to express marker genes from all three germ layers: endoderm, ectoderm,
and mesoderm (Figure 3F). The generated cell lines were also analyzed for their karyo-
types and were both found to be normal (Figure 4A and B).
Characterization of the cardiomyocytes differentiated from iPS cells
Generated iPS cells were differentiated into spontaneously beating CMs that expressed
different cardiac markers. Using RT-PCR, it was shown that troponin T (TNTT2),
Figure 3 Characterization of iPS cells for their pluripotency. Number 1 represents the cell line UTA.04602.
WT and 2 the line UTA.04607.WT. A: iPS cells formed typical colonies for pluripotent stem cells that are rather
compact and round in shape. B: The iPS cell colonies typically had well defined edges and distinct cell borders,
and the iPS cells had a high nucleus to cytoplasm -ratio and a large nucleoli characteristic for stem cells.
C: Endogenous pluripotency gene expression was studied using RT-PCR. Nanog, Oct4, Sox2 and Rex1 were all
expressed at mRNA level in the iPS cells. β-actin and GAPDH were used as housekeeping control genes for both
endogenous and exogenous markers. D: The expression of pluripotency genes was also studied at the protein
level by immunocytochemical staining. The iPS cell expressed several markers for the pluripotent state:
Nanog, Oct4, Sox2, SSEA4, TRA-1-60, and TRA-1-81 (all in red). Pictures in the left panel are from the line
UTA.04602.WT and the ones on the right side are from UTA.04607.WT. Blue in all pictures indicates the
DAPI staining of nuclei. E: Using RT-PCR, it was shown that all the transgenes were silenced in the iPS cells.
Negative control is marked with “-” and positive control with “+”. F: Embryoid body (EB) -assay was used to
define the pluripotency of the iPS cells in vitro. Markers for all three germ layers were detected from the EBs
formed from both cell lines. Alpha-fetoprotein (AFP) was used as a marker for endoderm, kinase insert domain
receptor (KDR, also known as vascular endothelial growth factor receptor 2 (VEGFR-2) was used as a marker for
mesoderm and nestin was used as an ectoderm marker. GAPDH was used as an endogenous control gene.
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MLC2v, MLC2a, connexin-43 (Cx-43), myosin heavy chain (MYH7), hERG, and GATA4
were expressed in the cells (data not shown for hERG and GATA4) (Figure 5A). The
expression of cardiac marker genes at the protein level was also confirmed (Figure 5B).
With immunocytochemical staining, it was also shown that both atrial and ventricular
cells were present among the iPS cell-derived CMs (data not shown). The electrical
properties of the iPS cell-derived CMs were also characterized using a microelectrode
array that revealed that the cell aggregates exhibited appropriate beating rates and field
potentials (Figure 5C and D).
Beating signals of iPS cell-derived CMs
The method was applied on iPS-derived CMs to obtain beating signals. One such signal
that shows two beats is shown in Figure 6A. For radial components, contraction was
Figure 4 Karyotype analysis from iPS cells. A & B: The lines were verified for normal karyotypes
(G: UTA.04602.WT and H: UTA.04607.WT).
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defined negative (Figure 6A II) and relaxation positive (Figure 6A III). Figure 6B illus-
trates a typical signal.
From the 13 measured cells, the time parameters of the different phases of the beat-
ing were calculated from the sum displacement signal using the proposed method. The
phases were the following: contraction, time the cell was contracted, relaxation, and the
time the cell was relaxed. The average values of three analysis signals for each cell were
calculated. The results for each cell measurement are presented in Table 1.
Figure 6C shows all 16 velocity signals obtained from one of the measured cells.
Figure 5 Cardiomyocytes differentiated from the iPS cells. A: Several cardiac markers were discovered
using RT-PCR indicating their expression at mRNA level. Data from UTA.04602.WT is shown here. B: By
immunocytochemical staining it was shown that the iPS cell-derived cardiac cells express proteins
specific for cardiomyocytes. Cardiac troponin T, α-actinin, myosin heavy chain (MHC) and atrial myosin
light chain 2 (MLC2a) were detected from the cells. The pictures on the left side are from the line
UTA.04602.WT and the pictures on the right side are from UTA.04607.WT. In the pictures showing MHC
and MLC2a with green fluorescent, red indicates troponin T and in all pictures DAPI staining of nuclei is
seen in blue. C & D: A micro electrode array (MEA) was used to define the electrical properties of the
iPS cell-derived cardiomyocytes. The beating rates (BR) and field potential durations (FPD) of cell
aggregates were evaluated (B: UTA.04602.WT, BR = 58, FPD = 283 ms and C: UTA.04607.WT,
BR = 66, FPD = 391 ms).
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Method verification using artificial displacement images
The DIC analysis results created using artificial displacement images are illustrated in
Figure 7. The figure shows (A) the division of the cell into analysis sectors, (B) the dis-
placement vector field during the contraction phase, (C) the known displacement vel-
ocity, and (D) the results of the DIC analysis (red) shown with the known displacement
velocity (blue). The average correlation coefficient between the known displacement
field and the analysis results for all 16 signals was 0.9525.
For noise resistance testing, 8 videos with speckle noise were created using different
noise variances. The proposed analysis was applied to these videos. For each video, 3
segments were chosen. The average correlation between the resulting signals and the
known displacement was calculated as a function of noise variance. The results for
three different sectors are shown in Table 2. Example images of different noise levels
are shown in Figure 8A-D.
Comparison with current clamp recording
Spontaneously beating iPS cell-derived CMs had the characteristics of ventricular- type
cells. The cells were beating individually and not part of a larger beating cell cluster.
Figure 6 The beating signals obtained from an iPS cell-derived CM. A: The classification of beating
phases. The time between each individual beat is marked with I. Contraction movement is defined as
negative movement (marked with II) and relaxation movement as positive (marked with III). B: An enlarged
image of the sector 8 radial component. C: The beating signals of each sector obtained from one of the
measured CMs. For various sectors, the contraction seems to push certain areas away from the perceived
beating focus point. This results in an upward peak in lieu of a downward peak due to the fusiform nature
of the beating. While most sectors produce a signal of high quality, sectors such as radial 5 have too little
movement to generate a well-formed displacement signal.
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Table 1 Multiple cell analysis
Cell Frequency (bpm) Contraction (ms) Contracted (ms) Relaxation (ms) Relaxed (ms)
1 12.03 451 18 571 3949
2 18.20 419 0 612 2265
3 22.78 321 0 444 1868
4 23.64 360 1 447 1730
5 24.12 164 0 202 2122
6 24.56 427 8 535 1472
7 25.98 179 0 346 1784
8 26.34 225 13 594 1446
9 29.13 225 0 318 1517
10 36.45 267 1 324 1053
11 41.82 216 3 295 921
12 43.13 274 30 361 727
13 66.34 209 7 315 373
Results obtained from multiple cell analysis. The times of the different beating phases in milliseconds and the
corresponding beats per minute (bpm) were measured from 13 cells.
Figure 7 Comparison of measured and known motion signals in different sectors. A CM image was
modified using image-processing methods with varying parameters to create a video resembling the
contraction and relaxation of the cell. In the upper row are illustrated A: the sector division, B: the velocity
vector field during the contraction, and C: the known displacement velocity. Since the artificial displacement
has circular symmetry, a horizontal cross-sectional displacement is shown. D: The proposed method was
applied to the video data and the signal marked with red was obtained. A blue signal illustrates the known
displacement field.
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The velocity vector data was integrated with respect to time in order to obtain pos-
ition data, and compared with the current clamp data to see the relationship between
the mechanical and electrical activity. The time between the peaks of electrical activity
and mechanical activity was calculated from the synchronized data.
The DIC signal onset occurred after the action potential onset and the action poten-
tial declined earlier. Figure 9 shows both signals from one of the recorded cells in the
same graph. The basic action potential parameters for the recorded cell are listed in
Table 3. The time difference between the peaks of action potentials and the maximum
displacement was 306 ms with a 40 ms standard deviation. The result is in line with
previously reported values [22].
Discussion
We developed a microscope video analysis method to provide accurate and detailed in-
formation on the beating motion dynamics of single CMs, especially those derived from
stem cells. We observed that our DIC-based methods are promising for the study of
Table 2 Analysis result correlation with known displacement
Radial component 1 Radial component 3 Radial component 5
Noise variance AVG SD AVG SD AVG SD
0 0.964 0.000 0.952 0.000 0.939 0.000
0.003 0.922 0.034 0.956 0.005 0.781 0.150
0.005 0.761 0.111 0.950 0.013 0.532 0.152
0.007 0.480 0.364 0.926 0.076 0.359 0.389
0.009 0.490 0.177 0.894 0.050 0.456 0.209
0.011 0.423 0.342 0.671 0.310 0.334 0.228
0.013 0.183 0.385 0.441 0.250 0.325 0.324
0.015 0.259 0.335 0.435 0.440 −0.041 0.410
The average correlations (AVG) of the analysis results with the known displacement field and their standard deviations
(SD). Noise with variances ranging from 0 to 0.015, with example images shown in Figure 6A-D, was added to video
frames that comprised the artificial displacement images of a cardiomyocyte. The average correlation of 8 videos
between the analysis results and the known displacement was determined, along with the standard deviation.
Figure 8 Assessment of the effect of noise on video beating analysis. Varying degrees of speckle noise
variance were added to a video for testing noise resistance. A-D: Example images for four noise variance
levels are shown: 0, 0.003, 0.005, and 0.015.
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the mechanical functions of CMs because they enable the cell geometry-based beating
parameters of cells to be calculated. Previously, DIC had been used for the analysis of
cell cultures [11] and the morphogenesis of the heart and changes in blood flow during
embryogenesis [23]. The displacement vector analysis approach has also been used for
the analysis of the motion of living embryos [24]. In these in vivo studies, fluorescent
particles were injected into the embryos and the motion of the particles inside the heart
was analyzed. Our method does not require the invasion of the cell or the use of an
artificial tracer and can be used for detailed single cell analysis.
DIC was found to be a viable complement to electrical studies in CM research. In
this study, we demonstrated that MQD can be successfully used to analyze single beat-
ing CMs. Further, dividing the cell into sectors and calculating the radial and tangential
signals for different parts of the cell provides a way to derive basic cell motion direc-
tions and thus motion signals related to cell geometry. This enabled the robust detec-
tion of all movements. This is especially important for iPS cell-derived CMs that do
not beat as uniformly as fully matured native CMs. As also shown here, the beating
does not have a main contraction axis and the beating shows fusiform characteristics.
In comparison to other similar methods that analyse contraction [10,11], our analysis
that uses a sector approach is advantageous for iPS cell-derived CMs that lack the well-
organized structure of mature native cells. Our results show that the eight sectors and
directional components provide signals that can be used to analyze the mechanical be-
havior of an IPS cell-derived CM. Because it does not depend on mathematical estima-
tors such as the principal components of motion vectors, the method is simple and
Figure 9 Combined current clamp and displacement data for a cell. A: Concurrent action potential
and displacement signal, integrated with respect to time from the movement data obtained from the video
data, are plotted in the same figure. The action potential data is shown in red and the movement data in
black. For current clamp data, the potential in mV is shown, whereas for movement data, the y-axis is
arbitrary. B: Image from the video data used for the analysis of a CM being recorded with current clamp.
C: An enlarged part of the signal showing the time difference between the action potential and the
displacement signal.
Table 3 Action potential parameters
Unpatched (bpm) Patched (bpm) Vmax (dV/dT) APD10 (ms) APD50 (ms) APD90 (ms) APA (mV)
39 42.52 43.08 97.67 279.53 371.00 116.30
CM action potential parameters in current clamp experiment. Beats per minute (bpm) for unpatched and patched cells
are listed. Maximal rise velocity (Vmax), action potential durations at 10%, 50% and 90% of repolarization (APD10, APD50,
and APD90, respectively), and action potential amplitude (APA) are listed.
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robust. In our method dividing the cell into sectors depends on the visual selection of
the beating focus point. While this approach allows flexibility in analysis, it could result in
a source of user based error. As the optimal selection of the beating focus point is not in-
herently clear, automated methods for beating focus point detection well warranted.
Our results indicate that our method provides a reliable signal, and the results of the
simulated data show that the method performs well in challenging noise conditions.
The sector analysis withstood noise very well and provided high correlation figures
compared to simulated movements. In addition, the speckle noise applied in the noise
resistance provides a good approximation of video noise. The simulation results indi-
cate that our method is also applicable with relatively low quality video data and that
the standard cameras used in microscopes are capable of producing video data that can
be used for reliable motion analysis.
We used current clamp, considered as a gold standard for the analysis of single CMs
[25] as a reference method to verify the timing of beating. The region of interest for
the analysis was partly hampered by the patch pipette that blocked a large part of the
view to the cell. Still, the mechanical behavior of the beating cells, which corresponded
to electrical activity measured with current clamp, could be detected with the MQD
method with good accuracy. Furthermore, we observed that the beating of the cell dur-
ing the patching was noticeably weaker indicating that patching can alter the function.
Thus, non-invasive and non-label methods such as those presented here are well war-
ranted for the detailed functional analysis of CMs.
Some issues should be taken into account when making the video recordings and the
motion analysis. For example, the cells in our test were of varying sizes and, despite
our best efforts, the video focus was not uniform for all cells. In some videos, noise in
the recording and video packing artifacts caused noise in the motion analysis signal. This
was especially observed for the cells that had weak beating, videos that were slightly out of
focus, and cells that had a uniform surface pattern. The calculated contraction and relax-
ation times for different cells were, however, similarly proportioned despite the noise. Based
on these findings, it can be stated that high quality recordings are not required. Since the
method creates the signal based on the moving patterns inside the cell, it can also provide a
good signal when the cell is attached to the surface and the outline does not move.
In many cases, the dissociated CMs are attached to the bottom of the culture plate in
such a way that the outline of the cell does not move and the movement can only be
seen by observing the moving patterns inside the cell. Some cells, however, also had a
moving outline. As a result, the cells have varying and fusiform movement patterns.
However, our method was able to derive the movement dynamics of all these cells by
using the cell geometry-based sectorial and directional summation of the PIV vectors.
The sectorial approach has specific benefits for the analysis of cells such as stem cell-
derived CMs with varying and inhomogeneous movement patterns inside the cells or
with a lack of a main axis of contractility. Due to these reasons, quantifying the extent
of the contraction or contractility of the dissociated CMs derived from iPS cells, e.g. in
pixels per time unit or movement in micrometers, is not meaningful.
Conclusions
MQD analysis using a sector approach provides a novel way for the non-invasive and
non-labeled function analysis of the biomechanics of CMs, especially those derived
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from stem cells. Motion analysis in general has clear advantages over other existing
methods: it requires very little training for personnel, it does not require external hardware
apart from a microscope and a video camera, it can be used for high throughput screening,
and it is non-invasive and label-free. Motion analysis can also reveal information that is be-
yond the electrical properties and ion movements of the cardiac cells such as actual bio-
mechanical timing and possible intracellular motion defects. Motion analysis is, therefore,
an important addition to any electrical study. Moreover, the motion analysis method may
provide an important addition to the traditional way of studying cell functionality, especially
the actual mechanical movement, namely the timing of contraction and relaxation of CMs.
Our method is especially designed to provide robust motion information from fusiform
inhomogeneously beating dissociated CMs derived from stem cells.
In conclusion, these capabilities in conjunction with improved stem cell technologies
that produce patient specific cell lines make the proposed system a good candidate for
high throughput drug screening, safety analysis, and the basic studies of cardiac diseases
using stem cell-derived CMs.
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Background: Long QT syndrome (LQTS) is associated with increased risk of ventricular arrhythmias and cardiac
arrest. LQTS type 1 (LQT1), the most prevalent subtype of LQTS, is caused by defects of slow delayed rectiﬁer po-
tassium current (IKs) that lead to abnormal cardiac repolarization. Here we used pluripotent stem cell (iPSC)-
technology to investigate both the electrophysiological and also for the ﬁrst time themechanical beating behav-
ior of genetically deﬁned, LQT1 speciﬁc cardiomyocytes (CMs) carrying different mutations.
Methods:We established in vitromodels for LQT1 caused by twomutations (G589D or ivs7-2ANG). LQT1 speciﬁc
CMswere derived from patient speciﬁc iPSCs and characterized for their electrophysiology using a current clamp
and Ca2+-imaging. Their mechanical beating characteristics were analyzed with video-image analysis method.
Results and conclusions: Both LQT1-CM-types showed prolonged repolarization, but only those with G589D pre-
sented early after-depolarizations at baseline. Increased amounts of abnormal Ca2+ transients were detected in
both types of LQT1-CMs. Surprisingly, also the mechanical beating behavior demonstrated clear abnormalities
and additionally the abnormalities were different with the two mutations: prolonged contraction was seen in
G589D-CMs while impaired relaxation was observed in ivs7-2ANG-CMs.
The CMs carrying two different LQT1 speciﬁc mutations (G589D or ivs7-2ANG) presented clear differences in
their electrical properties as well as in their mechanical beating behavior. Results from different methods corre-
lated well with each other suggesting that simplymechanical beating behavior of CMs could be used for screen-
ing of diseased CMs and possibly for diagnostic purposes in the future.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Long QT syndrome (LQTS) is an electric disorder of the heart that
predisposes patients to arrhythmias and sudden cardiac death. The ar-
rhythmias related to LQTS are distinctive ventricular arrhythmias called
Torsades de Pointes (TdP) [1]. LQTS type 1 (LQT1) is themost prevalent
subtype of the disease. It is caused by mutations in KCNQ1 gene
encoding theα-subunit of the channel responsible for the slow compo-
nent of the delayed rectiﬁer potassium current (IKs) [2,3]. The inade-
quate IKs current leads to prolongation of repolarization time of action
potentials (APs) in single CMs and to prolonged QT interval seen in
electrocardiogram (ECG). Various mutations in KCNQ1 have been iden-
tiﬁed to cause LQT1 possibly with varying clinical phenotypes [4,5].
Currently different LQTS subtypes are diagnosed with gene muta-
tions in particular genes. However, there is a huge spectrum of muta-
tions in each gene and the severity of the disease has been observed
to be more dramatic due to mutations in some genetic regions
compared to others [4,6]. Also in cell culture studies with transfected
cells, different mutations in the same gene have had different effects
on the electrical properties of the cells [7,8]. While some mutations
(e.g. G589D) seem to have rather mild and recessive effect on the IKs
current [8], other mutations (e.g. ivs7-2ANG) cause a complete loss-of-
function of the IKs channel in a dominant negative fashion [7]. Little is
known about the mechanisms of the ivs7-2ANG to cause the loss-of-
function effect on IKs current while G589D mutation seems to be a
clear trafﬁcking mutation with normal functioning of the channel but
with hindered transportation to the plasma membrane [9].
With induced pluripotent stem cell (iPSC) technology, it is possible
to generate genetically deﬁned stem cell lines [10,11] and differentiate
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these into any cell type of interest. Thereby, e.g. LQTS-speciﬁc CMs can
be generated and studied in vitro [12–18]. Traditionally the functionality
of CMs in cell culture is determined by electrical or optical analysis, such
as patch clamp-technique and microelectrode array (MEA) or calcium
(Ca2+)-imaging and voltage sensitive probes. However, all these
methods have some limitations. Patch clamp-technique is time con-
suming as well as invasive and cells die after measurements. Voltage
sensitive dyes and the tracers used in Ca2+-imaging may alter the elec-
trophysiological properties of CMs and the cells may also be damaged
by photo-toxicity [19] or compartmentalization [20] and cells die after
analysis. MEA can efﬁciently be used for cell clusters but due to the
physical dimensions of the electrodes and limitations in the sensitivity,
it is not suitable with single cells. In addition, thesemethods detect only
ion ﬂuxes that obviously are important but some other, currently even
unknown factors inﬂuencing the beating of CMs may be neglected.
The analysis of mechanical beating properties could reveal additional
information beyond the electrical phenomena and this analysis is nei-
ther invasive nor toxic and cells can be monitored for a long time.
In this study we present the electromechanical properties of LQT1-
CMs having different mutations in the KCNQ1 gene (G589D or ivs7-
2ANG). The electrical andmechanical behavior of the cells was analyzed
using a single cell current clamp, Ca2+-imaging and light microscopy
video-image analysis. CMs with either of the LQT1-genotypes had sig-
niﬁcantly prolonged APs, but only CMswith G589Dmutation had spon-
taneous early afterdepolarizations (EADs) at baseline. Additionally, also
abnormal Ca2+ transientswere observed in LQT1-CMs.We also demon-
strate that the mechanical beating behavior of the CMs with different
KCNQ1 genotypes has distinct mutation-speciﬁc features. This is the
ﬁrst published work where mechanical beating properties of LQTS are
studied at the single cell level and theﬁrst evidence that LQTS can be de-
tected by monitoring the mechanical beating of the cells.
2. Methods
The studywas approvedby the ethical committee of PirkanmaaHos-
pital District (R08070) andwritten consent was obtained from all ﬁbro-
blast donors.
2.1. Clinical information
LQT1 patient carrying G589D mutation is a 46-year-old female with
corrected QT interval (QTc) of 464ms. She has been suffering from syn-
copal spells. The other LQT1 patient is a 51-year-old female carrying
ivs7-2ANG in KCNQ1. She has suffered from dizziness, darkening of
vision and episodes of unconsciousness. Her QTc is 489 ms. Both of
these patient are on β-blocker medication. Control iPSCs were generat-
ed from a healthy female, 55 years of age with QTc of 406 ms. The pa-
tients with LQT1 were on beta blockers and no irregularities in the
QTc were found in the resting condition (Fig. 3 A–C).
2.2. Cell culture conditions
Primary ﬁbroblasts from the skin biopsy were cultured under ﬁbro-
blast culturing conditions using Dulbecco's modiﬁed Eagle medium
(DMEM, Lonza, Basel, Switzerland) with 10% FBS (Lonza), 2 mM
glutamax (Life Technologies Ltd, Paisley, UK) and 50 U/ml penicillin/
streptomycin (Lonza). 293FT-cells (Life Technologies Ltd) were cul-
tured in the same conditions with 1% nonessential amino acids (NEAA,
Cambrex, East Rutherford, NJ, USA). Plat-E-cells (Cell Biolabs, San
Diego, CA, USA) and irradiated/mitomycin C (Sigma-Aldrich, St. Louis,
MO, USA) treated mouse embryonic ﬁbroblasts (MEF) (Millipore,
Billerica, MA, USA) were maintained similarly but without antibiotics.
iPSCs were sustained together with MEF feeder cells in KSR-medium
containing knockout (KO)-DMEM (Life Technologies Ltd), 20% KO-
serum replacement (KO-SR, Life Technologies Ltd), NEAA, glutamax,
penicillin/streptomycin, 0.1 mM β-mercaptoethanol (Life Technologies
Ltd), and 4 ng/ml basic ﬁbroblast growth factor (bFGF, R&D Systems
Inc., Minneapolis, MN, USA). All the cells were grown at 37 °C and 5%
CO2 and the medium was changed every other day for iPSCs and two
times a week for all the other cells.
2.3. Generation and characterization of iPSC lines
The LQT1 patients carried either the G589D mutation of KCNQ1
(KCNQ1-FinA) or the ivs7-2ANG mutation in KCNQ1 (KCNQ1-FinB)
[21]. Skin biopsies from the donors were cultured in 0.2% gelatin
(Sigma-Aldrich)-coated ﬂasks under ﬁbroblast culturing conditions.
iPSC lines were established using lentivirus infection followed by retro-
virus infection. The full protocol has been described by Takahashi and
colleagues[10]. Cells, plasmids and reagents used in this protocol in-
clude: 293FT cells, Plat-E cells, pLenti6/UbC/mSlc7a1-vector (Addgene,
Cambridge, MA, USA), ViraPower™ Packaging Mix (Life Technologies
Ltd), Lipofectamine™ 2000 (Life Technologies Ltd), Fugene 6 (Roche Di-
agnostics, Mannheim, Germany), and pMX retroviral vectors (hOCT3/4,
hSOX2, hKLF4 and hc-MYC, all from Addgene). Several lines were
established from both patients and from control individual and two
from each were selected for further characterization. Studied cell lines
were UTA.00208.LQT1 and UTA.00211.LQT1 generated from KCNQ1
patient with G589D mutation, UTA.00102.LQT1 and UTA.00118.LQT1
generated from KCNQ1 patient with ivs7-2ANG mutation, and
UTA.04602.WT and UTA.04607.WT generated from healthy control
individuals.
Characterization of control iPSC lines is described in detail by Ahola
and colleagues [22]. LQT1 speciﬁc iPSCs were characterized similarly
by RT-PCR, immunocytochemistry, embryoid body (EB) and teratoma
formation. Teratomas were generated from one control iPSC line
(UTA.04602.WT) and two LQT1-lines one carrying G589D mutation
and the other ivs7-2ANG in KCNQ1. In addition, the karyotypes of all
the lines were analyzed. The lines were also assayed with PCR and re-
striction reactions to detect the correctmutations ofKCNQ1 from the ge-
nomic DNA and the control iPSC line was veriﬁed not to carry these
mutations. DNA was isolated using DNA Tissue XS-kit (Macherey-
Nagel GmbH & Co., Düren, Germany) and multiplied with AmpliTaq
360 Polymerase (Life Technologies Ltd) with 100 ng of template,
2 mM of MgCl2, 200 μM of NTPs, 0.5 μM of primers (G589D forward:
ttg act ctc agc tac ctc cc, reverse: tgc agg agc ttc acg ttc ac, ivs7-2ANG for-
ward: ggg gag ctg tag ctt cca ta, reverse: agc caa atg cat ggt gag at,
Biomers.net GmbH, Ulm, Germany), and 1 U/ μl of enzyme in total vol-
ume of 40 μl. Reaction conditions: 96 °C for 10min (96 °C for 30 s, 60 °C
for 30 s, 72 °C for 2min), 35 cycles, 72 °C for 5min. Digestion for KCNQ1-
G589D was done with HIN6I (Thermo Fisher Scientiﬁc, Inc., Waltham,
MA, USA) with Tango Buffer (Thermo Fisher Scientiﬁc, Inc.), and for
KCNQ1-ivs7-2ANG with Dde1 (Thermo Fisher Scientiﬁc, Inc.) using
FastDigest Buffer (Thermo Fisher Scientiﬁc, Inc.) both with 10 μl from
PCR in total volume of 20 μl at 37 °C over night. Products were run on
4% agarose gel (EuroClone S.p.A., Milano, Italy): wild type (WT) for
G589D (G589D-WT) generates product sizes 146, 82 and 39 bp, hetero-
zygote (Hez) for G589D (G589D-Hez) generates an extra fragment of
185 bp, ivs7-2ANG-WT produces sizes 228, 39 and 33 bp and ivs7-
2ANG-Hez an extra product with size of 261 bp. Extra fragments are
caused by vanishing of the cleavage sites due to the mutations
(G589D: 146 + 39 = 185, ivs7-2ANG: 228 + 33 = 261) (Fig. 2).
2.4. Cardiac differentiation and immunocytochemical characterization
of CMs
CM differentiation was accomplished by co-culturing iPSCs with
END-2 cells (a gift from Prof. Mummery, Humbrecht Institute, Utrecht,
The Netherlands). END-2 cells were cultured as described byMummery
and colleagues [23]. Differentiation was initiated by dissecting the un-
differentiated iPSC colonies mechanically into aggregates containing
a few hundred cells. These cells were then plated onto mitomycin
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C-treated END-2 cells in KSR medium without serum, serum replace-
ment, or basic ﬁbroblast growth factor but with 2.92 mg/ml of ascorbic
acid [4] (Sigma-Aldrich). The cell colonies were monitored daily by mi-
croscopy, and the medium was changed after 5, 8, and 12 days. After
14 days of culturing, 10% serum replacement was added to the ascorbic
acid free medium.
For immunocytochemical staining the beating areas of the cell
colonies were cut with a scalpel and treated with collagenase A
(Roche Diagnostics, Mannheim, Germany). Dissociated cells were
plated on 0.1% gelatin-coated 24-well platewells in KO-DMEM contain-
ing 20% FBS. A maximum of seven days after dissociation, beating cells
were ﬁxed with 4% paraformaldehyde (PFA, Sigma-Aldrich) for immu-
nostaining with cardiac markers: anti-cardiac-troponin-T (1:1500,
Abcam, Cambridge, MA, USA), anti-α-actinin (1:1500, Sigma-Aldrich),
anti-myosin-heavy-chain (MHC, 1:100, Millipore), anti-ventricular-
myosin-light-chain (MLC2v, 1:150, Abcam) and anti-atrial-myosin-
light-chain (MLC2a, 1:300, Abcam). The secondary antibodies were
Alexa-Fluor-568-donkey-anti-goat-IgG, Alexa-Fluor-568-goat-anti-
mouse-IgG, Alexa-Fluor-488-donkey-anti-rabbit-IgG, and Alexa-Fluor-
488-donkey-anti-mouse-IgG (all 1:800, all from Life Technologies Ltd).
2.5. Video recording
For the video recordings CMaggregateswere dissociated in the same
way as for immunocytochemical analysis (see above). Videos were re-
corded within a week from dissociation using video microscopy
(Nikon Eclipse TS100, Nikon Corporation, Tokyo, Japan) with a video
camera Optika DIGI-12 (Optika Microscopes, Ponteranica, Italy). 30–
60 second long monochrome videos were recorded with 720 × 480
resolution and 30 frames per second. Beatingwas determined as normal
if the rhythm was regular and the phases of contraction and relaxation
followed each other without any delay or additional movement of the
cell. Any deviation from that was considered as abnormal beating.
2.6. Beating analysis
In total 58 videos (13 controls, 24 LQT1-G589D (FinA)-speciﬁc and
25 LQT1-ivs7-2ANG (FinB)-speciﬁc) were analyzed using digital image
correlation (DIC) based analysis method, as described by Ahola et al.
[22]. In brief, the velocity vector ﬁelds representing video image gray
level changes in pixel level were calculated from subsequent video
frames using a minimum quadratic difference based DIC method. For
each CM, the beating focus point was visually determined and the CM
was divided into 8 sectors, each comprising of 45° sector, around the
beating focus point. With each selection, motion towards the beating
focus point was determined as radial, and perpendicular motion as tan-
gential movement. The sum radial and tangential components were
computed for each sector.
Out of the 16 possible signals obtained from a CM 3 signals were se-
lected based on the signal quality. From these signals the average pa-
rameters of beating were deﬁned: (1) duration of the contraction,
(2) timewhen contracted, (3) duration of the relaxation, (4) incomplete
relaxation time and (5) time when relaxed.
2.7. Allelic imbalance
Allelic discrimination between theWT andmutated KCNQ1 alleles in
CMs derived from different iPSC lines was done by qPCR using standard
curves. In order to establish a KCNQ1 allelic standard curves, the plasmid
with WT KCNQ1 and the plasmid containing the mutant allele were
combined with following ratios: 1:0, 8:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:8
and 0:1, respectively, for the qPCR reactions [12]. The standard curves
were done similarly for both mutations (G589D and ivs7-2ANG) ad-
dressed in this study. Plasmids used for the curve preparation were
pBluescript SK+ plasmids (Addgene) with the inserted gene at the
BamHI/NotI-site. The standard curves were plotted log2 of WT/mutant
ratios of plasmids versus corresponding ΔCt values. The ΔCt values
were deﬁned by subtracting Ct value of WT allele from Ct value of the
allele with the mutation. In standard curves, ΔCt values for plasmid ra-
tios are represented in statistical form of mean ± standard deviation
(n = 3) [18].
In addition,ΔCt values were deﬁned for KCNQ1mutations and those
were used for locate spots of KCNQ1 mutated samples on plasmid-
derived standard curves. The location of spot deﬁnes allelic imbalance
of mutation when compared to nearby plasmid ratios.
To determine the allelic imbalance of KCNQ1 in CMs originated from
different mutation speciﬁc cell lines (UTA.00208.LQT1with G589D, and
UTA.00118.LQT1 containing ivs7-2ANG) the clusters of beating areas
were ﬁrst cut using a scalpel and total RNA was puriﬁed from the cell
clusters with a NucleoSpin® RNA II Kit (Macherey-Nagel GmbH & Co.)
according to the manufacturer's protocol. The isolated RNA was con-
verted into cDNAs using a High Capacity cDNA Reverse Transcription
Kit (Life Technologies Ltd). For allelic discrimination the primers and
probes were designed by Custom TaqMan® SNP Genotyping Assay ser-
vice (Life Technologies Ltd). qPCR reactions were done using 7.5 μl 2×
TaqMan® Universal PCR Master Mix, 0.375 μl Custom TaqMan® SNP
Genotyping Assay, and 2.125 μl sterile water with total volumes of
12 μl and 3 μl of cDNA or plasmid DNA added into the reaction. The pro-
gram was initiated with 2 min at 50 °C and 10 min at 95 °C following
40 cycles of 15 s at 95 °C and 1 min at 60 °C.
2.8. Current clamp-measurements
2.8.1. Potassium channel blockers
Rapid delayed rectifying potassium (IKr or hERG) channel blocker, N-
[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl]
methanesulfonamide dihydrochloride (E-4031 [24] Sigma-Aldrich)was
dissolved in H2O (stock 2.11 mM) and stored at−20 °C. IKs blocker, 2-
(4-chlorophenoxy)-2-methyl-N-[5 [(methylsulfonyl)amino]tricyclo
[3.3.1.13,7]dec-2-yl]-propanamide (JNJ303 [25] Tocris Bioscience,
Bristol, United Kingdom) was dissolved in DMSO (stock 25 mM) and
stored at −20 °C. Experimental HEPES based perfusate with E-4031
and JNJ303 was freshly prepared on the day of use by dissolving the
stocks to ﬁnal concentrations of 100 nM and 300 nM (DMSO 0.03%), re-
spectively. Action potentials (APs) were unaffected by a 0.03% DMSO
vehicle tested in 5/5 CMs.
2.8.2. Measurement of action potentials
APs were recorded from spontaneously beating CMs in current-
clamp mode using the perforated patch conﬁguration [26] The HEPES
based extracellular perfusate consisted of (in mM): 143 NaCl, 4.8 KCl,
1.8 CaCl2, 1.2 MgCl2, 5 glucose, and 10 HEPES, pH was adjusted to 7.4
with NaOH (at room temperature) and the osmolarity set to 308 ±
2 mOsm with sucrose (Gonotec, Osmomat 030, Labo Line Oy, Helsinki,
Finland). The intracellular solution consisted of (in mM): 122 KMeSO4,
30 KCl, 1 MgCl2, and 10 HEPES. KOH was used to set pH to 7.15 and
the osmolarity was set to 302 ± 2 mOsm. Amphotericin B (Sigma-Al-
drich) was used as a membrane perforation agent and dissolved in
DMSO to a ﬁnal concentration in the patch pipette of 0.24mg/ml. Disso-
ciation of the spontaneously beating CMs was done similarly as for im-
munocytochemical staining and for video recordings but the cells were
plated onto 0.1% gelatin-coated cover glasses of 5mm⌀ for patch clamp-
measurements. The CMs were recorded on days 6–7 after plating.
Coverglasses with CMs were fast transferred to a preheated 36 ± 1 °C
fast RC-24N perfusion chamber (Warner Instruments LLC, Hamden,
CT, USA). An SH-27B inline heater (Warner Instruments LLC) was used
to preheat the perfusate. Cells were rested in the extracellular perfusate
for more than 10 min prior to patching. Patch electrodes (model
PG150T, Harvard Apparatus, Holliston, MA, USA) were pulled with a
PC-10 puller (Narishige International Limited, London, UK) and ﬂame
polished with microforge MF-900 (Narishige International Limited) to
a resistance of 3.0–3.5 MΩ measured in the bath perfusate. Drugs
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were applied using a gravity controlled VC3 perfusion system (ALA Sci-
entiﬁc Instruments, Farmingdale, NY, USA). APs were recorded in gap-
free modewith pClamp 10.2 using the Axopatch 200B patch clamp am-
pliﬁer connected to an acquisition computer via AD/DA Digidata 1440
(Molecular devices LLC). Current-clamp recordings were digitally sam-
pled at 20 kHz and ﬁltered at 5 kHz using the low pass Bessel ﬁlter on
the recording ampliﬁer. Numbers of CMs measured (n) are presented
in the Tables 2A and 2B, and Tables 3A and 3B.
2.8.3. Extraction of action potential characteristics
Following stabilization of the spontaneously generated APs in
current-clampmode, a baseline of minimum of 2 min was acquired be-
fore drug application. Gap-free traces of individual CM recordings were
then imported intoMicrocal Origin™ 8.6 or 9.0 and processed by an au-
tomated script. Beats per minute (BPM), AP duration at 50% and 90% of
repolarization (APD50 and APD90), AP amplitude (APA), and maximum
diastolic potential (MDP) were extracted. dV/dT (Vmax, maximal up-
stroke velocity) was extracted from the differentiated time course
traces as peak values corresponding to each single AP. Single AP charac-
teristics were then plotted as a function of time for evaluation and a se-
ries of minimum of 15 APs were averaged for each CM and used in the
statistical analysis. Ventricular-like CMs were deﬁned by APD90/
APD50 b 1.3 and APAN95 mV, atrial-like by APD90/APD50 N 1.3 and
APAN95 mV and ﬁnally nodal-like were deﬁned by APD90/APD50 N 1.3
and APA b 95 mV.
2.9. Combined current clamp-measurements and video analysis
APs from a CM of each cell line (control, G589D and ivs7-2ANG)
were recorded using a current clamp. During the current clamp-
measurement, a concurrent video was recorded using an inverted IX71
microscope (Olympus Corporation, Hamburg, Germany) and an
ANDOR iXon 885 CCD camera (Andor Technology, Belfast, Northern
Ireland). The video recordings were then analyzed using the previously
described method [22]. A good quality beating motion signal was select-
ed, and theAP and themotion signal for each cell linewere synchronized.
2.10. Calcium imaging
CMs were dissociated as described in the section about immunocy-
tochemical staining and plated onto 0.1% gelatin-coated 13 mm cover
slips. 6–8 days after dissociation the cells were loaded with 4 μM Fura-
2 AM (Life Technologies Ltd) for 30 min in HEPES based medium at
37 °C. After incubation the cover slips were moved to an RC-25 record-
ing chamber (Warner Instruments LLC) and perfused with 36 ± 1 °C
HEPES based solution (in mM): 137 NaCl, 5 KCl, 0.44 KH2PO4, 20
HEPES, 4.2 NaHCO3, 5 D-glucose, 2 CaCl2, 1.2 MgCl2 and 1 Na-pyruvate
with pH adjusted to 7.4 with NaOH. Ca2+-measurements were done
with an inverted IX71 microscope and UApo/340 ×20 air objective
(Olympus Corporation). Images were acquired with an ANDOR iXon
885 CCD camera (Andor Technology). A Polychrome V light source
(15 nm bandwidth) and the camera were synchronized by an external
DSP controller (TILL Photonics, Munich, Germany). TILLvisION software
was used to acquire image data (TILL Photonics). Fura-2 in spontane-
ously beating cells was exited at 340 nm and 380 nm light and emission
was detected at 505 nmand the data presented as ratios. The Ca2+ han-
dlingwas extracted for 15 s sweeps of spontaneous baseline beating and
categorized into different rhythm categories based on the types of ab-
normalities observed: normal beating with stable amplitude (N), ar-
rhythmias with double or more Ca2+ peaks (AD), and arrhythmias
with small amplitude Ca2+ events between the stable amplitude Ca2+
spikes (AS). A criterion for the AD group was a Ca2+ spike with double
or several peaks which do not reach the baseline. For the AS group the
presence of a small amplitude Ca2+ event of at least 10% of the preced-
ing Ca2+ spike amplitude was required. Numbers (n) of CMs measured
were: for G589D speciﬁc cells the n = 87, for 7-2ANGmutated the n =
80, and for control CMs the n = 45.
2.11. Statistical analysis
The variance between two experiments or more was calculated in
Microcal Origin™ 9.0. Variance between two individual experiments
was accessed using the two sample t-test and between more than two
individual experiments the one-way ANOVA-test was used and follow-
ed by a Scheffe's post hoc-test. In drug experiments, the baseline and
drug effectwere compared using paired sample t-test. p b 0.05was con-
sidered signiﬁcantly different and levels of signiﬁcance are represented
as (*) p b 0.05 and (**) p b 0.01. Data is shown as mean ± S.E.M. if not
otherwise stated.
3. Results
3.1. Pluripotency of the iPSCs
All the iPSC lines used in this study were veriﬁed for their
pluripotency (control iPSCs have been characterized earlier [22]). Both
control and LQT1-speciﬁc lines formed colonies typical for human plurip-
otent stem cells (Fig. 1 A). The iPSCs also expressed markers for pluripo-
tent state shown both by RT-PCT and immunocytochemistry (Fig. 1 C
and E), and the transgenes were silenced (Fig. 1 B). In vitro pluripotency
was shownby embryoid body (EB) formation (Fig. 1G) and in vivoby ter-
atoma forming assay (Fig. 1 F). All the lineswere also veriﬁed for the nor-
mal karyotype (Fig. 1 D).
3.2. Biochemical and genetic analysis of iPSC derived CMs
The expression pattern of spontaneously single beating cells was typ-
ical for CMs exhibiting troponin T,α-actinin, myosin heavy chain (MHC),
atrial speciﬁc myosin light chain (MLC2a) and ventricular myosin light
chain (MLC2v). Fig. 2 A–Cdepicts representative immunostainings of con-
trol (Fig. 2 A), G589D (Fig. 2 B) and ivs7-2ANG (Fig. 2 C) speciﬁc cell lines.
The LQT1-speciﬁc lines were found to carry the correct mutations
and these mutations were not found in control lines. This was deter-
mined by RT-PCR analysis and restriction enzymedigestion (Fig. 2 D–F).
3.3. Mechanical properties of LQT1-speciﬁc CMs
We ﬁrst visually analyzed the beating behavior of single CMs in
videos obtained from the two control lines, the two G589D speciﬁc
lines and the two ivs7-2ANG speciﬁc lines. Control CMs used in the
video analysis had a normal beating pattern (marginal irregularities,
see below) with only contraction and relaxation phases following
each other. However, with our two G589D speciﬁc lines we also ob-
served a large proportion of abnormally beating cells with a prolonged
phase of contracted state before relaxation. The two ivs7-2ANG lines
were also having a prolonged contraction/relaxation cycle. These cells
typically had normal contraction but the relaxation phase was
prolonged having vacillation before cells fully relaxed (see Supplemen-
tary videos 1–3).
Fig. 1. Pluripotency of iPSC lines. A: All the iPSC lines formed colonies typical for pluripotent stem cells. B and C: All the exogenous transgenes (Oct3/4, Sox2, Klf4 and c-Myc) were silenced
(B) and endogenousmarkers for pluripotent state (Nanog, Sox2, Oct3/4 and Rex1) were expressed (C). β-Actinwas used as a housekeeping gene. D: All the iPS cell lines had normal kar-
yotype. E: Immunocytochemistry demonstrated the expression of pluripotency markers. F: Cell types derived from all three germ layers were found in teratomas. G: The expression of
markers for the three germ layers was detected from EBs by RT-PCR.
23A.L. Kiviaho et al. / IJC Heart & Vasculature 8 (2015) 19–31
Videos from control as well as LQT1-CMs with either of the muta-
tionswere analyzed in detail according to the displacementmodel illus-
trated in Fig. 4 A (see also the Methods section). Representative signals
from single CMs from both LQT1-speciﬁc cell lines (G589D or ivs7-
2ANG) as well as from control CM are presented in Fig. 3 D–F. Normally
beating control CMs (n= 13) comprised only of the phases 1 (contrac-
tion), 3 (relaxation) and 5 (relaxed) (Fig. 4 B). However, in 17/24 CMs
with G589D mutation, a prolonged contraction time was observed:
They exhibited an additional phase 2 between contraction and relaxa-
tion phases, and during that phase the CMs stayed contracted. In a
minor proportion (2/17) of G589D-CMs, a phase 4 (incomplete relaxa-
tion)was also found (Table 1, Fig. 4 C). CMs carrying the ivs7-2ANGmu-
tation also exhibited a prolonged contraction (phase 2, in 17/25), but
the duration of the phase 2 was not as prominent as in G589D-CMs. In-
stead, ivs7-2ANG-CMs typically had rather normal contraction, but the
relaxation was abnormal and prolonged (in 15/17 CMs) due to vacilla-
tion (incomplete relaxation, phase 4, Table 1, Fig. 4 D). The time dura-
tions of different phases in control CMs and in CMs with the two LQT1
speciﬁc mutations are summarized in Table 1. There was some overlap
in the abnormal beating behavior between the two mutations: Howev-
er, only 12% (2/17) of the cells with G589D failed to relax normally, but
88% (15/17) of the cells with ivs7-2ANG demonstrated some prolonga-
tion in the contraction phase (phase 2). Beating patterns comparable to
controls were also observed in CMs with G589D (n = 7/24, 29%) or
ivs7-2ANG (n = 8/25, 32%).
When the absolute time of contraction (phases 1 and 2), relaxation
(phases 3 and 5) and incomplete relaxation (phase 4) was plotted
against the beating frequency the contraction time for the control cell
population (Fig. 4 E) stayed at the range of 0.25–0.5 s corresponding
the contraction time of human heart [27]. The relaxation time increased
with a decreased beating rate also resembling the behavior of human
heart. The abnormally beating LQT1-CMs presented contraction times
of up to 0.75 s, while the contraction times of the control cells were
less than 0.5 s (a not statistically signiﬁcant difference, one-way
ANOVA). If incomplete relaxation (phase 4) was added to the contrac-
tion time, the total times when the cells were not relaxed, were even
more different from the times observed in normally beating cells al-
though the difference was still not statistically signiﬁcant (Fig. 4 F and
G). The normally beating LQT1-CMs resembled control CMs regarding
their contraction-relaxation properties (Supplementary Fig. 1).
3.4. Allelic imbalance in patient speciﬁc cells
The allelic discriminations between the WT and mutated KCNQ1 al-
leles in CMs speciﬁc for either G589D or ivs7-2ANG mutation were de-
termined. The expression ratio between the WT and the G589D-
KCNQ1 was found to be 4:1 (WT:mutated) in both LQT1-G589D cell
lines (Supplementary Fig. 2). For the KCNQ1-ivs7-2ANG mutation the
discovered ratio was 3:1 (WT:mutated) (Supplementary Fig. 2).
3.5. Electrical properties of LQTS-speciﬁc CMs
3.5.1. Baseline characteristics
Representative APs from ventricular CMs (both G589D and ivs7-
2ANG-speciﬁc) as well as from control CM are presented in Fig. 3 G–I.
The majority of the CMs recordedwere ventricular-like and only amar-
ginal proportion was nodal-like (Table 2A). As expected, the APDswere
signiﬁcantly prolonged in nodal-, atrial- and ventricular-like LQT1-CMs
compared to the control CMs (Fig. 5 D, ANOVA, p b 0.05). MDPs for
atrial- and ventricular-like CMs were recorded from −65 mV to
−82 mV with overshoots of around +40 mV. In contrast, nodal-like
CMs were more depolarized and around −66 mV with overshoots
less than +25 mV (Table 2A).
Fig. 2. Characterization of iPSC derived CMs. A–C: The CMs expressed cardiac-speciﬁc proteins. The scale bars refer to 100 μm. D–F: The LQT1-speciﬁc lines carried the correct mutations
while noG589D or ivs7-2ANGmutationswere found in control cell lines. “A” in theﬁgure refers toG589Dmutation and “B” to ivs7-2ANG. Control CMs produced products of 146 and 82 bp
(and 39 bp, not shown in the ﬁgure) for G589D, and 228 bp-product (also fragments of 39 and 33 bp, not shown in the ﬁgure) for the region corresponding ivs7-2ANGmutation (D). Het-
erozygous G589D speciﬁc lines (one shown in E) created an extra product of 185 bp and heterozygous ivs7-2ANG lines had an extra product with the size of 261 bp (one in F). G and H
illustrate the cleavage sites for the restriction enzymes used, their disappearance due to themutations and the sizes of the products from the reactions for G589D (G) and ivs7-2ANG (H).
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In the G589D-speciﬁc CMs, but not in controls or in ivs7-2ANG-
speciﬁc CMs, spontaneous baseline early afterdepolarizations (EADs)
were observed in 16.7% (5/30) of ventricular-like CMs (Fig. 5 E,
Table 2B). These CMs with baseline EADs were not used in the drug
studies. Nevertheless, in these cells with spontaneous EADs we found
a consistent elevation of the APD90/APD50 ratios (N1.8) compared to
baseline ratios without EADs (b1.3). The ratio prolongation is due to
the presence of EADs evoking around−25mV, and thereby prolonging
only the APD90 value (see Fig. 5 E).
3.5.2. Effect of JNJ303 and E-4031
Ventricular-like CMs were exposed to the IKs blocker, JNJ303
(300 nM) and APs from the baseline, in the presence of JNJ303 and
after wash out was extracted (Fig. 5 F). In control CMs (n = 10),
JNJ303 signiﬁcantly prolonged APD50 and APD90 by a similar proportion
of 31% and 28%, respectively, but other AP characteristicswere unaffect-
ed (Table 3A). However, the effect of JNJ303 was only marginal on the
APD50 and APD90 in G589D-speciﬁc cells (prolongation of 7.7% and
8.7%, respectively, Fig. 5 F, middle panel), and in ivs7-2ANG-speciﬁc
CMsnoeffectswere observed (Table 3A, Fig. 5 F, lower panel). The effect
of JNJ303 was fully reversible following the wash out, and the beating
frequency was not signiﬁcantly affected. In a few cells from each
group the JNJ303 block was veriﬁed by a consecutive application,
which always was similar to the ﬁrst (Fig. 5 F, LQT1-G589D). The
APD90/APD50 ratios for the control, G589D-speciﬁc- and ivs7-2ANG-
speciﬁc CMs at baselines and in the presence of JNJ303 were similar
and found to be between 1.19–1.27.
To evaluate our IKsﬁndingswe also applied the IKr (hERG) blocker, E-
4031 (100 nM) on ventricular-like CMs. The effect of E-4031 from three
representative current-clamp recordings is shown in Fig. 5 G. In control
cells the APD50 and APD90 were prolonged by E-4031 (30% and 74%, re-
spectively), and the APD90/APD50 ratio was now increased from 1.21
(baseline) to 1.67 (E-4031) but no EADs were evoked (Fig. 5 G, upper
panel, Table 3B). In contrast, all ventricular-like CMs in the G589D-
speciﬁc group (5 cells) and in the ivs7-2ANG-speciﬁc group (7 cells) ex-
hibited EADswhen exposed to E-4031 (Fig. 5 G,middle and lower panel,
respectively). The G589D-CMs had APD50 and APD90 signiﬁcantly
prolonged by 70% and 318% (paired sample t-test), respectively, and
ADP90/APD50 ratios were found to be increased from 1.16 (baseline) to
2.18 (E-4031). In the CMs with ivs7-2ANG, APD50 and APD90 were
even more signiﬁcantly prolonged by 412% and 771% (paired sample
t-test), respectively, and ADP90/APD50 ratios were found to be increased
from 1.14 (baseline) to 2.09 (E-4031). In contrast to the effects of
JNJ303, E-4031 decreased the beating frequency of all CMs (paired sam-
ple t-test). All CMs tested with E-4031 became signiﬁcantly depolarized
during exposure (paired sample t-test), but the overshoot (peak) was
not affected by E-4031 (Fig. 5 G, Table 3B). Even though APDs nearly re-
covered followingwash out the,MDPs recovered only partially (Fig. 5 G,
right panels) after exposure to E-4031. In line with this, the beating fre-
quency increased following the wash out (data not shown).
3.6. Comparison of the electrical and mechanical phenotypes
The mechanical analysis was also conducted together with the cur-
rent clamp-measurements (Fig. 6). Thereby themechanical and electro-
physiological phenotypes could be compared and the timing of the
electrical activity and the contraction/relaxation of the cells could be
evaluated. In both cell types, control CMs (Fig. 6 A) and LQT1 speciﬁc
Fig. 3. ECGs of the donors and functionality of iPSC derived CMs. A–C: ECGs from the primary cell donors. D–F: Video recording analysis of control (D), G589D (E) and ivs7-2ANG
(F)-speciﬁc CMs. Contraction is indicated with downward peak and the upward peak refers to relaxation. Bars (E) indicate the phase 2 (see Fig. 4 A) and show the time when the CMs
stayed contracted and the highlighted areas (F) refer to the time of incomplete relaxation (phase 4 in Fig. 4 A). G–I: Ventricular APs from control CMs (G) and LQT1-speciﬁc CMs carrying
G589D (H) or ivs7-2ANG (I). J–L: Ca2+-imaging signals from control (J) and LQT1-speciﬁc CMs (K, L). Themost prevalent type of abnormal Ca2+ transients in ivs7-2ANG-speciﬁc CMswas
additional small Ca2+ transients (AS) (L, extra peaks marked with arrows) but in G589D CMs double or more Ca2+ peaks (AD) (K) in addition to AS were seen.
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CMs (Fig. 6 B), the AP was immediately followed by the contraction. In
LQT1 speciﬁc CMs the APD was clearly prolonged and the mechanical
abnormality correlated nicely with this prolongation (Fig. 6 B). Also,
the mechanical activity of the LQT1 speciﬁc cells seemed to continue
longer after the electrical activity had already stopped when compared
to control CMs.
3.7. Ca2+ handling of LQT1-speciﬁc CMs
To further study the functionality of LQT1 speciﬁc CMs, Ca2+ tran-
sients were measured during spontaneous baseline beating. In G589D
and ivs7-2ANG speciﬁc as well as in controls three major responses
were found. A robust beating pattern with stable Ca2+ amplitude and
frequency were characteristic for the majority of the control CMs (N),
while arrhythmias with double or more Ca2+ peaks (AD) or arrhyth-
mias with small amplitude Ca2+ events between the stable amplitude
Ca2+ spikes (AS) were frequently seen in G589D and ivs7-2ANG CMs
(Fig. 7 A, Supplementary Table 1). Both types of arrhythmias (AD and
AS) were seen in all cell types though the Ca2+ transient abnormalities
were more prevalent in both LQT1 speciﬁc cell lines compared to con-
trol CMs (Fig. 7 B). The cells with G589D had the highest proportion of
ADs (23%). The duration of the calcium elevation was signiﬁcantly lon-
ger in CMs with G589D exhibiting ADs compared to those showing AS
type of arrhythmia or normal beating (p b 0.01, one-way ANOVA). AS-
arrhythmia were also more pronounced in CMs with G589D resulting
in signiﬁcantly lower beating frequency (p b 0.02, one-way ANOVA).
Fig. 4. Analysis of LQT1-CMs using digital image correlation. A: An artiﬁcial illustration of a beating signal. 1: time of contraction (phase 1), 2: time in contracted state (phase 2), 3: time of
relaxation (phase 3), 4: time of incomplete relaxation (phase 4), and 5: time in relaxed state (phase 5) (see phases also in Table 1). The same colors and patterns are used in panels B–G.
B: Beating pattern of control CMs. C: Beating pattern of G589D-CMs. D: Beating pattern of ivs7-2ANG-CMs. The cells are presented in order of beating rate: control CMs: 12–66 beats/min,
G589D-CMs: 8–62 beats/min and ivs7-2ANG-CMs: 9–45 beats/min. E–G: The time duration from the beginning of contraction to the beginning of relaxation and from the beginning of
relaxation to the beginning of contraction are presented. Contraction time was in the range of 0.25–0.5 s in control CMs (E). In LQT1-CMs the contraction time was longer or incomplete
relaxation was present (F and G). The points for contraction time are enlarged to highlight the differences in the contraction times between control CMs and LQT1 speciﬁc CMs (a point
with a value of 1.75 ms in G589D-ﬁgure is not included).
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Representative Ca2+ signals from single CMs from both LQT1-speciﬁc
cell lines (G589D or ivs7-2ANG) as well as from control CM are shown
in Fig. 3 J–L.
4. Discussion
In the present study we analyzed LQT1-speciﬁc CMs carrying either
G589D or ivs7-2ANG mutation in the KCNQ1 gene. The LQT1-CMs with
either mutation had prolonged AP durations. EADs were spontaneously
present only in CMs with G589Dmutation but not with ivs7-2ANGmu-
tation. However, EADs could be evoked pharmacologically in CMs with
either mutation. In control CMs EADs were absent at baseline and they
could not be induced with IKs or IKr blockers. Ca2+ transients were
also aberrant in both types (G589D and ivs7-2ANG) of LQT1-CMshaving
large double spikes or extra spikeswith small amplitude. In control CMs
contraction and relaxation happened fast with no pause in-between.
However, this beating behavior in LQT1-CMs was clearly abnormal.
Using video recording analysis, LQT1-speciﬁc CMswere found to exhibit
two distinct forms of abnormal mechanical beating behavior: CMs car-
rying G589D mutation typically stayed contracted for prolonged time
while CMs with ivs7-2ANG mutation showed an incomplete relaxation
phase.
Our current clamp data demonstrates that the APDs measured from
LQT1-CMswith either of themutations (G589D or ivs7-2ANG)were sig-
niﬁcantly prolonged. Heterozygous expression of the G589D and ivs7-
2ANGmutations in non-cardiac cells has earlier shown that both muta-
tions have a dominant negative effect in gene expression systems [7,28],
although the expression of G589Dmutation did not lead to altered cur-
rent density, the cAMP induced up-regulation of IKs was abolished by
the mutation [28]. The ivs7-2ANG mutation on the other hand, almost
completely abolished the IKs current when transiently expressed in
non-cardiac cells [7]. The lack of IKs reduction in the G589D transfected
non-cardiac cells may be due to trafﬁcking problems caused by G589D:
the mutated protein does not reach the cell surface [9]. The effect of
G589D in LQTS has also been explained by disrupted β-adrenergic acti-
vation of IKs [29] but this study clearly shows that the disease phenotype
caused byG589D is not solely dependent on central nervous system and
activation of β-adrenergic receptor since it is present also in single dis-
sociated CMs.
As mentioned, baseline-APDs were signiﬁcantly prolonged in LQT1-
CMs compared to the control CMs.With LQT1-CMwe could further de-
tect that ventricular-like CMs were only marginally affected or
completely unaffected by IKs blockage. The lack of effect of IKs blockade
in our LQT1-CMs is in accordance with the previous observation that
the baseline IKs current is decreased by about 75% in LQT1-CMs [18].
In our study, G589D-CMs had longer baseline-APD90 than ivs7-2ANG-
CMs and spontaneous EADs were observed only in G589D-CMs, but
none in CMswith ivs7-2ANG nor in control CMs. However, the APD pro-
longation with IKr blockage always evoked EADs in both types of LQT1-
speciﬁc CMs but not in control CMs. The IKr block also induced a depolar-
ization of the baseline as previously shown [30].
CMs carrying either one of the LQT1mutations demonstrated abnor-
malities in intracellular Ca2+ transients, but the abnormal featureswere
more common in G589Dmutated CMs similarly as these CMs hadmore
severe abnormalities in current clamp analysis. Abnormal Ca2+ tran-
sients could be occasionally observed also in control CMs (6% of the
cells), but at least third of the LQT1-CMs presented Ca2+ abnormalities.
In LQTS-CMs, EADs have been thought to result from late membrane-
Table 1
The average times (ms) and standardmean errors for each individual beating phase and the total sum of the phases. Phase 1 is the time of contraction, phase 2 refers to the timewhen the
cells stay contracted, phase 3 is the relaxation time, and phase 4 indicates the time of incomplete relaxation. The timewhen the cells are relaxed (phase 5) is not displayed in the table. (*)
indicates p b 0.05 and (***) indicates p b 0.001 (one-way ANOVA) for abnormal G589D-CMs vs. control CMs and vs. abnormal ivs7-2A>G-CMs concerning the phase 2. For abnormal ivs7-
2A>G-CMsvs. abnormalG589D-CMs (two sample t-test) in the case of thephase 4 (*) also indicates p b 0.05 and (***) indicates p b 0.001. Data is presented asmean±S.E.M. The abnormal
behavior of the cells is highlighted with bold.
BPM Phase 1 Phase 2 Phase 3 Phase 4 Sum P 1–4
Control
Normal n = 11 29.3 ± 4.4** 294.3 ± 31.9 4.7 ± 1.9 426.0 ± 41.9 N/A 725.0 ± 70.2
Abnormal n = 0 N/A N/A N/A N/A N/A N/A
G589D
Normal n = 7 33.2 ± 6.5 275.9 ± 19.2 15.5 ± 5.7 362.0 ± 19.3 0.0 ± 0 653.4 ± 27.5
Abnormal n = 17 23.6 ± 3.6 285.2 ± 26.3 180.8 ± 28.8*
(n = 17/17)
365.1 ± 29.1 37.3 ± 36.7
(n = 2/17)
868 ± 74.8
ivs7-2ANG
Normal n = 8 30.6 ± 5.7 248.2 ± 31.1 5.0 ± 2.9 383.0 ± 48.0 0.0 ± 0 636.3 ± 79.0
Abnormal n = 17 25.2 ± 2.3 318.7 ± 39.9 46.3 ± 13.6
(n = 15/17)
424.8 ± 44.4 366.7 ± 66.9***
(n = 17/17)
1156.4 ± 123.0
Table 2A
Baseline characteristics of spontaneous action potentials (APs) from control cardiomyocytes (CMs) as well as from LQT1-G589D- and LQT1-ivs7-2ANG-speciﬁc CMs. (*) indicates signif-
icance levels of p b 0.05 and (**) p b 0.01. Signiﬁcance levels were obtained by one-way ANOVA of grouped data from nodal, atrial and ventricular CMs, respectively. Data is presented as
mean ± S.E.M. CMs with baseline arrhythmia are not included (see Table 2B).
Number of cells
[n (%)]
BPM APD50
(ms)
APD90
(ms)
APA
(mV)
MDP
(mV)
Vmax
(dV/dT)
Control
Nodal-like 2 (6.7) 75.7 ± 4.4 104.4 ± 2.1 159.1 ± 0.4 88.7 ± 0.6 −66.0 ± 0.3 8.70 ± 2.3
Atrial-like 4 (13.3) 61.5 ± 8.5 132.6 ± 13.6 189.1 ± 32.2 100.4 ± 3.0 −71.6 ± 3.4 26.1 ± 17.9
Ventricular-like 24 (80.0) 55.6 ± 3.4 291.8 ± 21.5 349.6 ± 22.9 110.2 ± 2.4 −69.6 ± 1.5 19.5 ± 4.7
LQT1 (G589D)
Nodal-like 2 (5.1) 54.5 ± 4.1 164.5 ± 6.2* 309.2 ± 39.7* 83.4 ± 3.7 −63.6 ± 1.7 4.2 ± 7.1
Atrial-like 12 (30.8) 38.9 ± 4.5 335.7 ± 36.2** 477.7 ± 51.4** 106.4 ± 2.8 −70.5 ± 2.0 23.9 ± 6.9
Ventricular-like 25 (64.1) 37.7 ± 4.6* 458.5 ± 57.4** 545.3 ± 62.6** 109.0 ± 3.1 −73.6 ± 1.6 14.8 ± 1.8
LQT1 (ivs7-2ANG)
Nodal-like 2 (6.1) 69.4 ± 6.0 170.5 ± 17.3 232.1 ± 7.7* 93.0 ± 1.3 −61.0 ± 9.6 9.5 ± 1.5
Atrial-like 6 (18.2) 50.9 ± 9.9 187.8 ± 15.0* 287.8 ± 18.5* 101.2 ± 2.2 −66.0 ± 2.6 16.3 ± 4.2
Ventricular-like 25 (75.7) 45.6 ± 2.8* 416.1 ± 22.1** 481.5 ± 23.6** 115.1 ± 1.3 −72.3 ± 1.0 16.2 ± 2.4
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inward currents, such as the spontaneous reactivation of the L-type
Ca2+-channel during prolonged action potential duration [31]. There-
fore it can be assumed that abnormalities in Ca2+ transients shown in
this study may correspond to EADs and lead to severe arrhythmias. A
similar ﬁnding has been also earlier observed and demonstrated com-
bining patch clamp and Ca2+-imaging methods [32]. Further studies
Fig. 5. Current clamp-recordings from control and LQT1-CMs carrying either G589D or ivs7-2ANG. Beating CMs un-patched (A), patched in relaxed phase (B), and patched in contracted
phase (C). Arrows indicate the positions where the contraction can be seen (C). D: Current clamp-recordings of ventricular-, atrial- and nodal-like APs are depicted for control (upper
panel), G589D (middle panel) and ivs7-2ANG (lower panel)-CMs. E: Baseline characteristics of spontaneous APs with early after depolarizations (EADs) in G589D-speciﬁc CMs: dashed
line represents 0 mV and arrows indicate EADs. The effects of JNJ303 (F), and E-4031 (G) are shown for ventricular-like AP recordings from controls, as well as from G589D and ivs7-
2ANG-CMs. Baseline (1), (2) effect of IKs (JNJ303) or IKs (E-4031) blocker, and (3) wash out measurement which fully recovers the effect of JNJ303 but only partially reverses the baseline
AP characteristics after the E-4031 treatment. Arrows indicate EADs. The right panels show the time courses for the overshoot (Max), MDP, APD90 and APD50. Marks (1), (2) and (3) in-
dicate the times of AP extraction, and the bar represents the exposure of the cells for JNJ303 or E-4031.
Table 2B
Baseline characteristics for G589D-CMs with EADs. Data is presented as mean ± S.E.M.
Number of cells
(n)
BPM APD50
(ms)
APD90
(ms)
APA
(mV)
MDP
(mV)
Vmax
(dV/dT)
LQT1 (G589D)
Ventricular-like 5 30.1 ± 4.4 820.3 ± 93.1 1559.6 ± 407.1 112.8 ± 3.8 −71.5 ± 2.7 12.7 ± 2.3
Table 3A
Effect of IKs block on ventricular-like cardiomyocytes (CMs). Statistical difference of paired sample t-test is indicated by (*) p b 0.05 and (**) p b 0.01. Data is presented as mean ± S.E.M.
Number of cells
(n)
BPM APD50
(ms)
APD90
(ms)
APA
(mV)
MDP
(mV)
Vmax
(dV/dT)
Control
Baseline 10 48.3 ± 8.4 264.7 ± 47.0 334.0 ± 30.1 103.6 ± 3.9 −69.0 ± 2.5 25.3 ± 10.4
300 nM JNJ303 42.8 ± 7.6* 346.6 ± 68.0** 428.2 ± 79.9** 106.3 ± 4.6 −69.7 ± 2.6 27.8 ± 12.3
LQT1 (G589D)
Baseline 9 44.7 ± 5.5 393.0 ± 57.8 500.4 ± 76.0 108.3 ± 3.1 −71.9 ± 2.6 11.6 ± 2.6
300 nM JNJ303 38.7 ± 5.2 423.6 ± 64.4 544.0 ± 86.0 106.9 ± 2.8 −70.8 ± 2.3 10.9 ± 2.1
LQT1 (ivs7-2ANG)
Baseline 6 44.5 ± 3.2 387.0 ± 49.3 458.1 ± 51.6 112.4 ± 4.2 −74.2 ± 2.6 9.8 ± 1.9
300 nM JNJ303 43.1 ± 4.6 386.0 ± 36.0 452.0 ± 37.9 111.1 ± 3.6 −72.0 ± 3.1 9.8 ± 1.9
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are needed to clarify themechanismof the different Ca2+ transients ob-
served in our study and their correlation with the EADs as well as with
the motion abnormalities observed with the two different LQT1 related
mutations.
In addition to conventional methods (patch clamp and Ca2+-imag-
ing), we also analyzed the mechanical beating behavior of single
LQT1-speciﬁc CMs by video imaging and this analysis revealed either
prolonged contraction (G589D) or disturbed relaxation (ivs7-2ANG) of
the cells. This abnormality has not been reported earlier in iPSC-
derived LQTS speciﬁc CMs, but the observation is in line with a clinical
observation of prolonged contraction duration in LQTS mutation car-
riers compared to healthy individuals [33]. In this study, combined cur-
rent clamp-measurements and video analysis of the mechanical
behavior demonstrated the correlation between the prolonged APD
and abnormal mechanical phenotype also in single LQT1 speciﬁc CMs.
The two patients of this study are both heterozygous for the LQT1-
mutations and the allelic discrimination study revealed an imbalance
in the expression of the WT and mutated forms of KCNQ1. The ratio of
expression (WT:mutated) for G589D was found to be 4:1 and for ivs7-
2ANG the ratio was 3:1. It was reported earlier that LQT1-CMs with
R190Qmutation exhibited equal expression of wild type andmutant al-
leles [18]. With the expression ratios observed in our study, the proba-
bility that one or more mutated α-subunits are participating in
forming the tetrameric IKs channel is about 70%. This is in accordance
with the functional abnormalities observed in the videos recorded
from our CMs. Ca2+-imaging also revealed abnormal Ca2+ transients
in LQT1 CMs but the proportions of abnormal CMs were slightly lower
than those obtained with video imaging. The presence of spontaneous
EADs were, however, considerably lower than other abnormalities. It
is possible that there are compensatory mechanisms involved in
Fig. 6. Combined current clamp-measurements and video analysis. Control CMs (A) aswell as the LQT1 speciﬁc CMs (B) showed a nice correlation in timing of the contraction and the AP:
Contraction followed immediately after the initiation of AP. In LQT1 speciﬁc CMs theAPDwas clearly prolonged compared to the control cells and themechanical abnormality observed by
video analysis correlated with the prolongation of the APD (B).
Table 3B
Effect of IKr block on ventricular-like CMs. Ventricular-like LQT1-speciﬁc CMs all showed early after-depolarizations (EADs) in the presence of E-4031. Statistical difference of paired sample
t-test is indicated by (*) p b 0.05, (**) p b 0.01 and (***) p b 0.001. Data is presented as mean ± S.E.M.
Number of cells
(n)
BPM APD50
(ms)
APD90
(ms)
APA
(mV)
MDP
(mV)
Vmax
(dV/dT)
Control−EADs
Baseline 5 68.8 ± 4.3 256.8 ± 30.4 308.0 ± 30.1 111.4 ± 3.5 −74.6 ± 3.6 10.1 ± 1.4
100 nM E-4031 60.2 ± 7.6 332.4 ± 82.5 535.3 ± 102.9* 83.3 ± 7.5** −52.1 ± 1.5** 6.2 ± 1.8
LQT1 (G589D)+EADs
Baseline 5 43.2 ± 3.5 458.6 ± 25.1 536.0 ± 33.8 114.6 ± 0.4 −81.1 ± 0.9 13.7 ± 2.9
100 nM E-4031 23.5 ± 4.4* 781.7 ± 16.2*** 1703.8 ± 100.8** 103.6 ± 1.7* −70.7 ± 2.9* 9.3 ± 1.5*
LQT1 (ivs7-2ANG)+EADs
Baseline 7 42.5 ± 3.4 464.7 ± 49.3 526.1 ± 53.6 117.5 ± 1.4 −73.6 ± 1.8 14.1 ± 0.9
100 nM E-4031 13.8 ± 2.6*** 1915.7 ± 468.8* 4055.8 ± 1173.1* 109.7 ± 2.6** −64.1 ± 2.7** 11.3 ± 1.0**
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electrical data obtained by patch clamp, resulting in a lower frequency
of abnormalities compared to other methods. It is also important to
point out that the ratios obtained by allelic imbalancemeasurements re-
ﬂect the situation at mRNA level and do not accurately depict the pro-
portions of the two alleles expressed at protein level since the
transcripts may be alternatively processed before translation into pro-
teins. Further, there is a possibility that the expression ratio of the WT
and mutated allele may vary from cell to cell. It is also possible that
the cells with different beating properties could represent also a partic-
ular CM subpopulation (ventricular, atrial or nodal).
Our ﬁndings support the previous studies [4,6] suggesting that mu-
tations in different parts of theKCNQ1 gene are associatedwith different
clinical outcomes. However, no clinically distinct differences between
the patient groups carrying the two mutations presented in this study
have been reported. QTc of G589D-carriers has been reported to be
462 ± 38 if recorded from patients without any medication at the
time of ECG recording. For the ivs7-2ANG the corresponding QTc value
has been reported to be 470 ± 31 [21]. Both patients investigated
here were symptomatic. G589D-patient, 46-year-old female has been
suffering from syncopal spells. The other patient, 51-year-old female
carrying ivs7-2ANG in KCNQ1, has suffered from dizziness, darkening
of vision and more recently also from episodes of unconsciousness. On
cell level G589D-CMs demonstrated more severely prolonged APDs
which could be visualized as prolonged contracted state in beating
CMs. The ivs7-2ANG-CMs had less severe APD prolongation at baseline,
but theyweremore sensitive to agents blocking other ion channels. Ad-
ditionally their beating behavior presented problems in relaxation
phase suggesting other, currently unknown problems in repolarization
currents in these cells. Since the patients present clinically similar phe-
notypes, it is most likely that there are some compensatory elements
inﬂuencing the intact heart which moderate the clinical outcome. The
highly organized transverse (t)-tubule structures in ventricularmyocar-
diummight partially balance the abnormalities in the Ca2+ transients of
G589Dand ivs7-2ANG-CMs [34]. At the same time, it is also possible that
the typical abnormality that we observed in G589D-cells, namely
prolonged contraction time, could actually generate more severe symp-
toms due to a shortened relaxation time.
This is the ﬁrst time that two different LQTS relatedmutations in the
same gene are reported to result in differences in functional properties
of the patient speciﬁc CMs. Additionally, this is the ﬁrst report to dem-
onstrate abnormal mechanical beating properties of LQTS-speciﬁc sin-
gle CMs. Earlier, the mechanical abnormalities with increased diastolic
phase have been reported at the level of a whole heart of LQTS patients
[33] but the abnormal mechanical phenotype in LQTS speciﬁc single
cells is a novel and rather unexpected ﬁnding. Here we demonstrate
that the disease speciﬁc beating of the cells can be distinguished from
the normal behavior of single CMs just by analyzing themechanical fea-
tures of the beating. This novel method for characterization of CMsmay
generate additional detailed information from the beating of the cells
and also from LQTS in general. In addition, this simple detectionmethod
allows developing it further for high through-put screening for LQTS
speciﬁc – and also other cardiac disease speciﬁc – CMs.
5. Conclusion
CMs derived from two symptomatic LQT1 patients carrying two dif-
ferent KCNQ1mutations presented different manifestations when their
electrical or mechanical beating properties were analyzed. APDs were
signiﬁcantly prolonged in both types of LQT1-CMs, but spontaneous
EADs were present only in G589D-CMs. Mechanical beating behavior
of G589D-CMs presented mostly prolonged contraction phase while
inv7-2ANG-CMs had a fairly normal contraction time, but failed to
relax properly. These results also demonstrate that simply by analyzing
the mechanical beating behavior of the cells, the diseased CMs can be
distinguished from the normal ones, providing a simple platform for di-
agnostic applications using iPSC derived CMs in the future.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcha.2015.04.008.
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Fig. 7.Analysis of Ca2+ transients of control and LQT1 speciﬁc CMs. (A) Three different transient categories: normal transientswith stable amplitude (N), arrhythmiaswith double ormore
Ca2+ peaks (AD), and small amplitude Ca2+ events (arrows) (AS) were found. (B) Doughnut charts indicate the percentage of the control and LQT1 speciﬁc CMs under each transient
category (N, AD and AS).
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Abstract—Induced pluripotent stem cell derived cardiomy-
ocytes (iPSC-CM) provide a powerful platform for disease
modeling and drug development in vitro. Traditionally,
electrophysiological methods or ﬂuorescent dyes (e.g. cal-
cium) have been used in their functional characterization.
Recently, video microscopy has enabled non-invasive anal-
ysis of CM contractile motion. Simultaneous assessments of
motion and calcium transients have not been generally
conducted, as motion detection methods are affected by
changing pixel intensities in calcium imaging. Here, we
present for the ﬁrst time a protocol for simultaneous video-
based measurement of contraction and calcium with ﬂuores-
cent dye Fluo-4 videos without corrections, providing data
on both ionic and mechanic activity. The method and its
accuracy are assessed by measuring the effect of ﬂuorescence
and background light on transient widths and contraction
velocity amplitudes. We demonstrate the method by showing
the contraction-calcium relation and measuring the transient
time intervals in catecholaminergic polymorphic ventricular
tachycardia patient speciﬁc iPSC-CMs and healthy controls.
Our validation shows that the simultaneous method provides
comparable data to combined individual measurements,
providing a new tool for measuring CM biomechanics and
calcium simultaneously. Our results with calcium sensitive
dyes suggest the method could be expanded to use with other
ﬂuorescent reporters as well.
Keywords—Biomechanics, Fluorescence, Motion analysis,
Calcium-contraction coupling.
ABBREVIATIONS
CaPIV Calcium particle image velocimetry
CD Contraction duration
CM Cardiomyocyte
CPVT Catecholaminergic polymorphic ventricu-
lar tachycardia
CTD Calcium transient duration
hiPSC Human induced pluripotent stem cell
iPSC Induced pluripotent stem cell
iPSC-CM Induced pluripotent stem cell derived car-
diomyocyte
PIV Particle image velocimetry
RYR Cardiac ryanodine receptor
MQD Minimum quadratic difference
WT Wild type
INTRODUCTION
Cardiovascular diseases represent the leading cause
of death globally. Additionally, adverse eﬀects of car-
dioactive and non-cardiac drugs remain the most
common reason for market withdrawal. Induced
pluripotent stem cell derived cardiomyocytes (iPSC-
CM) have presented a promising platform for both
disease modeling and drug development with healthy
and patient speciﬁc cells. These studies have been tra-
ditionally done using electrical measurements, while
methods for measuring mechanical function of cells
without extensive instrumentation have only recently
been emerging. High throughput methods for drug
screening with iPSC-CMs are needed, as the large
variability in electrophysiological results regarding
iPSC-CM bring about the need for a greater number of
experiments.15 These methods could be used in addi-
tion for development of personalized therapy for ge-
netic cardiac diseases, such as catecholaminergic
polymorphic ventricular tachycardia (CPVT).10
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The commonly used methods for analyzing elec-
trophysiological functions of cardiomyocytes (CM)
include calcium imaging,18 patch clamping8,11 and
microelectrode array11 studies. However, these mea-
surements often require manual operation by trained
personnel and thus are not well suited towards high-
throughput applications. In addition, while the ionic
function they measure control the mechanical function
of the CMs, the resulting signals do not relate directly
to the resulting biomechanics that is the actual CM
functional aspect. CM biomechanics has traditionally
been measured in vitro using atomic force
microscopy,19 mechanical transduction with microp-
osts4,22 and traction force microscopy.21 Video-based
methods have been developed and studied by us1,2,9
and by several other groups.6,7,14 As the method is
non-invasive and has easy to use instrumentation, vi-
deo analysis has good high-throughput capabilities.
Calcium imaging can be used as a powerful tool for
high throughput proﬁling of drug responses in vitro. In
CMs, calcium plays a key role as a second messenger
of excitation contraction coupling. Drug effects are
reﬂected as changes in calcium transient proﬁle. With
ﬂuorescent calcium reporter dyes, either small mole-
cule or genetically encoded, it is possible to visualize
and record calcium ﬂuxes inside CMs. Special high
throughput imaging apparatuses, for example Hama-
matsu FDSS,3 allow simultaneous reading of calcium
transients from up to hundreds of samples. These
platforms can be used to study several disease models
and drugs in a short time period compared to con-
ventional microscopes. High content screening pro-
duces large amount of data, which require automated
software for handling and analyzing the massive
amounts of data.17
The major beneﬁt of human iPSC (hiPSC) in CM
studies is their power to provide CMs from speciﬁc
phenotypes. Here CPVT cells was selected as targeted
application example for our novel methodology.
CPVT is a rare but severe inherited cardiac disease in
structurally normal hearts, which may lead to sudden
cardiac death. CPVT patients experience arrhythmias
during mental or physical stress. CPVT is associated
with mutations in RYR2 gene, coding for cardiac
ryanodine receptor (RYR), among few other disease-
associated genes. Therapy includes drug treatment
with beta-blockers, implantable cardiac deﬁbrillators
or left cardiac sympathetic denervation.23 The calcium
abnormalities arising from mutations in RYR2 reﬂect
to contractile motion of CMs. Therefore, CPVT
speciﬁc iPSC-CMs are interesting platform to study
not only calcium kinetics but also the contractile mo-
tion simultaneously.
So far, the ionic and mechanical functions have been
studied simultaneously using speciﬁc platforms, such
as on microposts.4,22 Video-based measurements,
however, do not require such systems: microscopes and
video cameras are typical laboratory instruments,
which as such enable video-based measurements.
Methods to provide combined ionic and biomechanic
assessment of the CMs could offer novel avenues to
look into disease mechanisms and drug effects. Previ-
ously, it has not been able to track motion in bright
ﬁeld microscopy simultaneously with ﬂuorescent re-
porters due to the effects of ﬂuorescent induced
changes in pixel intensity on the motion detection
methods. In previous studies the ﬂuorescence back-
ground has been subtracted from images with mixed
phase-contrast and ﬂuorescence.6 In another study,
calcium reporter GCaMP6f –gene was used and
simultaneous measurement was conducted with com-
puted local intensity normalization in each interroga-
tion window to counteract the effect of the intensity
changes.7
In this study, we combine concurrent calcium
imaging with our previously developed video analysis
method, which uses minimum quadratic diﬀerence
(MQD) based particle image velocimetry (PIV) and
assess biomechanical and ionic function simultane-
ously from videos of ﬂuorescent calcium imaging. As
in the MQD method we used1 sets equal weight to all
image pixels,5 we hypothesized that the method could
work also in calcium imaging by increasing back-
ground lighting conditions to make motion more vis-
ible. To verify our hypothesis, consecutive frames with
ﬂuorescent calcium dye excitation and transmission
channels were measured with two background light
levels. We validated the method by comparing con-
traction and calcium transient widths as well as PIV
amplitudes from frames with and without the ﬂuores-
cent excitation, and with and without background
light. We demonstrated the method by measuring the
relation of contraction and calcium in wild type (WT)
and CPVT cells, and calculated the time interval
between the maximum signal onset and offset rates of
change in both signals.
MATERIALS AND METHODS
Patient-Speciﬁc Human iPSC Lines
Details on hiPSC culturing and CM diﬀerentiation
are available in supplements.
In this study both normal control CMs and diseased
CMs prone to arrhythmias were used. The diseased
CPVT cells were derived from patients having muta-
tions in RYR2 gene, associated with structural changes
in RYR, resulting in abnormal release of Ca2+ from
sarcoplasmic reticulum and increased ventricular
arrhythmias when heart rate increases. Two CPVT
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patient speciﬁc hiPSC lines were used:
UTA.05605.CPVT carrying exon 3 deletion and
UTA.05404.CPVT carrying V4563F mutation in
RYR2 gene (referred to as CPVTa and CPVTb
respectively). UTA.04602.WT cell line was used as a
control. The collection of biopsies for generating pa-
tient speciﬁc hiPSC lines was approved by the ethical
committee of Pirkanmaa Hospital District (Aalto-Se-
ta¨la¨ R08070) and written informed consent was
obtained from all the donors.
Imaging Protocol
Details on imaging protocol are available in sup-
plements.
CMs plated on glass coverslips were loaded with
Fluo-4 AM. Imaging was done using Olympus IX71
inverted microscope with Polychrome V and TH4-200
light sources and Andor iXon 885 EMCCD camera.
Cells were perfused with warmed (37 C) perfusate
medium. Two channels were recorded consecutively:
the Olympus light source was turned on to obtain vi-
deo image while still being able to discern Ca2+ ﬂuc-
tuations. The recording process is illustrated in Fig. 1a.
In total, 25 videos were recorded: 7 CPVTa, 5 CPVTb
and 13 WT videos. The recordings were all baseline
measurements.
Video Data Processing
The obtained recordings, consisting of video imag-
ing and calcium imaging data with light source oﬀ and
on, were categorized and processed. The region of
interest for each recording was selected based on both
intensity of the calcium ﬂuctuations and observed
motion.
MQD based PIV, as described previously,1,2,9 was
used for determining velocity vector ﬁelds in the video
image series. The process was applied to both trans-
mission and calcium imaging with background light on,
resulting in two series of velocity vector ﬁelds from
which motion signals are calculated: one from the
frames with only visible light—traditional PIV mea-
surement—and another from the frames with ﬂuores-
cent emission of calcium indicator, deﬁned as calcium
PIV (CaPIV). Only the frames with light source on were
included in these sets. Calcium signals were calculated
from the pixel intensity in each frame. With respect to
the light source status, two consecutive data series were
obtained: calcium with ﬂuorescent light from Poly-
chrome V—Ca (dark)—and calcium with light from
both Polychrome V and Olympus TH4-200 (transmis-
sion) - Ca (bright). With this method, four signal types
were obtained—two from both modalities: calcium and
motion. The process is illustrated in Fig. 1a.
Using our previously described method, shortly, the
directional motion signals indicating contraction and
relaxation velocities were obtained from velocity vec-
tor ﬁelds by determining a CM beating focus point.
The motion directed towards it was deﬁned as radial
movement and the perpendicular motion as tangential,
resulting in motion signals. As opposed to the previous
article, each vector was divided in these components
with respect to their location. The same region of
interest was used for calcium imaging. Further, con-
traction signals were calculated from the motion sig-
nals by integration with respect to time. Linear
detrending was applied to the resulting signals to cor-
rect the baseline.
As a non-ratiometric dye was used and absolute
contraction amplitude was not assessed, calcium,
contraction and motion signals were all normalized to
interval [0,1] by linear rescaling for visualization. The
motion signal baseline was then set to zero, with con-
traction being positive and relaxation negative. For
calcium and contraction signals, one beat long cross-
FIGURE 1. Imaging protocol, processing of the video channels and deﬁnition of transient duration parameters. (a) Fluorescent
calcium and visible light were recorded in consecutive frames. Midway during the recording, light source was turned on to
increase the background light intensity, allowing video signal to be captured. Traditional PIV was measured from the frames with
only visible light and CaPIV signal was measured from frames with calcium ﬂuorescence present. Calcium signal was categorized
based on the background light intensity to Ca (dark) and Ca (bright). (b) Transient duration parameters are deﬁned as percentages
from the peak maximum, similarly as when classifying action potentials.
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correlation based averaged signal templates were cal-
culated, as described earlier.2 The averaging was syn-
chronized based on the maximum rate of change
during the onset of the contraction or transient. A
correlation coefﬁcient of 0.5 was used to exclude only
the most abnormal beats.
Signal Comparison
The similarity of the recorded signals was measured
by determining parameters describing the waveform
widths and amplitudes. The duration of the contrac-
tion in the templates was characterized by calculating
contraction duration (CD) parameters and the dura-
tion of calcium by calcium transient duration (CTD)
parameters. The durations at percentages of the max-
imum peak height were deﬁned as shown in Fig. 1-
b—an approach similar to characterization of action
potentials. The used parameters were CD10, CD25,
CD50, CD80 and CD90, representing the width of the
peak at each percentage measured from the peak in
each waveform. For calcium, the same CTD parame-
ters were determined, respectively.
Temporal diﬀerences between the contraction and
calcium transient were measured using the combined
signals from the maximum rate of change in the onset
and oﬀset of CaPIV and Ca (bright). As the calcium
transients may have several peaks of diﬀerent heights,
this approach was selected instead of comparing the
time diﬀerence between peaks themselves.
Statistics
Mean values and standard deviations of CDs and
CTDs, as well as temporal diﬀerences between con-
traction and calcium were calculated. CDs and CTDs
were tested against each other using a two-sample t test
with all combinations of PIV, CaPIV, Ca (dark) and
Ca (bright). In addition, durations fromWT cell videos
(n = 13) were tested against those measured from
CPVT cell videos (CPVTa n = 7, CPVTb n = 5)
regarding all combinations of signal types from the
same modality—calcium and motion. Waveform
amplitude similarity was determined by calculating the
symmetric mean absolute percentage error of con-
traction motion velocity magnitudes of each contrac-
tion in PIV and CaPIV signals. Linear regression was
used to map width parameters against the other signal
types, and their similarity was estimated using linear
regression R2 parameter. P-values below 0.05 were
considered statistically signiﬁcant. The statistical
analysis was performed in MATLAB R2014a, The
Mathworks, Inc.
RESULTS
Beating Characteristics
For WT, the average beating rate was 22 beats per
min with a ± 10.8 standard deviation. For CPVTa and
CPVTb the values were 20.7 ± 12.9 and 12.2 ± 5.6
beats per min, respectively. The number of beats in
CPVT videos were lower than in WT videos as some
videos only had two beats with the background light
on/oﬀ.
Representative Signals
Representative signals with synchronized motion
(CaPIV) and calcium signals (Ca (bright)) were calcu-
lated. For each cell line, both motion and contraction
signals are shown with overlaid calcium transients in
Fig. 2. In motion signals (left side), an upward peak
signiﬁes contractile and downward peak relaxation
movement velocity. Motion signal is used for illus-
trating the ﬁne details of the movement. Contraction
signal (right side)—the integral of the motion signal
with respect to time—shows displacement during a
contraction. The contraction signal enables easier
comparison of calcium and contraction. For this
illustration, the signals were linearly normalized sepa-
rately for visualization.
In the visual inspection of the displacement and
calcium signals from studied WT cell populations,
contraction started only after increase in calcium
transient had started. Contraction signals typically had
a steeper oﬀset slope than calcium, which had a longer
tail, and started to fall slightly earlier. In CPVTa cells,
in some signals motion followed the calcium transient
with a longer delay than in WT. No evident afterde-
polarizations or tailing of calcium was present in the
signals. In CPVTb, the contraction signal started to
fall slightly later than the calcium transient.
Method Validation
The simultaneous recording method was validated
by comparing signals obtained from PIV (motion from
videos without ﬂuorescence), CaPIV (motion from vi-
deos with ﬂuorescence), Ca (bright) (calcium with
background light) and Ca (dark) (without background
light) signals. CTD parameters from the two calcium
signals, CD parameters from the two contraction sig-
nals, and amplitudes from the two motion velocity
signals were calculated.
PIV and CaPIV did not show statistically signiﬁcant
diﬀerences between the means of CD parameters. This
can be seen in Fig. 3, where the overlaid CaPIV (in
blue) and PIV (red) show a very similar curve, with
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minor deviations showing near the baseline. Similarly,
Ca (bright) and Ca (dark) did not exhibit signiﬁcant
differences in CTD parameters. This indicates that no
major differences were induced by the change in
lighting to enable the combined signal measurement.
The symmetric mean absolute percentage errors
between PIV and CaPIV contraction velocity ampli-
tudes were calculated for the contractions in each
recording. The diﬀerence was found to be
6.42 ± 3.44% in WT, 4.11 ± 5.01% in CPVTa and
2.73 ± 1.57% in CPVTb. The total error for all
recordings was 5.04 ± 3.87%.
Assessment of Cell Line Functions Using Simultaneous
Contraction and Calcium
Contraction and Calcium Signal Characteristics
The widths of the contraction peak in CaPIV and
the calcium transient Ca (bright) in the simultaneous
measurement were characterized by parameters indi-
cating their duration at percentages of the peak max-
imum height. The CD- and CTD-parameters were
calculated at signal levels 10, 25, 50, 80 and 90 and
shown in Table 1.
In both CD and CTD parameters, the standard
deviation was very high indicating high variance within
the cell lines.
Similarity of Signals Between Modalities
Linear regressions between pairs of contrac-
tion/calcium transient durations for the four diﬀerent
signals were calculated. The results are shown in
Table 2. Pairs of the same modality (leftmost tables)
FIGURE 2. Representative motion (left side) and displacement (right side) signals plotted over calcium transients for the three
cell lines. In the motion signals, the contractile movement velocity is represented with and upward peak and the relaxation
movement velocity as a downward peak in red, while calcium transient is shown in blue. In the displacement signals (right side),
representing the motion velocity signal integral with respect to time, contraction is shown in red and calcium transient in blue.
Representative signals are shown for the three cell lines.
FIGURE 3. A representative displacement measurement
showing overlaid CaPIV (blue) with ﬂuorescence and PIV
(shown in red) without ﬂuorescence.
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show high R2 values: PIV exhibits very high coefﬁcient
of determination (R2) values with CaPIV in both WT
and CPVT cells. Only in CD90 the value of CPVTb R2
was below 0.9. Likewise, high R2 values were obtained
from regression between Ca (bright) and Ca (dark)
even though the signals were not concurrent like mo-
tion signals. In calcium, R2 values below 0.9 were seen
in CPVTa CTD25 and CTD90, and a relatively low
value in CTD10 of CPVTb. Low R2 values were typi-
cally seen in cross-modality pairs near the baseline
(CD/CTD80 and CD/CTD90), especially in CPVTa.
These results indicate the simultaneous measurement
works well—the signals of the same modality are in-
deed very similar in shape. Further, the simultaneous
motion and calcium measurements show a disconnec-
tion of calcium and motion in CPVT lines—especially
CPVTa—which is not evident in calcium measure-
ments.
Calcium-Motion Coupling
The concurrent calcium-contraction measurement
allows the measurement of synchronicity in calcium
and motion dynamics. Here, we looked at the temporal
diﬀerences between these signals by calculating the
time points of maximum rate of change in the onsets
and oﬀsets of calcium transient and motion from Ca
(bright) and CaPIV, respectively. The obtained values
are shown in Table 3.
Positive time values in onset and oﬀset indicate that
motion signal is following the calcium transient. Some
negative values in oﬀset were obtained indicating that
motion reached its peak relaxation velocity before
maximum calcium decline velocity. In Table 3 this is
indicated by large standard deviation compared to the
offset value especially for CPVTa. Although CPVTa
shows a higher onset and CPVTb a higher offset in
mean times, the ﬁndings are not statistically signiﬁcant
due to the large variability. Also these results reveal
that CPVTa and CPVTb show different contraction-
calcium coupling dynamics from WT but also different
from each other.
The diﬀerence between the means of motion and
calcium signal parameters was statistically signiﬁcant
in WT in all parameters (p< 0.05 in CD/CTD10,
p< 0.01 in the remaining parameters), but not in
CPVTa or CPVTb. This ﬁnding shows that measure-
ments of motion and calcium provide complementary
information and insight on the Ca2+ and contraction
coupling dynamics.
When comparing the cell lines, the motion modali-
ties PIV and CaPIV did not exhibit signiﬁcant diﬀer-
ences between the contraction durations of WT and
CPVT cell lines. However, calcium modalities Ca
(bright) and Ca (dark) showed signiﬁcant diﬀerences
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between means of WT and CPVTb in CTD80 and
CTD90. Neither calcium nor motion modalities dis-
played signiﬁcant diﬀerences between WT and CPVTa.
DISCUSSION
We developed and demonstrated a method for
simultaneous CM motion and calcium transient
recording from ﬂuorescent videos. The method uses
simultaneous application of both transmission and
ﬂuorescent light source. In traditional methods the
calcium based ﬂuorescent signal could represent a
source of error for PIV analysis and further, the
brightﬁeld imaging could aﬀect the calcium imaging
transients. We tested the method susceptibility to both
error sources by separating these factors with inter-
lacing brightﬁeld and ﬂuorescent video frames and
observed that a simultaneous measurement of calcium
and contraction is feasible.
We recorded consecutive frames of brightﬁeld
imaging and calcium ﬂuorescent imaging in iPSC-CMs
on video, with background light on and oﬀ. Four
diﬀerent signals were obtained: motion from bright-
ﬁeld video (PIV), motion from video with ﬂuorescence
(CaPIV), calcium imaging without background light
(Ca (dark)) and calcium imaging with background
light (Ca (bright)). We characterized the signals for
both validation and demonstration of the method.
With this procedure, we aimed to demonstrate that
CM contraction could be quantiﬁed reliably while
running a simultaneous ﬂuorescent measurement.
Further, we demonstrated the usefulness of the
simultaneous measurement by comparing the calcium
and contraction signals, calculating time intervals
between calcium and motion, and analyzing the dif-
ferences between WT and two diﬀerent CPVT cell
lines.
Eﬀect of Fluorescent Light on Motion Analysis
Previously, the intensity changes caused by ﬂuores-
cence have prevented simultaneous motion measure-
ments. MQD, however, does not put emphasis on
bright pixels thus making it a plausible method for the
task. Our results show that the intensity ﬂuctuation
eﬀect by ﬂuorescent light is negligible to both timing
and magnitude of the motion signal. This is the ﬁrst
time such measurement and assessment of accuracy
TABLE 2. Linear regression of CD and CTD parameters.
PIV/CaPIV PIV/Ca (bright) CaPIV/Ca (bright)
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb
10 0.983 0.997 0.975 0.663 0.128 0.430 0.698 0.136 0.511
25 0.943 0.997 0.996 0.737 0.540 0.897 0.698 0.537 0.888
50 0.965 0.997 0.995 0.637 0.731 0.732 0.612 0.684 0.752
80 0.967 0.991 0.976 0.640 0.129 0.451 0.630 0.091 0.384
90 0.966 0.989 0.817 0.710 0.000 0.186 0.724 0.003 0.057
Ca (bright)/Ca (dark) PIV/Ca (dark) CaPIV/Ca (dark)
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb
10 0.914 0.913 0.567 0.518 0.138 0.958 0.525 0.150 0.945
25 0.939 0.753 0.859 0.685 0.605 0.834 0.612 0.616 0.793
50 0.951 0.970 0.991 0.552 0.741 0.742 0.507 0.702 0.760
80 0.968 0.946 0.992 0.573 0.155 0.539 0.564 0.119 0.473
90 0.950 0.778 0.961 0.686 0.070 0.274 0.685 0.111 0.082
Linear regression between the contraction (CD)/calcium transient durations (CTD) at percentages of the maximum peak height (10, 25, 50, 80
and 90) for each pair of measured signals.
TABLE 3. Time intervals between calcium and contraction.
WT CPVTa CPVTb
Ca (bright) and CaPIV difference on onset 163 ± 132 ms 238 ± 136 ms 126 ± 102 ms
Ca (bright) and CaPIV difference on offset 40 ± 91 ms 24 ± 142 ms 113 ± 75 ms
Mean time differences and standard deviations between the calcium transient and contraction in different cell lines, in milliseconds. The
differences between cell lines are not statistically signiﬁcant.
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have been done without using corrections with a ﬂu-
orescent dye.
Our results indicate that MQD based analysis of
CM motion is minimally aﬀected by the presence of a
ﬂuorescence based measurement. In t-tests, there were
no signiﬁcant diﬀerences between the means of mea-
sured CD parameters. The R2 values in linear regres-
sion studies between normal brightﬁeld PIV and
CaPIV with ﬂuorescence were very high in all three cell
lines indicating the very low impact of ﬂuorescence
presence. There were small differences in the lower
parts of the peaks as well as a minor 5% difference in
magnitudes of contraction velocities. We believe this
measurement setup allows measuring of motion with a
variety of different ﬂuorescent indicators, as long as
movement is present. Determining a sufﬁcient level of
lighting for the measurements may be a key factor in
the acquisition of two simultaneous high quality
recordings.
Eﬀect of Bright Light on Calcium Imaging
Applying transmission light had only small eﬀect on
the calcium imaging waveforms. In linear regression
analysis, high R2 values were obtained between Ca
(bright) and Ca (dark), in all three cell lines. However,
in CPVT some lower regression values were obtained
due to a number of possible factors: calcium transients
Ca (bright) and Ca (dark) were not from the same
beats, the number of recorded cells in CPVT lines was
low and as the beating rate was lower, the number of
beats in each signal was smaller than in WT. As
illustrated in the CPVTa signals shown in Fig. 2, the
calcium transients could have multiple small peaks (i.e.
arrhythmias/abnormal transients) making the direct
comparison of peak width parameters difﬁcult. For
WT cells, the peaks were more regular and Ca (bright)
and Ca (dark) were both capable of characterizing the
cell lines similarly, as shown in t-tests. Ca (dark) and
Ca (bright) amplitudes were not compared, as the
comparison would not have been valid due to the
bleaching of ﬂuorescent dye during the measurement.
Moreover, it is evident that increased background light
increases the background noise level in ﬂuorescence
measurement. However, sufﬁcient transmission light or
constant ﬂuorescent light is needed for detection of
motion signal from the video. At the same time, the
ﬂuorescent emission of the dye should be strong en-
ough to be detected while the transmission video is
acquired. Increasing the light intensity or exposure
time of the sample may not be the best solutions since
they result in higher photobleaching of ﬂuorophores
and slower frame rates.
Ratiometric dyes have diﬀerent emission spectra for
bound and unbound states with the indicated ion, for
example with Fura-2. Therefore, it takes two consec-
utive channel recordings to capture the ratio between
these states, which takes longer and results in lower
frame rates in acquisition. In this case, as an additional
channel for brightﬁeld video is measured, non-ratio-
metric dyes, such as Fluo-4, are better since their
emission needs to be recorded only on one wavelength
rather than ratiometric dyes. The results indicate that
in calcium studies, with a focus on the waveforms in-
stead of absolute Ca2+ concentration, it is feasible to
apply also the brightﬁeld light to obtain additional
information on the mechanical activity without
affecting the calcium measurement.
Cell Line Diﬀerences
There was no statistically signiﬁcant diﬀerences in t-
tests between motion in WT and CPVT cell lines when
considering PIV or CaPIV. CPVT cells typically pre-
sent arrhythmias under adrenergic stimulation, but as
only the baseline beating is analyzed here, the motion
signals correspond to those of WT. These results would
indicate that the CPVT cells do not directly exhibit
beating phenotypes different from WT cells at baseline
conditions. Earlier, using PIV we have found differing
beating phenotypes in LQT cells, but of course also the
clinical presentation of the diseases are different.9
Ca (bright) and Ca (dark) showed statistically sig-
niﬁcant diﬀerences between WT and CPVTb in CTD80
and CTD90, but not between WT and CPVTa. These
diﬀerences could be caused by a higher variation in
diastolic calcium levels in CPVTb caused by a leakage
of calcium through RYRs in the cells. However, the
amplitude of these diastolic events is so low compared
to the actual calcium peak so there were no diﬀerences
in the parameters associated with the higher parts of
the peak (i.e. CTD10).
The combination of motion and calcium measure-
ments showed a varying disconnection of the two, as
shown by the R2 values (Table 2) especially for
CPVTa. The most prevalent cause for CPVT lies in
mutations in RYR2 gene coding for RYR.20 It is lo-
cated at the membrane of sarcoplasmic reticulum in
CMs and acts as a channel releasing calcium from
sarcoplasmic reticulum to cytosol. Mutations in RYR2
cause spontaneous calcium leakage through the chan-
nel and altered calcium transients inside CMs.13 In
CPVTb population, which carries a V4653F mutation
in RYR, the substituted amino acid is located in the
channel domain of the protein.16 It is thought to be a
gain-of-function point mutation, as most of the RYR
mutations, and alter the channels sensitivity or per-
meability to calcium ions.23 CPVTa population, which
carries an exon 3 deletion, has the structural defect on
the cytosolic part of the protein in the N-terminal
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domain and is associated with more severe clinical
outcome.12 The difference in the nature of these two
mutations could explain the differences in our results.
The disconnection between calcium and beating mo-
tion could be related to the earlier ﬁnding by Tang
et al. where the exon 3 deletion was found to be
resulting in an abnormal termination of calcium re-
lease through the RYR.24
Simultaneous Calcium and Motion Measurements
The combined simultaneous recording of motion
and calcium as shown here provides new tools for
studying the CM contraction mechanism. In t-tests
between motion and calcium modalities, statistical
diﬀerences were seen in WT cell lines, but not in
CPVTa/CPVTb. The lack of statistical diﬀerence
between motion and calcium in CPVT was surprising
and it may again be caused by the low number of
recorded cells or more heterogeneous beating patterns
and calcium transients. In linear regression analysis of
motion and calcium modalities, represented in Table 2,
CPVTa had lower R2 values than WT and CPVTb:
there was practically no relation between the mea-
surements in peak parameters characterizing the low
amplitudes.
Mean time diﬀerences of signal onset and oﬀset rate
of change maxima did not show statistically signiﬁcant
diﬀerences between the cell lines due to high variability
and low number of cells measured. However, CPVTa
did show indication of longer time intervals between
calcium and motion in onset, and CPVTb in oﬀset.
Overall, the results indicate that calcium and motion
go hand in hand as is expected, but one cannot directly
be deduced from the other. Although the low corre-
lation values in CPTVa may be caused by the low
number of samples, high correlation values were not
present for WT either where the sample number was
higher. This reinforces the idea that even if Ca2+ is the
driving force in CM contraction, calcium measurement
alone cannot be used to describe the mechanical
function in full detail. Further, motion alone does not
necessarily reﬂect the ionic functions, emphasizing the
need for the combined method suggested here as a new
tool for CM analysis.
Method Advantages
Video-based measurements are minimally invasive
and have low instrumentation requirements. These
aspects make them a feasible candidate for high-
throughput studies. For laboratories, this method can
be used in conjunction with other studies, as micro-
scopes and video cameras are mainstay laboratory
equipment. The threshold for including contraction
measurements in studies is lower than measurements
with other methods, because no additional equipment
is needed. Combining the method with ﬂuorescent
beads, substrate deformation and thus contraction
force could be measured as well. While here we have
considered individual cells and small clusters, the
method should be applicable for larger samples of
cardiac tissue, as long as 2-dimensional approach is
still feasible. As we have shown here, the possibility of
measuring CM contraction from calcium imaging data
also enables revisiting previous studies and expanding
on their results.
Study Limitations and Sources of Error
To validate the method we used interlaced video.
The time diﬀerence between PIV and CaPIV vi-
deos—by being consecutive frames and the relatively
low frame rate—must be taken into account when
estimating their diﬀerences and similarities. The frame
interlacing produces intrinsic time diﬀerences of 21.7
and 8.8 ms for our minimum frame rate 46 and max-
imum frame rate 114, respectively. A higher frame rate
with slow beating cells would give a more accurate
reading. However, the observed diﬀerences between
normal brightﬁeld PIV and ﬂuorescence CaPIV were
small, indicating that MQD-based motion measure-
ments are minimally obstructed by ﬂuorescence sig-
nals. We have previously explored waveform averaging
in brief,2 suggesting a frame rate of 60. Further studies
with a higher frame rate and more beats per video
would better quantify the difference in amplitudes for
measurements where absolute precision of magnitude
is required. Due to the low number of recordings, the
ﬁndings related to the disconnection between calcium
and motion in CPVT cells should be considered ten-
tative. A study focusing on calcium-motion coupling in
CPVT cells is required for reliability.
In this study, CMs were cultured on glass coverslips
where their morphology is diﬀerent from mature
human CMs. Therefore, results may be diﬀerent using
i.e. patterned CMs. However, our method should be
applicable to those studies also.
Our method uses simultaneous optimized trans-
mission and ﬂuorescent light sources. The results
showed that the added light source had very small ef-
fect on the detected ﬂuorescent signal. However, the
method is producing additional light load to the ﬂuo-
rescent dye and cells and thus photobleaching of the
dye and phototoxicity should be considered. As our
method uses no ﬂuorescent signal background correc-
tion, it is straightforward to compute and free from
possible correction errors.
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CONCLUSION
We have developed and evaluated a protocol for
simultaneous calcium and motion signal measurement.
By measuring the same motion from videos with and
without ﬂuorescence, we were able to validate and
quantify the accuracy of a simultaneous measurement.
Our results show that MQD based PIV is minimally
aﬀected by ﬂuorescence. Furthermore, by measuring
the calcium transients with and without background
light, we showed that simultaneous brightﬁeld imaging
causes minimal interference to the calcium measure-
ment. This is the ﬁrst time simultaneous measurements
of video-based CM motion with ﬂuorescent dye based
calcium transients are conducted without ﬂuorescent
video background corrections. It opens a new avenue
to study the simultaneous ionic and biomechanical
functions and the diﬀerences in their dynamics.
Our demonstration of simultaneous measurement
implies that combined imaging is applicable also with
other ﬂuorescent reporters. Combining the measure-
ment of motion would provide an additional layer of
information for ﬂuorescence studies. All these will
open a new door to greater understanding of elec-
tromechanical coupling in CM contraction, disease
mechanisms and drug eﬀects.
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